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1. Introduction 
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1 Introduction 
The overarching goal of epidemiology is to study the etiology of diseases. Diseases with 
substantial genetic components are called heritable diseases and are clustered into 
monogenic and complex diseases.  
Monogenic diseases are typically rare and caused by mutations in a single gene. 
Examples for monogenic diseases are Cystic Fibrosis, Huntington's disease, Sickle cell 
anemia or the fragile X syndrome.  
In contrast, complex diseases are characterized by a complicated interplay of multiple 
genetic and environmental factors. They are also referred to as multifactorial diseases. 
Examples for complex diseases are common diseases such as cancer, diabetes, 
cardiovascular disease, asthma, psychiatric illnesses, inflammatory diseases or obesity. 
Single genetic factors typically contribute very little to the development of complex diseases. 
However, an accumulation of multiple small but disadvantageous genetic factors in 
combination with environmental factors that may further be interacting with each other 
contributes substantially to the development of complex diseases.  
Genetic epidemiology is the scientific field that aims to unravel the complicated 
interplay of genetic and environmental factors that influence complex disease development 
(Khoury, Beaty, & Cohen, 1993). Revealing the underlying genetic mechanism is pivotal for 
understanding disease etiology and may lead to novel therapies, improved prediction or 
targeted prevention programs.  
1.1 Obesity and genetics of obesity 
Over the past decades, obesity has become one of the world’s major healthcare problems 
(Caballero, 2005). In particular the westernized countries have developed highly obesogenic 
environments that have led to a sharp increase in obesity prevalence: In Germany, more 
than 37% of individuals are estimated to be overweight (body mass index, BMI ≥ 25 kg/m2 
and BMI < 30 kg/m2) and another 20% are estimated to be obese (BMI ≥ 30 kg/m2) (Rubner-
Institut, 2008). Obesity is strongly associated with mortality, an association that is mediated 
through increased risk for different morbidities, such as cardiovascular diseases (e.g., 
coronary heart disease), metabolic diseases (e.g., type 2 diabetes), psychiatric diseases 
(e.g., depression), or cancer (Haslam & James, 2005; Samanic, Chow, Gridley, Jarvholm, & 
Fraumeni, 2006). Due to its severe consequences, obesity has overcome the impact of 
smoking and drinking on individual health and on total healthcare costs (Moriarty et al., 2012; 
Sturm, 2002).  
1. Introduction 
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 Obesity can generally be classified into two categories that are independently 
associated with increased risk for morbidity and mortality (Pischon et al., 2008): Overall 
obesity as measured by BMI reflects total body mass and central obesity as measured by 
waist circumference or waist-hip ratio (WHR) reflects abdominal obesity or body fat 
distribution.   
Obesity risk as well as BMI and WHR are known to be influenced by environmental 
factors, such as sex, age, smoking, nutritional factors and physical activity. For example, the 
obesity prevalence is generally higher in women than in men (Lovejoy, Sainsbury, & Stock 
Conference Working, 2009). Considering life course, men slowly accumulate fat around the 
waist, whereas women store more fat around hips at younger ages and begin to accumulate 
more fat around the waist after menopause, when estrogen levels drop (Kirchengast, 2010; 
Loomba-Albrecht & Styne, 2009). Furthermore, moderate smokers display lower body 
weight, lower BMI, but higher waist circumference than non-smokers and gain weight after 
smoking cessation (Chiolero, Faeh, Paccaud, & Cornuz, 2008). Notably, heavy smokers 
display increased weight and BMI, which may be due to an accumulation of risky behaviors, 
such as low physical activity or high caloric intake that overcomes the BMI decreasing effect 
of moderate smoking on obesity measures. Finally, a reasonable diet and increased physical 
activity lowers the risk of obesity and related diseases (Lakka & Bouchard, 2005), but both is 
incredibly difficult to implement into obese persons’ life styles.   
Both, overall and central obesity, involve substantial genetic components comprising 
high estimates of heritability (i.e., phenotypic variance explained by genetics, typically >70% 
for BMI, and >45% for WHR) (Farooqi & O'Rahilly, 2000; Rose, Newman, Mayer-Davis, & 
Selby, 1998; Zaitlen et al., 2013).  
Although obesity can generally be classified as a common complex disease, there are 
also some rare monogenic forms of obesity.  
The prominent melanocortin-4 receptor (MC4R) gene has multiple implications in 
obesity. Generally, MC4R acts in the central melanocortinergic system and regulates food 
and energy intake (Adan et al., 2006). On the one hand, a single rare mutation in MC4R 
gene was shown to cause a specific monogenic form of childhood obesity (Farooqi et al., 
2003). On the other hand, a common variant located near the MC4R gene (present in ~24% 
of the general population) was shown to be associated with increased BMI (Loos et al., 
2008). Although the single common MC4R variation explained only ~0.10% of the total BMI 
variation, it helped highlighting an interesting biological pathway: The common risk variant 
showed decreased MC4R protein levels in the hypothalamus that leads to increased appetite 
and decreased satiety (Qi, Kraft, Hunter, & Hu, 2008). Therefore, MC4R agonists are 
interesting candidates for the pharmacological development of drugs to treat not only rare 
monogenic forms but also the common form of obesity (Adan et al., 2006).  
1. Introduction 
7
Another prominent obesity gene that illustrates the complex interplay of genetic and 
environmental factors is the ‘fat mass and obesity associated’ (FTO) gene. Initially identified 
for its association with type 2 diabetes (T2D), follow-up analyses adjusted the T2D 
association for BMI and showed that the T2D association of the common FTO variant 
disappeared (Frayling et al., 2007). This suggested that the impact of the common risk 
variant in FTO (present in ~42% of the general population) on T2D was mediated through 
obesity. Functional follow-up studies using gene knock-out mice revealed that FTO variants 
were implicated in energy homeostasis (Fischer et al., 2009). This was one of the first 
successful attempts to translate genetic epidemiology association study results into 
functional processes and consequences affecting body weight regulation. Finally, one of the 
first gene-environment interactions highlighted for obesity was observed for FTO: The effect 
of FTO variants on obesity risk was shown to be attenuated by higher physical activity levels 
(Andreasen et al., 2008).  
Besides physical activity, other environmental factors such as sex, age, smoking or 
nutrition may modify genetic effects on obesity and may – at least in part – explain known 
differences in obesity measures between men and women, between smokers and non-
smokers, between individuals on high-calorie and low-calorie diet or explain the changes in 
body shape over life course. 
In summary, these examples illustrate the importance to investigate the genetic 
underpinning of obesity to further the understanding of involved mechanism that may 
ultimately lead to improved therapeutic options.  
1.2 Genetic association studies 
The aim of genetic association studies is to identify association between genetic variation 
and an outcome of interest, such as disease (e.g., type 2 diabetes) or disease-relevant 
parameters (e.g., BMI). The outcome is referred to as phenotype in the following.  
The most frequent forms of genetic variation in the Deoxyribonucleic Acid (DNA) are 
single nucleotide polymorphisms (SNPs). Each SNP denotes a single base-exchange that 
originated at some point during evolution and is located at a specific position in the DNA 
sequence (Figure 1). Most SNPs are bi-allelic comprising two possible nucleotide variations, 
also referred to as alleles. The combination of two alleles - one on the maternal and one on 
the paternal chromosome - makes up the so-called genotype of the SNP for a specific 
person. SNPs are called common if the less frequent allele (i.e., minor allele) is present in at 
least 5% of individuals in a population. Less frequent SNPs are called rare. More than 60 
million SNPs are known to date including approximately 10 million SNPs with minor allele 
frequency (MAF) greater than 1% (Sherry et al., 2001). 
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Figure 1. Schematic presentation of two SNPs. Shown are the coding and the 
complementary strand for both versions of chromosome 1 (paternal and maternal 
chromosome 1).  
 
 
In the early 2000s, SNP-phenotype associations have mainly been identified through 
hypothesis-driven candidate-gene approaches. Such approaches require a-priori knowledge 
on the biology of the phenotype and on the possible implications of potential candidate 
genes. The problem with this approach was that it required choosing the right candidate 
gene in advance, a process that can be difficult because the decision has to be made on the 
current state of knowledge, which may be limited. Overall, candidate-gene approaches were 
often unsuccessful, mostly because wrong candidates were chosen or because the power of 
single candidate-gene studies was too low.  
Instead, genome-wide association studies (GWAS) have recently been found to be 
more efficient. GWAS are hypothesis-free approaches that simultaneously screen a dense 
field of millions of SNPs - spread across the whole genome - for association. Importantly, to 
avoid large numbers of false positive findings, GWAS require rigorous control for the multiple 
testing of millions of variants.  
GWAS were only yet enabled through technical advances in genotyping since 2005 
(Hirschhorn & Daly, 2005). Improved chip-based microarray technologies nowadays allow 
study centres to effectively assess one million or more SNPs for large studies including 
thousands of individuals. A large number of genotyping chips have been developed over the 
past years (Distefano & Taverna, 2011). Besides genome-wide chips that cover SNPs 
equally spread across the whole genome, customized genotyping chips were designed that 
fine-map particular regions of interest. For example, the MetaboChip specifically covers 
regions associated with metabolic disorders, including obesity (Voight et al., 2012).  
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Besides advances in direct genotyping chip technologies, genotype imputation has 
largely contributed to the success of GWAS (Y. Li, Willer, Sanna, & Abecasis, 2009). 
Imputation methods allow for inferring unmeasured variants on the basis of reference 
sequence data. Imputation is pivotal for comparing association results across studies with 
different genotyping platforms. Over the past years, almost all GWAS have used imputed 
data with up to ~2.5M variants based on HapMap reference panels (International HapMap, 
2005).  
A challenge in GWAS is that genetic effects are typically small. For example, in 
obesity, the largest genetic effect observed for BMI (near FTO) explains only ~0.34% of the 
total BMI variation (Speliotes et al., 2010). Medium genetic effects on BMI are even smaller 
by ten-fold and explain only ~0.04% of the BMI variation. Given the multiple testing burdens, 
identification of such subtle effects necessitates large sample sizes and single GWAS 
involving ~1,000 individuals are often underpowered.  
One way to increase power to detect small genetic effect sizes is to pool multiple 
GWAS in so-called genome-wide association meta-analyses (GWAMAs). Meta-analysis of 
aggregated statistics across multiple studies and for each SNP genome-wide allows for 
increasing power when an individual participant data analysis is not possible. This is typically 
the case in genetic studies because study partners are most often not allowed to share 
individual level participant genotype data due to ethical constraints. Over the past years, 
many GWAMA consortia have emerged and multiplied the total sample size for several 
diseases and disease-relevant parameters. For example, one of the largest GWAMA 
consortia worldwide is the Genetic Investigation of Anthropometric Traits (GIANT) 
consortium. GIANT has set out to investigate the genetic underpinning of anthropometric and 
obesity traits (primarily focusing on height, BMI and WHR) involving hundreds of single 
GWAS and hundreds of thousands of individuals altogether.  
Taken together, GWAS and GWAMAs have successfully been employed over the 
past years and have led to a major increase in the number of known SNP-phenotype 
associations (Visscher, Brown, McCarthy, & Yang, 2012; Welter et al., 2014). So far, more 
than 14,000 SNP-phenotype associations have been reported that are accessible through 
publicly available data bases, such as the GWAS catalogue (Hindorff et al., 2009).  
Yet, despite the large success of GWAS, a substantial fraction of the heritability still 
remains unexplained for most phenotypes (Manolio et al., 2009). A fraction of the missing 
heritability might be explained by rare variants (MAF < 5%, expected to yield larger effect 
sizes than common variants) or by structural variation (e.g., copy number variants such as 
insertions or deletions), both of which have mostly been missed due to low power or due to 
unsuitable array designs (genotyping arrays primarily focused on common variants, i.e., 
SNPs with MAF > 5%). Detecting rare variant or structural variation effects requires 
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systematic screens that employ novel genotyping arrays as well as denser imputation 
reference panels. 
Another fraction of the missing heritability might be explained by gene-environment 
interaction effects that have been missed and ignored by the commonly conducted genome-
wide scans focussing on overall associations. Detecting gene-environment interaction effects 
requires systematic screens that employ large sample sizes, extended statistical methods 
and software tools that are applicable to large-scale genome-wide data sets. Yet, such 
methods are poorly understood and software tools are lacking.  
1.3 Statistical models and methods for genetic association 
studies 
The following chapter introduces statistical models and concepts of SNP-phenotype 
association testing, GWAS and GWAMAs.  
1.3.1 The linear regression model 
A general SNP-trait association test is based on regression methods that fit a Generalized 
Linear Model (GLM). A GLM allows for correcting for potential confounders by using 
additional covariables. For a continuous phenotype  𝑌 , a linear regression model is 
considered: 
𝑌 = ∝ +𝛽𝐺 + 𝛽𝐶1𝐶1 +⋯𝛽𝐶𝑘𝐶𝑘 +  𝜀,      𝜀~𝑁(0, 𝜎
2) (1). 
Here, 𝐺  denotes the SNP genotype, 𝐶𝑖  are the co-variables, 𝛼  is the intercept of the 
regression model, 𝛽  the genetic effect on   𝑌 , and 𝜀  a random error variable, also called 
residual. The linear regression model is based on some important assumptions that involve 
(i) lack of auto-correlation (i.e., residuals are assumed to be independent and to follow a 
normal distribution with zero mean and residual variance 𝜎2), (ii) homoscedasticity (i.e., the 
residual variance is assumed to be constant across genotype), and (iii) a linear and additive 
relationship between genotypes and phenotypes. To ensure comparability of the phenotype 
across studies, one approach is to normalize (or to standard normalize) the phenotype per 
study which yields 𝑌~𝑁(𝜇𝑌 , 𝜎𝑌
2) (or 𝑌~𝑁(0,1)).  
 In genetic epidemiology, regression models are usually adjusted for other 
epidemiological factors (added as co-variables) that either have an impact on the phenotype 
or have an impact on both, the phenotype and the genotype.  
Adjusting for factors that are known to influence the phenotype (only) reduces the 
phenotypic variance by the proportion that is explained through the respective co-variable 
and as such increases the power to find the genotype-phenotype association. For example, 
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due to their well-known influence on anthropometric traits, GIANT requests contributing study 
partners to adjust for sex and age.  
Adjusting for factors that are known to influence both the phenotype and the genotype 
(i.e., confounders), prevents from observing an association between genotype and 
phenotype that is actually driven by the hidden confounding variable. Genetic association 
models are usually adjusted for potential confounding through population stratification that 
reflects systematic diversities between population substructures. To avoid such confounding, 
in many cases the first ten independent genotype dimensions (principle components) are 
added to the regression model as co-variables.  
1.3.2 SNP genotype models 
Usual genotype models are the recessive, the dominant and the additive model. Consider a 
SNP with two alleles: Major allele A denoting the more frequent allele, and minor allele a 
denoting the less frequent allele. For a specific SNP, an individual can take three possible 
genotype states: AA (two copies of the major allele), Aa (one copy of the major and one of 
the minor allele) and aa (two copies of the minor allele).  
The dominant model implies that individuals with one or two copies of the minor allele 
exhibit the phenotype (with equal probability). Thus, the genotype variable is coded G = 0 for 
genotype AA and coded G = 1 for genotypes Aa and aa.  
The recessive model implies that only individuals with two copies of the minor allele 
exhibit the phenotype. Thus, the genotype variable is coded G = 0 for genotypes Aa and AA, 
and coded G = 1 for genotype aa. 
The commonly used additive model implies that the probability to exhibit the 
phenotype increases linearly with each additional copy of the minor allele. Thus, the 
genotype variable is coded G = 0 for genotype AA, G = 1 for genotype Aa and G = 2 for 
genotype aa. With MAF being the minor allele frequency of a particular SNP, the additively 
modelled SNP genotypes 0,1 and 2 occur with probabilities (1–MAF)2, 2MAF(1–MAF) and 
MAF2, respectively, if Hardy-Weinberg equilibrium is fulfilled (Edwards, 2008). For large 
sample sizes, the binomial genotype distribution approximates a normal distribution with 
genotypic mean 𝜇𝐺 = 2 ∙ 𝑀𝐴𝐹 and genotypic variance 𝜎𝐺
2 = 2𝑀𝐴𝐹(1 −𝑀𝐴𝐹).  
1.3.3 SNP association testing 
To infer whether the modelled SNP genotype is associated with the phenotype, i.e., whether 
the genetic effect on Y - estimated from the regression model - is significantly different from 
zero, a t test can be conducted that compares the null hypothesis 𝐻0: 𝛽 = 0versus the 
alternative hypothesis 𝐻𝐴: 𝛽 ≠ 0. Herewith, a test statistic  𝑇 = 𝑏/𝑠𝑒(𝑏) is employed, where n 
is the sample size, b is the observed genetic effect estimate of β, and se(b) the standard 
1. Introduction 
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error of b. Assuming the nulll hypothesis, the test statistic T follows a t distribution with n-2 
degrees of freedom (df), i.e., 𝑇 ~ 𝑡(𝑛 − 2)|𝐻0. The t test yields a SNP association P-Value P.  
1.3.4 Genome-wide association studies 
In GWAS, the association testing is conducted separately and simultaneously for the millions 
of SNPs available for a study. To avoid huge numbers of false positive findings, SNP-specific 
association results are corrected for the multiple testing. Typically in HapMap imputation 
based GWAS, a conservative genome-wide significance threshold of  = 5 x 10-8 is applied 
that Bonferroni-corrects the usual 5% -level for an approximate number of one million (1M) 
independent SNP association tests (Johnson et al., 2010).  
1.3.5 Genome-wide association meta-analyses 
For each SNP, each GWA study j provides study-specific summary estimates such as the 
genetic effect estimate 𝑏𝑗, the corresponding standard error 𝑠𝑒(𝑏𝑗), the association P-Value 
 𝑃𝑗 and the sample size 𝑛𝑗. To obtain pooled genetic effect estimates and standard errors for 
each SNP, an inverse-variance weighted meta-analysis can be conducted, computing 
𝑏 =
∑ 𝑏𝑗/𝑠𝑒(𝑏𝑗)2𝑗
∑ 1/𝑗 𝑠𝑒(𝑏
𝑗
)2
   and  𝑠𝑒(𝑏) = √
1
∑ 1/𝑗 𝑠𝑒(𝑏
𝑗
)2
 
(2). 
In the meta-analytical setting, b and se(b) are referred to as pooled genetic effect estimate 
and pooled standard error. As in single study association testing, a t test statistic 𝑇 =
𝑏/𝑠𝑒(𝑏)~ 𝑡(𝑛 − 2)|𝐻0  is utilized to infer, whether the pooled genetic effect is significantly 
different from zero. The t test yields a pooled overall association P-Value P. The meta-
analysis formulae (2) assume a fixed effect model across studies. For homogeneous genetic 
effects across studies, the pooled genetic effect estimates and standard errors are 
approximately the same as the genetic effect estimates and standard errors obtained from a 
single regression model using one large study involving all individuals (Behrens, Winkler, 
Gorski, Leitzmann, & Heid, 2011).   
1.4 Genome-wide association meta-analyses for obesity 
traits: The GIANT consortium 
One of the largest GWAMA consortia worldwide is the Genetic Investigation of 
ANthropometrics Traits (GIANT) consortium (Figure 2). This consortium has set out to 
describe the genetic underpinning of anthropometric and obesity traits. For the obesity traits, 
the primary focus is on body mass index (BMI, as a measure of overall obesity) and on waist 
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hip ratio adjusted for BMI (WHRadjBMI, as a measure of central obesity that is independent of 
BMI).  
Since 2006, GIANT has published multiple rounds of meta-analyses on these primary 
traits, with each round iteratively increasing the total sample size, increasing the total number 
of studies involved, adding novel genotyping chip technologies and incorporating larger 
imputation reference panels (Heid et al., 2010; Lindgren et al., 2009; Loos et al., 2008; 
Speliotes et al., 2010; Willer et al., 2009). In 2010, the number of identified loci was raised to 
32 for BMI (using discovery GWAS data from up to 123,865 individuals) and to 14 for 
WHRadjBMI (using discovery GWAS data from up to 77,167 individuals).  
 
 
 
Figure 2. GIANT consortium studies involved in the 2010 meta-analyses (for more 
information see the GIANT consortium website, www.broadinstitute.org/collaboration/giant). 
 
 
Due to the known sex-differences in obesity measures, the identified loci were 
investigated for sex-differences in consecutive follow-up analyses (using men- and women-
specific GWAS results that have been provided by the study partners). No significant sex-
difference was observed in any of the 32 detected BMI loci. In contrast, seven of the 14 
overall associated WHRadjBMI loci were found to be sex-specific, and all of the seven 
displayed significantly stronger effects in women than in men (Heid et al., 2010). 
Remarkably, these sex-differences were detected for variants that were initially identified for 
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overall association, an approach that might have missed other sexually dimorphic variants. 
Thus, a systematic genome-wide screen to identify sex-differences in genetic effects of 
anthropometric traits was warranted.  
In addition, further GIANT projects were initiated to investigate whether other obesity 
risk factors modify the genetic effect on obesity traits. These include GWAMAs stratified by 
smoking status (non-smokers vs. current smokers), stratified by physical activity status 
(inactive vs. active), as well as stratified by age and sex (men≤50y vs. women≤50y vs. 
men>50y vs. women>50y). The latter project aims to investigate whether genetic variation 
contributes to the age-dependent decrease (after menopause in women) in sex-difference of 
body shape (Kuk, Saunders, Davidson, & Ross, 2009; Wells, 2007). In order to reflect 
menopause in women, age was dichotomized at 50 years of age (corresponds to mean age 
of menopause in women).   
Unraveling such stratum-differences in genetic effects is key to improve the 
understanding of the genetic underpinning of obesity, key to explain some of the missing 
heritability, and may be key to identify novel therapeutic opportunities.  
1.5 Gene-strata interaction effects in genetic association 
studies 
Genetic effects that differ between strata (e.g., between men and women) can equivalently 
be denoted as gene-strata (G x S) interaction effects. G x S interaction effects are a specific 
form of gene-environment interaction effects that involve a dichotomous environmental 
(stratification) variable S (e.g., SEX coded as 0/1 for men/women). Such effects modify the 
genetic effect on a phenotype between strata, a circumstance that can reduce power to find 
the overall (strata-combined) effect in the overall GWAMA (Behrens et al., 2011). So far, 
many GWAS and GWAMA projects have focused on overall effects, while ignoring G x S 
interaction effects that might explain a substantial fraction of the missing heritability.  
The following chapters introduce statistical models and available methods to account 
for and to identify G x S interaction effects given the GWAMA setting.  
1.5.1 Modelling gene-strata interaction effects in large-scale GWAMAs 
Assuming the large-scale GWAMA configuration, G x S interaction effects can either be 
modelled by conducting a stratified GWAMA or by conducting an interaction GWAMA 
(Figure 3). In the following, considerations are limited to linear regression models involving 
continuous phenotypes Y, additively modeled genotypes G and dichotomous stratification 
variables S.  
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Figure 3. Modelling G x S interaction effects in large-scale GWAMAs.  
 
 
The interaction GWAMA model – involving a single dichotomous environmental 
variable S - is given by the regression model that includes a G x S interaction term:   
𝑌 = 𝛼 + 𝛽𝐺𝐺 + 𝛽𝑆𝑆 + 𝛽𝐺𝑥𝑆𝐺𝑥𝑆 + 𝜀,      𝜀~𝑁(0, 𝜎
2) (3). 
Here, 𝛽𝐺 is the genetic effect on the phenotype, 𝛽𝑆 the effect of the stratification variable on 
the phenotype, and 𝛽𝐺𝑥𝑆 the G x S interaction effect on the phenotype. For each SNP, each 
study fits the interaction model and obtains study-specific effect and interaction estimates 
with standard errors. Pooled genetic effect estimates bG and pooled G x S interaction effect 
estimates bGxS are obtained from inverse-variance weighted meta-analyses of the respective 
study-specific estimates. Testing for G x S interaction effects can be accomplished by 
performing a t test on the pooled interaction estimates bGxS.  
Assuming two strata, the stratified GWAMA model involves two linear regression 
models (one for each stratum):   
𝑌1 =∝1+ 𝛽1𝐺1 + 𝜀1,      𝜀1~𝑁(0, 𝜎1
2) 
𝑌2 =∝2+𝛽2𝐺2 + 𝜀2,      𝜀2~𝑁(0, 𝜎2
2) 
(4). 
The stratification is done by a dichotomous variable that separates each study sample into 
two subgroups. A stratum-specific regression model is fitted for each SNP and in each study 
separately yielding stratum-specific effect estimates with standard errors. Pooled stratum-
specific genetic effect estimates, b1 and b2, are obtained from stratum-specific inverse-
variance weighted meta-analyses. Testing for G x S interaction can be accomplished by 
testing the pooled stratum-specific estimates for difference (Randall et al., 2013). 
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1.5.2 Methods to account for and to identify gene-strata interaction 
effects 
When defining methods to tackle G x S interaction effects, it is extremely important to 
distinguish between two major aims: On the one hand one might be interested in methods to 
identify SNP effects while accounting for interaction; on the other hand one might be 
interested in detecting the interaction per se for a specific locus.  
Several methods have been described that improve power to identify SNP effects 
while accounting for interaction. For example, the simple approach of stratum-specific 
association testing (using the pooled stratum-specific estimates gathered from a stratified 
GWAMA) has been shown to improve power to find stratum-sensitive variants (Behrens et 
al., 2011). Other methods focus on the detection of joint (main + interaction) effects (Kraft, 
Yen, Stram, Morrison, & Gauderman, 2007) and those methods have recently been 
extended to the interaction GWAMA model (Manning et al., 2011) and to the stratified 
GWAMA model (Aschard, Hancock, London, & Kraft, 2010). Importantly, a significant joint 
effect does not automatically imply significant interaction. Disentangling whether a significant 
joint effect is due to main effect, interaction effect, or both, has to be outlined additionally. 
There is some concern as to whether this can be done using the obtained main and 
interaction estimates from the data set that was used for discovery of joint effects.  
Similarly, several methods have been described that aim at identification of gene-
environment interaction effects. However, most of the reported methods are tailored for 
single studies with dichotomous disease outcomes (D. Li & Conti, 2009; Mukherjee & 
Chatterjee, 2008; Piegorsch, Weinberg, & Taylor, 1994). Their applicability to continuous 
outcomes, and to the large-scale GWAMA setting, may be limited and has not yet been 
shown. A structured and detailed comparison of GWAMA approaches - aiming at 
identification of G x S interaction effects for continuous outcomes - with regards to type 1 
error and power while considering varying types of interaction effects, study designs, and 
statistical tests, is lacking. For example, for the GIANT sex-stratified GWAMAs for WHRadjBMI, 
it is not yet clear what screening approach is optimal to identify loci with significant sex-
difference.  
1.6 Objectives 
Genome-wide association meta-analyses (GWAMAs) of obesity traits have proven to 
successfully pinpoint associated genetic variants. For example, in 2010, a large-scale 
GWAMA for WHRadjBMI (waist-hip ratio adjusted for BMI, as a measure of central obesity) 
detected significant associations at 14 genetic loci.  
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Interestingly, seven of the 14 loci displayed significantly stronger genetic effects in 
women than in men. Remarkably, these sex-differences were detected for variants that were 
initially selected for overall (sex-combined) association. Yet, a systematic genome-wide 
screen to identify variants displaying sex-difference was lacking and the dimension of sex-
differences in the genetics of anthropometric traits was unknown. Sex-stratified GWAS data 
had already been available at that time for most studies involved in the 2010 GIANT 
consortium meta-analyses. However, there was uncertainty as to what screening approach 
should be applied ideally to identify sex-difference from the available sex-stratified GWAS. A 
systematic methodological evaluation of approaches with regard to type 1 error and power to 
identify sex-difference was lacking.  
Additionally, two further GIANT projects were in planning that aimed at the 
identification of other stratum-differences in genetic effects for obesity traits. One project 
started to conduct a smoking-stratified GWAMA (to identify differences in genetic effects 
between current smokers and non-smokers), the other started to conduct an activity-status 
stratified GWAMA (to identify differences in genetic effects between physically active and 
inactive individuals). In contrast to the balanced sex-stratified GWAMA design (similar 
numbers of men and women involved) these two projects reflect an unbalanced design: For 
example there are fewer smokers than non-smokers available for the analyses. The impact 
of unequal stratum sizes on the identification of stratum-difference had not been clear.  
A further project was in planning that aimed to identify age- and sex-dependent 
genetic effects for obesity traits. The rationale behind this analysis was that body shape 
changes in women upon menopause (approximately at 50 years of age) resulting in a more 
android body shape that is less different from men. Age- and sex-stratified GWAMAs (four 
strata: younger men, older men, younger women, older men; age stratified at 50 years of 
age) were supposed to be employed to investigate potential 3-way G x AGE x SEX 
interaction effects. But again, there was uncertainty as to what approach should be applied to 
ideally find such 3-way interaction effects from the age- and sex-stratified GWAMA results.  
 Finally, large-scale stratified GWAMAs are high-dimensional complex analyses. For 
example, GIANT involves multiple stratified GWAS results (each carrying millions of SNP-
specific association test results) from hundreds of studies, for multiple genotyping platforms 
and imputation reference panels, for multiple anthropometric and obesity traits as well as for 
multiple environmental stratification variables. This involves the handling of thousands of 
individual GWAS result files - each with millions of SNP-specific association testing results. 
Ensuring validity of each single GWAS result and of the obtained GWAMA result requires 
extended quality control procedures and software that is able to cope with thousands of large 
association result files. Furthermore, software was required that provides extended statistical 
and graphical functionality to evaluate stratified GWAMA results.  
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To address the described research gaps, the four main objectives of this work were defined 
as follows: 
1. Develop and improve stratified GWAMA approaches to identify difference in genetic 
effects between two strata (chapter 2). 
2. Extend methods to identify 3-way G x AGE x SEX interaction effects from an age- 
and sex-stratified GWAMA (chapter 3). 
3. Apply optimized methods to stratified GWAMA results from the GIANT consortium 
(chapter 4).  
4. Develop software to facilitate quality control and statistical evaluation of stratified 
GWAMAs (chapter 5). 
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2 Stratified GWAMA approaches to screen for 
difference between two strata  
Generally, stratum-difference is defined as the difference in genetic effects between two 
strata (e.g., men and women). The overarching aim of the following chapter is to provide a 
systematic methodological evaluation of stratified GWAMA screening approaches that are 
based on two strata and aim at identifying stratum-difference.  
Generally, an approach is defined here as a combination or concatenation of multiple 
statistical tests (i.e., steps) that are applicable to stratified GWAMA outcomes and that are 
implemented in one or two independent data sets (i.e., stages). Relevant statistical tests are 
introduced and a systematic scheme of approaches is presented.  
The performance of the approaches was compared by simulation-based estimation of 
type 1 error and by analytical computations of power. Varying realistic scenarios were 
considered and an attempt to recommend approaches - based on study design and based 
on type of stratum-difference - was made.  
Three general types of stratum-difference were defined (Figure 4). Assuming an 
effect in one stratum (e.g., women), the effect in the other (i.e., men) may be opposite 
(opposite effect direction, OED), lacking (single-stratum effect, SSE) or be concordant but 
less pronounced (concordant effect direction, CED).  
 
 
 
Figure 4. Different types of stratum-specific effects on the example of sex-difference 
(assuming a positive effect in women).   
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2.1 Materials and Methods 
The following chapters describe the prerequisites of the methodological evaluation of 
stratified GWAMA approaches to identify stratum-difference.  
After presenting general assumptions (chapter 2.1.1), relevant statistical tests are 
introduced (chapters 2.1.2 and 2.1.3) and then used to construct several screening 
approaches (chapter 2.1.4). A systematic scheme of approaches was developed that is 
utilized to compare performance (type 1 error and power) between approaches. Details 
about the simulation-based type 1 error evaluation (chapter 2.1.5), the derivation of analytical 
power formulae as well as about the analytical power computations (chapter 2.1.6), are 
presented.  
2.1.1 Assumptions and definitions 
In the following, considerations are based on a stratified GWAMA model involving two strata 
(as given by equation (4)), a continuous phenotype (e.g., WHRadjBMI), a dichotomous 
stratification variable (e.g., sex) and additively modeled genotypes. It is assumed that the 
stratified GWAMAs have already been conducted so that pooled stratum-specific effect 
estimates and standard errors are available.  
Stratum-specific continuous phenotypes are assumed to follow identical normal 
distributions, 𝑌1~𝑁(𝜇𝑌, 𝜎𝑌
2) and 𝑌2~𝑁(𝜇𝑌, 𝜎𝑌
2).  
Similarly, stratum-specific additively modeled genotypes 𝐺1 and 𝐺2 are assumed to 
follow equal genotype distributions across strata implying identical minor allele frequencies 
(MAF) and thus identical genotype means 𝜇𝐺 = 𝜇𝐺1 = 𝜇𝐺2 = 2𝑀𝐴𝐹  and identical genotype 
variances 𝜎𝐺
2 = 𝜎𝐺1
2 = 𝜎𝐺2
2 = 2𝑀𝐴𝐹(1 −𝑀𝐴𝐹). This assumption builds upon the assumption of 
random mating between strata.  
Importantly, the GWAMAs are assumed to only include GWAS from similar 
populations. Similar populations involve equal MAF across studies. This implies equal 
genotype distributions and homogeneous genetic effects across studies. Based on this 
assumption, meta-analysis of multiple study-specific SNP summary statistics yields 
approximatively identical results as a ‘mega-analysis’ of all individuals in one single large 
study (Evangelou & Ioannidis, 2013). Therefore, the meta-analysis concept was ignored in 
the following and one large study involving all individuals was assumed. 
A sex-stratified GWAMA is defined as men- and women-specific GWAMA involving 
equal sex-specific sample sizes,  𝑛𝑀 = 𝑛𝐹. For a general stratified GWAMA, stratum-specific 
sample sizes are allowed to be unequal, 𝑛2 = 𝑓 ∙ 𝑛1, where f is the ratio of stratum 2 sample 
size to stratum 1 sample size (f = 1 for the sex-stratified GWAMA setting). 
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2.1.2 Testing for stratum-difference 
To investigate stratum-difference given a stratified GWAMA model with two strata, a 
difference test can be conducted that compares the pooled stratum-specific genetic effect 
estimates (𝐻0: 𝑏1 = 𝑏2): 
𝑍𝐷𝑖𝑓𝑓 =
𝑏1 − 𝑏2
√𝑠𝑒(𝑏1)
2
+ 𝑠𝑒(𝑏2)
2
~𝑁(0,1) |𝐻0 (5). 
Assuming the null hypothesis being true, the z statistic follows a standard normal distribution. 
The z test yields the difference P-Value PDiff.  
Under the assumption of independent samples, unrelated subjects and no latent 
covariate interacting with S (the stratification variable), the difference test is mathematically 
equivalent to testing the pooled G x S interaction estimate bGxS obtained from an interaction 
GWAMA model (as given by equation (3)).  
In order to correct for potential correlation between stratum-specific effects b1 and b2, 
an alternative of the difference test can be employed: 
𝑍𝐷𝑖𝑓𝑓 =
𝑏1 − 𝑏2
√𝑠𝑒(𝑏1)
2
+ 𝑠𝑒(𝑏2)
2
− 2𝑟 ∙ 𝑠𝑒(𝑏1) ∙ 𝑠𝑒(𝑏2)
~𝑁(0,1) |𝐻0 (6). 
Here, r denotes the Spearman rank correlation between b1 and b2 that is estimated from the 
two stratum-specific genome-wide data sets. For example, such correlation could stem from 
family studies that contribute related individuals to both strata, e.g., brothers and sisters 
contributing to a sex-stratified GWAMA. Such relatedness would result in ‘less different’ 
effect estimates, increased type 2 error and deflated PDiff. The correction should only be used 
with genome-wide data sets that allow for accurate estimation of the correlation.  
In the following, unrelated subjects across strata are assumed and stratum-specific 
estimates b1 and b2 are assumed to be uncorrelated. 
2.1.3 Statistical tests to filter stratified GWAMA data sets prior to 
difference testing 
Often in GWAMA literature, the difference (or interaction) testing is limited to SNPs that were 
initially selected using other statistical tests, such as stratum-specific, overall or joint (main + 
interaction) association tests (Heid et al., 2010; Manning et al., 2012; Randall et al., 2013). 
For example, Heid and colleagues primarily screened for overall (strata-combined) 
associated variants for WHRadjBMI, and subsequently tested the identified (overall associated) 
SNPs for sex-difference.  
 In order to construct stratified GWAMA approaches that reflect such analyses, three 
filtering tests are considered that can directly be applied to stratified GWAMA outcomes b1 
and b2, with respective standard errors se(b1) and se(b2): 
2. Screening for difference between two strata 
22 
 A stratified test can be performed to infer whether any of the stratum-specific effects is 
associated with the phenotype (𝐻0: 𝑏1 = 0 ∧ 𝑏2 = 0): The stratified test employs two t 
tests, 𝑇1 = 𝑏1/𝑠𝑒(𝑏1)~𝑡(𝑛1 − 2) |𝐻0  and  𝑇2 = 𝑏2/𝑠𝑒(𝑏2)~𝑡(𝑛2 − 2) |𝐻0 , that yield stratum-
specific association P-Values, P1 and P2. Finally, a stratified association P-Value is 
defined as PStrat = 2*min(P1,P2), which is corrected for the multiple testing of two strata.  
 An overall test can be performed to infer whether the overall (strata-combined) effect is 
associated with the phenotype (𝐻0: 𝑏𝑂𝑣𝑒𝑟𝑎𝑙𝑙 = 0):  
 𝑇𝑂𝑣𝑒𝑟𝑎𝑙𝑙 =
𝑏𝑂𝑣𝑒𝑟𝑎𝑙𝑙
𝑠𝑒(𝑏𝑂𝑣𝑒𝑟𝑎𝑙𝑙)
~𝑡(𝑛𝑂𝑣𝑒𝑟𝑎𝑙𝑙 − 2) |𝐻0 (7), 
where nOverall is the strata-combined sample size (𝑛𝑂𝑣𝑒𝑟𝑎𝑙𝑙 = 𝑛1 + 𝑛2), and where bOverall 
and se(bOverall) are the overall genetic effect estimate with standard error that are obtained 
from inverse-variance weighted meta-analysis of the two strata: 
𝑏𝑂𝑣𝑒𝑟𝑎𝑙𝑙 =
𝑏1 𝑠𝑒(𝑏1)
2⁄ + 𝑏2 𝑠𝑒(𝑏2)
2⁄
1 𝑠𝑒(𝑏1)2⁄ + 1 𝑠𝑒(𝑏2)2⁄
   
𝑠𝑒(𝑏𝑂𝑣𝑒𝑟𝑎𝑙𝑙) = √
1
1 𝑠𝑒(𝑏1)2⁄ + 1 𝑠𝑒(𝑏2)2⁄
 
(8). 
The t test yields the overall association P-Value POverall.  
 A joint test can be performed to infer whether the joint effect of both the main effect and 
the interaction effect is associated with the phenotype (𝐻0: 𝑏𝐺 = 0 ∧ 𝑏𝐺𝑥𝑆 = 0): 
𝐶𝐽𝑜𝑖𝑛𝑡 = (
𝑏1
𝑠𝑒(𝑏1)
)
2
+ (
𝑏2
𝑠𝑒(𝑏2)
)
2
~𝜒2(2) |𝐻0 (9). 
The chi-square test yields the joint-test P-Value PJoint. The joint test based on stratum-
specific effects originates from the joint test that simultaneously tests for main and 
interaction effects in an interaction model (Kraft et al., 2007). The two versions of the  
joint tests are identical, if the G x S interaction is modelled with dichotomized S (Aschard 
et al., 2010).  
2.1.4 A systematic scheme of stratified GWAMA approaches to identify 
stratum-difference  
The introduced statistical tests are used to construct several stratified GWAMA approaches, 
each of which aims at screening for variants with significant stratum-difference. Generally, an 
approach is designed with multiple steps (statistical tests). The last step of each approach is 
to test for difference. The stratified, the overall, or the joint test, are solely employed for 
filtering the genome-wide data sets prior to the difference testing. Multiple steps are either 
implemented within a single data set (1-stage design) or implemented within two 
independent data sets (discovery and replication data set, 2-stage design). For the 2-stage 
approaches, the filtering is conducted in the discovery stage data and difference testing is 
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either conducted using the replication stage data only (replication-based 2-stage approach) 
or using the combined (discovery + replication) stage data (combined 2-stage approach).  
To distinguish between approaches, a general notation is introduced: [.] indicates a 
stage and ‘Testα’ denotes the step-specific test and the respective -level. For example, 
[Overallα1→Diffαdiff] denotes a 1-stage approach that involves filtering on POverall < 1 and 
testing the selected SNPs for difference and that employs identical subjects for both steps. 
Alternatively, [Overallα1]→[Diffαdiff]  (or [[Overallα1]→Diffαdiff] ) denotes the respective 
replication-based 2-stage (or combined 2-stage) approach that involves testing the selected 
SNPs for difference using the replication (or combined discovery + replication) subjects.  
Based on this notation, a systematic scheme of the considered approaches was 
developed and summarized in Figure 5. 
 
 
 
Figure 5.  Systematic scheme of stratified GWAMA approaches to identify stratum-difference 
(gws:= 5 x 10
-8; 1 = -level for the filtering step; 2 = -level for the additional discovery filter 
on difference; Bonf = Bonferroni-corrected -level). 
 
 
Generally, all of the considered approaches aim at using Bonferroni-corrected -
levels for the final difference test, Bonf = 0.05/M, where M is the number of independent 
difference tests performed.  
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The most intuitive approach is the 1-stage approach [Diffαgws], which screens for 
difference at a genome-wide significance level, Bonf = gws = 5 x 10
-8 (= 0.05/106, Bonferroni-
corrected for an approximate number of one million independent tests). The genome-wide 
significance level is a well-established screening threshold in GWAS of HapMap imputed 
data (Johnson et al., 2010).  
Extending this intuitive approach to the 2-stage design, the difference test can either 
be implemented as a replication-based 2-stage approach [Diffα1]→[DiffαBonf]  or as a 
combined 2-stage approach [[Diffα1]→Diffαgws] . Due to employing a single statistical test 
(difference test), the design of the two approaches is similar to a general 2-stage GWAMA 
approach that screens for overall SNP association and for which the implementation into 
various 2-stage designs has been discussed before (Skol, Scott, Abecasis, & Boehnke, 
2006). For the replication-based 2-stage approach [Diffα1]→[DiffαBonf], it is well known that 
significance for the final test can be attained using a Bonferroni-corrected -level that is 
corrected for the independent number of SNPs tested (selected from the discovery data). For 
the combined (discovery + replication) 2-stage approach [[Diffα1]→Diffαgws] , overlapping 
subjects between ‘discovery stage SNP selection’ and ‘combined stage difference testing’ 
are used, which is why the -level of the final difference test has to be adjusted to the 
genome-wide significance level in order to yield valid type 1 error rates.  
Further approaches are considered that involve initial filtering on stratified, overall or 
joint association tests. Their implementation into 1- and 2-stage designs has to be validated 
with regards to type 1 error and their impact on power to find stratum-difference has to be 
investigated.  
For the replication-based 2-stage approaches, an additional discovery filter on 
difference is considered, e.g., for approach [Joint1e-5,Diff0.05]→[DiffαBonf], see Figure 5. The 
rationale behind this filter is that it increases power for the replication stage difference test by 
(i) lowering the multiple testing burden due to taking less SNPs forward, and (ii) by focusing 
on variants that are more likely to be truly dimorphic than variants that do not display any 
difference in discovery.  
Practically, common stratified GWAMA projects aim at identification of any type of 
stratum-difference and it is likely that the optimal approach varies by type of stratum-
difference. Thus, it is expected that multiple approaches have to be outlined in parallel in 
order to efficiently identify the various types of stratum-difference. In fact, this necessitates 
an additional multiple-testing correction for the final difference tests that have to be corrected 
for the number of screening approaches. Notably, each screening approach itself already 
employs a conservative Bonferroni-correction. Thus and in order to avoid overly conservative 
correction, such ‘final’ correction is ignored in the following.  
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Technically, single genetic loci contain multiple correlated SNPs that are all located 
nearby within a specific region. To avoid overly conservative control of the final difference 
test, the filtered subsets of SNPs are clumped into independent regions and region-wide 
lead-SNPs are selected that are independent of other lead-SNPs (from other regions). 
Commonly used clumping criteria are LD-based (e.g., pairwise r2 > 0.2, between SNPs of a 
specific region) or distance-based (e.g., distance < 500KB, pairwise between SNPs of a 
specific region). In the following, considerations are limited to a distance-based clumping 
criterion: distance < 500KB. The lead-SNP of a specific region is defined as the SNP with the 
lowest P-Value across all SNPs of the respective region. Importantly, the independent lead-
SNPs are those that are put forward and are tested for difference in the final step. The total 
number of selected lead-SNPs is denoted as M in the following (as introduced before). To 
correct for the multiple difference testing of M independent lead SNPs, the -level of the 
difference test undergoes a Bonferroni–correction, Bonf = 0.05/M (except for approaches 
[Diffα𝑔𝑤𝑠] and [[Diffα1]→Diffα𝑔𝑤𝑠] that employ genome-wide significant -levels for the final 
difference test).  
2.1.5 Simulation-based evaluation of type 1 error 
A simulation-based evaluation of type 1 error rates was performed for all of the defined 
approaches. Methodological details of the simulations are described in the following.  
Simulated data sets were created that follow the null hypothesis of ‘No difference in 
genetic effects between strata’ (𝐻0: 𝑏1 = 𝑏2 ). More specifically, two versions of the null 
hypothesis were created: One assumes lack of stratum-specific effects (𝐻0
𝑛𝑜𝑒𝑓𝑓𝑒𝑐𝑡: 𝑏1 = 𝑏2 =
0), the other assumes identical (unequal zero) stratum-specific effects (𝐻0
𝑒𝑓𝑓𝑒𝑐𝑡: 𝑏1 = 𝑏2 ≠ 0).   
First, real genotypes were obtained for 1,500 men and 1,500 women from the KORA 
study (Wichmann, Gieger, Illig, & Group, 2005) for one well-imputed SNP: rs8138968 (MAF = 
0.3).  
 Second, simulated sex-specific phenotypes (for the 1,500 men and 1,500 women) 
were created according to Y~N(0,1) (to reflect  𝐻0
𝑛𝑜𝑒𝑓𝑓𝑒𝑐𝑡
), and according to Y|G=0~N(0,1), 
Y|G=1~N(b80%,1)  and Y|G=2~N(2*b80%,1) (to reflect  𝐻0
𝑒𝑓𝑓𝑒𝑐𝑡
). Herewith, b80% corresponds to 
the minimum effect size detectable with 80% power by 1,500 samples (at  = 0.05), and 
G=0, G=1 or G=2 denote the group of individuals carrying 0, 1, or 2 minor alleles, 
respectively. Using G*Power, b80% was estimated to be 0.111 for rs8138968 (Faul, Erdfelder, 
Buchner, & Lang, 2009). 
Third, for each null hypothesis, the simulated phenotypes were sex-specifically tested 
for association with the real SNP genotypes. Men- and a women-specific genetic effect 
estimates, with standard errors and association P-Values, were derived.  
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Fourth, for each null hypothesis, the simulation and sex-specific association testing 
was repeated 1,000,000 times yielding 1,000,000 men- and women-specific genetic effect 
estimates, with standard errors and association P-Values.  
Finally, for each null hypothesis, the defined 1-stage approaches were applied to the 
respective 1,000,000 sex-specific genetic effect estimates. Herewith, the -level for the initial 
filtering was set to 1 = 0.05 (which corresponds to the estimation of b80%). For each 
approach, type 1 error rate (T1ER) of the final difference test was calculated by the 
proportion of nominally significant test results among all difference tests: T1ER = 
#(PDiff<0.05)/Mfilt, where Mfilt is the number of simulated data points passing the filtering 
(corresponding to the previously introduced M).  
To reflect the full range of allele frequencies, the described procedure was repeated 
for two further SNPs: rs6002481 (MAF = 0.02), and rs6007738 (MAF = 0.5). Again, well-
imputed real genotypes were taken from the KORA study. Again using G*Power, for the 
phenotype simulation of  𝐻0
𝑒𝑓𝑓𝑒𝑐𝑡
, b80% was estimated to be 0.364 and 0.102, for rs6002481 
and rs6007738, respectively.  
To investigate the type 1 error of the 2-stage approaches, the 1,500 men and 1,500 
women were split into two stages (yielding 750 men and 750 women for each stage), and the 
procedure was repeated by stage. Again using G*Power, for the phenotype simulation 
of  𝐻0
𝑒𝑓𝑓𝑒𝑐𝑡
, b80% was estimated to be 0.514, 0.157 and 0.144, for rs6002481, rs8138968 and 
rs6007738, respectively. Herewith, b80% reflects the minimum effect size that can be detected 
with 80% power by 750 samples (at  = 0.05).  
To investigate whether varying sample size between strata has a negative impact on 
type 1 error of the difference test, the procedure was repeated multiple times with fixed 
sample size in women (nF = 1,500) and varying sample size in men (nM = 150 to 1,500).  
2.1.6 Analytical computation of power  
Power comparisons aim at finding the best stratified GWAMA approach to identify stratum-
difference. First, analytical power formulae were derived for the single statistical tests, i.e., for 
the difference, the stratified, the overall, and for the joint test. Second, power formulae for the 
approaches were obtained by combining the respective test-specific power formulae.  
In order to model various types of stratum-difference, each formula was derived in 
dependence of stratum-specific explained variances 𝑅1
2  and  𝑅2
2 . Given the genotypic 
variance  𝜎𝐺
2 , the stratum-specific phenotypic variance 𝜎𝑌
2  and the stratum-specific sample 
size 𝑛𝑖, the explained variance 𝑅𝑖
2 of a stratum-specific linear regression model is connected 
to the estimated stratum-specific genetic effect 𝑏𝑖 (Rosner, 2006), by 
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𝑅𝑖
2 = 𝑏𝑖
2 𝜎𝐺
2
𝜎𝑌
2 
(10). 
For large sample sizes, it can be shown that the standard error of the genetic effect estimate 
is related to the explained variance (Rosner, 2006) by 
𝑠𝑒(𝑏𝑖)
2 =
(1 − 𝑅𝑖
2)𝜎𝑌
2
𝑛𝑖𝜎𝐺
2  
(11). 
Taking the direction of genetic effect into account, the absolute value of the stratum-specific 
explained variance is defined here, as  
|𝑅𝑖| =
{
 
 −√𝑅𝑖
2 , for 𝑏𝑖 ≥ 0
√𝑅𝑖
2  , for 𝑏𝑖 < 0
 (12). 
This notation is often referred to as ‘effect size’ in the following and is particularly useful to 
mathematically distinguish between the three general types of stratum-difference: 
 |𝑅1| ∙ |𝑅2| < 0  denotes an OED effect 
 𝑅1
2 > 0 ∧   𝑅2
2 = 0 denotes an SSE effect (here: effect in stratum 1) 
  𝑅1
2 > 𝑅2
2 > 0 ∧ |𝑅1| ∙ |𝑅2| > 0 denotes a CED effect (here: stronger effect in stratum 1) 
To further distinguish between OED (or CED) effects, the notation OEDp (or CEDp) is 
introduced where p denotes the percentage of variance explained in stratum 2 compared to 
stratum 1, 𝑝 = 𝑅2
2 / 𝑅1
2. For example, OED25% denotes an effect that is opposite between 
strata and for which the variance explained in stratum 2 is a quarter of the size of the 
variance explained in stratum 1; CED50% denotes an effect that is concordant between strata 
and for which the variance explained in stratum 2 is half the size of the variance explained in 
stratum 1.   
2.1.6.1 Power formulae for the statistical tests 
In the following, power formulae for the single statistical tests are presented. To allow 
modelling various scenarios of stage designs and various types of stratum-difference, each 
formula was derived in dependence of stratum-specific sample-sizes and in dependence of 
stratum-specific explained variances.  
Difference test:  
The difference test involves the z statistic 𝑍𝐷𝑖𝑓𝑓 (given by equation (5)). The power of the 
difference test is given by 
𝑃𝑤𝑟𝐷𝑖𝑓𝑓(𝛼) = 𝑃 (𝑍𝐷𝑖𝑓𝑓 ≤ 𝑧𝛼
2
|𝐻𝐴) + 𝑃 (𝑍𝐷𝑖𝑓𝑓 ≥ 𝑧1−𝛼2
|𝐻𝐴)
= Φ(−𝑧
1−
𝛼
2
−
𝑏1 − 𝑏2
√𝑠𝑒(𝑏1)2 − 𝑠𝑒(𝑏2)2
) + Φ(−𝑧
1−
𝛼
2
+
𝑏1 − 𝑏2
√𝑠𝑒(𝑏1)2 − 𝑠𝑒(𝑏2)2
) 
(13), 
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where Φ  denotes the cumulative standard normal distribution and 𝑧𝑞  denotes the q-th 
quantile of Φ. Utilizing equations (10) and (11) yields: 
𝑃𝑤𝑟𝐷𝑖𝑓𝑓(𝛼, 𝑅1
2, 𝑅2
2, 𝑛1, 𝑓)
= Φ
(
 −𝑧
1−
𝛼
2
−√𝑛1
|𝑅1| − |𝑅2|
√1 − 𝑅1
2 +
1
𝑓 (1 − 𝑅2
2)
)
 
+Φ
(
 −𝑧
1−
𝛼
2
+√𝑛1
|𝑅1| − 1|𝑅2|
√1 − 𝑅1
2 +
1
𝑓 (1 − 𝑅2
2)
)
  
(14). 
Stratified test: 
The stratified test involves two stratum-specific t tests that are performed simultaneously. For 
stratum i, the power of the t test is given by  
𝑃𝑤𝑟𝑡(𝛼𝑖, 𝑛𝑖) = 𝑃 (𝑇 ≤ 𝑡𝑛𝑖−2,
𝛼𝑖
2
|𝐻𝐴) + 𝑃 (𝑇 ≥ 𝑡𝑛𝑖−2,1−
𝛼𝑖
2
|𝐻𝐴)
= 𝑡𝑛𝑖−2 (−𝑡𝑛𝑖−2,1−
𝛼𝑖
2
−
𝑏𝑖
𝑠𝑒(𝑏𝑖)
) + 𝑡𝑛−2 (−𝑡𝑛𝑖−2,1−
𝛼𝑖
2
+
𝑏𝑖
𝑠𝑒(𝑏𝑖)
) (15), 
where 𝑡𝑛𝑖−2 is the cumulative distribution function of a t distribution with 𝑛𝑖 − 2 df, 𝑡𝑛𝑖−2,𝑞 is 
the q-th quantile of   𝑡𝑛𝑖−2  and 𝑏𝑖  and 𝑠𝑒(𝑏𝑖)  are the genetic effect and standard error of 
stratum i. Utilizing equations (10) and (11) yields:   
𝑃𝑤𝑟𝑡(𝛼𝑖, 𝑅𝑖
2, 𝑛𝑖) = 𝑡𝑛𝑖−2(−𝑡𝑛𝑖−2,1−
𝛼𝑖
2
−√
𝑛𝑖𝑅𝑖
2
1 − 𝑅𝑖
2)+ 𝑡𝑛𝑖−2(−𝑡𝑛𝑖−2,1−
𝛼𝑖
2
+√
𝑛𝑖𝑅𝑖
2
1 − 𝑅𝑖
2) (16). 
To obtain the power of the stratified test (combination of two stratum-specific t tests), the 
power formulae of the stratum-specific t tests have to be combined and the stratum-specific 
-levels have to be corrected for the multiple testing of two stratum-specific t tests. 
Leveraging independence of stratum-specific t tests (due to using independent subjects), the 
power of the stratified test is given as follows: 
𝑃𝑤𝑟𝑆𝑡𝑟𝑎𝑡(𝛼, 𝑅1
2, 𝑅2
2, 𝑛1, 𝑓)
= 𝑃𝑤𝑟𝑡 (
𝛼
2
, 𝑅1
2, 𝑛1) + 𝑃𝑤𝑟𝑡 (
𝛼
2
, 𝑅2
2, 𝑓𝑛1) − 𝑃𝑤𝑟𝑡 (
𝛼
2
, 𝑅1
2, 𝑛1)𝑃𝑤𝑟𝑡 (
𝛼
2
, 𝑅2
2, 𝑓𝑛1) 
(17). 
Overall test: 
The overall test involves the t test statistic 𝑇 = 𝑏𝑂𝑣𝑒𝑟𝑎𝑙𝑙/𝑠𝑒(𝑏𝑂𝑣𝑒𝑟𝑎𝑙𝑙). The power formula for 
the overall test is based on using bOverall, se(bOverall) and nOverall in the power formula of the t 
test (given by equation (15)). Expressing the overall parameters in terms of stratum-specific 
parameters (see equation (8), and with nOverall = n1 + f*n1) and utilizing equations (10) and 
(11) yields:    
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𝑃𝑤𝑟𝑂𝑣𝑒𝑟𝑎𝑙𝑙(𝛼, 𝑅1
2, 𝑅2
2, 𝑛1, 𝑓) =
= 𝑡(𝑛1+𝑓𝑛1)−2
(
 
 
 
−𝑡
(𝑛1+𝑓𝑛1)−2,1−
𝛼
2
−√𝑛1  
|𝑅1|
(1 − 𝑅1
2)
+
𝑓|𝑅2|
(1 − 𝑅2
2)
√
1
1 − 𝑅1
2 +
𝑓
(1 − 𝑅2
2)
)
 
 
 
+ 𝑡(𝑛1+𝑓𝑛1)−2
(
 
 
 
−𝑡
(𝑛1+𝑓𝑛1)−2,1−
𝛼
2
+√𝑛1  
|𝑅1|
(1 − 𝑅1
2)
+
𝑓|𝑅2|
(1 − 𝑅2
2)
√
1
1 − 𝑅1
2 +
𝑓
(1 − 𝑅2
2)
)
 
 
 
 
(18). 
 
Joint test: 
The joint test involves the chi-square test statistic 𝐶𝐽𝑜𝑖𝑛𝑡 (see equation (9)). The power of the 
joint test is given by  
𝑃𝑤𝑟𝐽𝑜𝑖𝑛𝑡(𝛼) = 𝑃(𝐶𝐽𝑜𝑖𝑛𝑡 ≥ 𝜒2,1−𝛼|𝐻𝐴) = 1 − Χ2,𝜆
2 (𝜒2,1−𝛼) (19), 
where 𝜒2,𝑞 is the q-th quantile of a chi-square distribution with 2 df and Χ2,𝜆
2  is the cumulative 
distribution function of a non-central chi-square distribution with 2 df and with non-centrality 
parameter 𝜆 that can be calculated as follows:  𝜆 = (
𝑏1
𝑠𝑒(𝑏1)
)
2
+ (
𝑏2
𝑠𝑒(𝑏2)
)
2
. Utilizing equations 
(10) and (11) yields  
𝜆(𝑅1
2, 𝑅2
2, 𝑛1, 𝑓) =
𝑛1𝑅1
2
1 − 𝑅1
2 +
𝑓𝑛1𝑅2
2
1 − 𝑅2
2 
(20). 
Thus, the power for the joint test is given as follows: 
𝑃𝑤𝑟𝐽𝑜𝑖𝑛𝑡(𝛼, 𝑅1
2, 𝑅2
2, 𝑛1, 𝑓) = 1 − Χ2,𝜆(𝑅12,𝑅22,𝑛1,𝑓)
2 (𝜒2,1−𝛼). (21). 
2.1.6.2 Power formulae for the approaches 
To obtain the power formula for an approach, the derived power formulae for the single 
statistical tests (i.e., steps implemented in the approach) have to be combined.  
Given independence of steps, the power of an approach is a product of the power of 
the implemented steps: 
 𝑃𝑤𝑟𝐴𝑝𝑝𝑟𝑜𝑎𝑐ℎ = 𝑃𝑤𝑟𝑆𝑡𝑒𝑝1∩𝑆𝑡𝑒𝑝2∩…∩𝑆𝑡𝑒𝑝𝑁 = ∏ 𝑃𝑤𝑟𝑆𝑡𝑒𝑝 𝑖
𝑁
𝑖=1  (22). 
For dependent steps, the power for the intersection of dependent steps has to be 
obtained from simulated probability distributions. 
Independence of steps can either be given through using independent data sets per 
step or through statistical independence of tests involved. Due to using independent data 
sets for filtering and difference testing, independence of steps is obvious for any replication-
based approach that does not include the additional discovery filtering step on difference, 
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e.g., [Joint1e-5]→[DiffαBonf]. In contrast, all replication-based 2-stage approaches that include 
the additional discovery filtering on difference, e.g., [Joint1e-5,Diff0.05]→[DiffαBonf] , require 
statistical independence of the two discovery steps in order to utilize equation (22) for the 
discovery-stage power calculation. Due to using overlapping data sets for filtering and 
difference testing, all 1-stage and combined 2-stage approaches require statistical 
independence of steps in order to utilize equation (22).  
To evaluate statistical independence or dependence of steps, the simulated data sets 
(initially created for the type 1 error evaluation of 1-stage approaches) were utilized: 
Assuming the null hypothesis of ‘No difference in genetic effects between strata’ (as implied 
by the simulated data sets), applying a filter that is dependent of the difference test would 
yield a deflated or inflated distribution of the difference test statistic. Vice versa, if no impact 
on the distribution of the difference test can be observed, then the difference and the filtering 
test can be considered as independent. The impact of filtering tests on the distribution of the 
difference test statistic was investigated using QQ plots. 
2.1.6.3 Details of the power computations 
Analytical power formulae were derived for all considered approaches. In order to compute 
the power, assumptions about stratum-specific sample sizes, explained variances and -
levels have to be made. Generally, parameters were defined to reflect realistic power 
computation scenarios that are similar to GIANT consortium stratified GWAMA scenarios.  
The total overall (strata-combined) sample size was fixed at 200,000 individuals. This 
is similar to the total sample sizes involved in sex-stratified or smoking-status stratified 
GWAMA projects of the GIANT consortium. The 2-stage approaches were defined to employ 
a balanced stage design, with each stage containing 100,000 individuals. 
Different types of stratum-specific genetic effects were modelled based on known and 
realistic genetic effect sizes taken from GIANT consortium GWAMAs on WHRadjBMI: A small 
(rs6784615 near STAB1), a medium (rs4684854 near PPARG) and a large (rs2820443 near 
LYPLAL1) genetic effect on WHRadjBMI that explained 0.014%, 0.058% and 0.167% of the 
WHRadjBMI variation in women, respectively (Heid et al., 2010; Randall et al., 2013).  
 The -levels for the filtering tests were arbitrarily set to 1 = 1 x 10
-5. For approach 
[Overallα1→DiffαBonf], 1 was further set to genome-wide significance, 1 = 5 x 10
-8, because 
this reflects the common design of many overall GWAMA projects. For the replication-based 
2-stage approaches that involve additional discovery filtering on difference, the -level of the 
discovery difference filter was arbitrary set to nominal significance (2 = 0.05).  
Finally, in order to obtain the Bonferroni-corrected -level (Bonf = 0.05/M) for the final 
difference test, the number of independent lead-SNPs tested for difference (=M) had to be 
estimated. For the sex-stratified GWAMA scenario, M was estimated from the real sex-
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stratified GIANT GENDER data set for WHRadjBMI (Randall et al., 2013) (see chapter 4.1.2 for 
details about the data set). For the general stratified GWAMA scenario, M was estimated 
from the real GIANT SMOKING data set for WHRadjBMI that comprises unbalanced stratum 
sizes (f = 3.483 or f = 0.287) (Justice et al, in progress) (see chapter 4.1.3 for details about 
the data set).  
 
2.2 Results 
The following chapters show results from the structured methodological comparison of 
stratified GWAMA approaches to identify stratum-difference. First, approaches were 
validated with regards to type 1 error (using simulation, chapter 2.2.1) and second, 
approaches were compared with regards to power (using analytical computations, chapter 
2.1.6).  
2.2.1 Simulation-based evaluation of type 1 error  
To evaluate approaches with regards to type 1 error, simulation-based estimations of type 1 
error rates were performed. First, type 1 error was inferred for all approaches and stage 
designs under the balanced sex-stratified GWAMA setting (chapter 2.2.1.1). Valid 1-stage 
sex-stratified GWAMA approaches were transferred to the general setting and the impact of 
unbalanced strata sizes was evaluated (chapter 2.2.1.2).  
 Prior to investigating type 1 error of the approaches, the simulated data sets were 
validated, i.e., were shown to truly reflect the implied null hypotheses of ‘No difference in 
genetic effects between strata’ (see Appendix 9.1).  
2.2.1.1 Type 1 error for the sex-stratified GWAMA approaches  
Generally, the type 1 error rate (T1ER) of an approach was estimated by calculating the 
number of nominally significant difference test results among all conducted difference tests. 
Assuming the null hypothesis of ‘No difference in genetic effects between strata’ and a 5% -
level, one would expect that 5% of difference tests reach nominal significance. Increased 
numbers of nominally significant test results pinpoint invalid approaches.  
For the 1-stage approaches, surprisingly, filtering the data-set for overall association 
did not inflate the T1ER of the difference test (for any modelled scenarios, Table 1).  
In contrast, filtering the data set for stratified or joint association strongly inflated the 
T1ER of the difference test (for all modelled scenarios, Table 1). Thus, for SNPs that are 
filtered on stratified or joint association, the difference cannot be established within the same 
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data set. To separate filtering from difference testing, such approaches require independent 
data sets, discovery (for filtering) and replication (for difference testing).  
All of the replication-based 2-stage approaches yielded valid type 1 error rates (T1ER 
ranged from 4.57% to 5.44% across approaches and modelled scenarios, Table 1). Thus (as 
expected) all replication-based 2-stage approaches, including the ones applying additional 
discovery filtering on difference, can be considered as valid. The reason for this is that the 
filtering in discovery samples cannot bias the difference test statistic when this is calculated 
using independent replication subjects.  
For the combined 2-stage approaches, all but one approach displayed an elevated 
T1ER for the final difference test (e.g., T1ER > 21.2% under 𝐻0
𝑛𝑜𝑒𝑓𝑓𝑒𝑐𝑡
, Table 1). Only the 
combined 2-stage approach [[Overallα1]→Diffαdiff] yielded valid T1ER that ranged from 4.99 
to 5.34% across modelled scenarios.  
As expected, due to violating type 1 error requirements, the combined 2-stage 
approach [[Diffα1]→DiffαBonf]  cannot adopt a Bonferroni-corrected -level for the final 
difference test (Bonf = 0.05/M, corrected for the number of SNPs tested). Nevertheless, 
adjusting the -level to genome-wide significance (gws = 5 x 10
-8) reflects a valid approach 
that may even be more efficient than adopting the analogous replication-based 2-stage 
design while obtaining significance from a Bonferroni-corrected -level (Skol et al., 2006).   
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Table 1. Simulation-based type 1 error rates (T1ER) for balanced sex-stratified GWAMA 
approaches to identify sex-difference. 
   
𝑯𝟎
𝒏𝒐𝒆𝒇𝒇𝒆𝒄𝒕
 𝑯𝟎
𝒆𝒇𝒇𝒆𝒄𝒕
 
Approach SNP MAF 
#Diff- 
tests
a
 
#Diff 
<0.05
b
 
T1ER  
[%] 
#Diff- 
tests
a
 
#Diff 
<0.05
b
 
T1ER 
[%] 
1-stage approaches 
[Diffαdiff] rs6002481 0.05 1,000,000 50,143 5.01 1,000,000 49,950 5.00 
 rs8138968 0.3 1,000,000 50,115 5.01 1,000,000 49,933 4.99 
 rs6007738 0.5 1,000,000 50,063 5.01 1,000,000 49,762 4.98 
[Overall0.05→Diffαdiff] rs6002481 0.05 50,076 2,556 5.10 969,452 48,473 5.00 
 rs8138968 0.3 50,053 2,491 4.98 975,179 48,657 4.99 
 rs6007738 0.5 50,390 2,542 5.04 977,003 48,591 4.97 
[Strat0.05→Diffαdiff] rs6002481 0.05 49,857 21,363 42.85 898,504 49,861 5.55 
 rs8138968 0.3 49,660 21,257 42.81 911,957 49,843 5.47 
 rs6007738 0.5 49,493 20,920 42.27 915,989 49,692 5.42 
[Joint0.05→Diffαdiff] rs6002481 0.05 50,328 25,128 49.93 939,251 49,807 5.30 
 rs8138968 0.3 50,215 25,025 49.84 949,404 49,810 5.25 
 rs6007738 0.5 50,163 24,771 49.38 952,489 49,649 5.21 
Replication-based 2-stage approaches 
[Diff0.05]→[Diffαdiff] rs6002481 0.05 50,205 2,565 5.11 50,074 2,563 5.12 
 rs8138968 0.3 50,517 2,533 5.01 50,395 2,554 5.07 
 rs6007738 0.5 50,352 2,534 5.03 49,889 2,485 4.98 
[Overall0.05]→[Diffαdiff] rs6002481 0.05 50,418 2,410 4.78 964,698 49,069 5.09 
 rs8138968 0.3 50,554 2,625 5.19 978,228 49,072 5.02 
 rs6007738 0.5 50,983 2,571 5.04 978,496 48,673 4.97 
[Strat0.05]→[Diffαdiff] rs6002481 0.05 49,699 2,447 4.92 892,319 45,443 5.09 
 rs8138968 0.3 49,841 2,607 5.23 918,662 46,163 5.03 
 rs6007738 0.5 50,443 2,500 4.96 920,233 45,804 4.98 
[Joint0.05]→[Diffαdiff] rs6002481 0.05 50,158 2,477 4.94 931,854 47,403 5.09 
 rs8138968 0.3 50,798 2,625 5.17 954,608 47,932 5.02 
 rs6007738 0.5 51,098 2,528 4.95 955,261 47,515 4.97 
[Overall0.05,Diff0.05]→ 
              [Diffαdiff] 
rs6002481 0.05 2,541 116 4.57 48,336 2,483 5.14 
rs8138968 0.3 2,443 133 5.44 49,279 2,486 5.04 
rs6007738 0.5 2,582 126 4.88 48,817 2,423 4.96 
[Strat0.05,Diff0.05]→ 
           [Diffαdiff] 
rs6002481 0.05 21,345 1,088 5.10 49,942 2,555 5.12 
rs8138968 0.3 21,319 1,080 5.07 50,324 2,548 5.06 
rs6007738 0.5 21,488 1,049 4.88 49,831 2,479 4.97 
[Joint0.05,Diff0.05]→ 
          [Diffαdiff] 
rs6002481 0.05 24,902 1,266 5.08 49,897 2,553 5.12 
rs8138968 0.3 25,262 1,269 5.02 50,290 2,546 5.06 
rs6007738 0.5 25,261 1,229 4.87 49,794 2,479 4.98 
Combined 2-stage approaches 
[[Diff0.05]→Diffαdiff] rs6002481 0.05 50,205 15,775 31.42 50,074 15,731 31.42 
 rs8138968 0.3 50,517 17,225 34.10 50,395 17,230 34.19 
 rs6007738 0.5 50,352 17,398 34.55 49,889 17,232 34.54 
[[Overall0.05]→Diffαdiff] rs6002481 0.05 50,418 2,675 5.31 964,698 48,580 5.04 
 rs8138968 0.3 50,554 2,659 5.26 978,228 49,076 5.02 
 rs6007738 0.5 50,983 2,650 5.20 978,496 49,135 5.02 
[[Strat0.05]→Diffαdiff] rs6002481 0.05 49,699 10,533 21.19 892,319 48,224 5.40 
 rs8138968 0.3 49,841 11,331 22.73 918,662 49,056 5.34 
 rs6007738 0.5 50,443 11,548 22.89 920,233 49,157 5.34 
[[Joint0.05]→Diffαdiff] rs6002481 0.05 50,158 11,455 22.84 931,854 48,594 5.21 
 rs8138968 0.3 50,798 12,353 24.32 954,608 49,149 5.15 
 rs6007738 0.5 51,098 12,517 24.50 955,261 49,216 5.15 
a
 Number of SNPs tested for difference; 
b
 Number of SNPs with nominal significant difference (PDiff < 0.05) 
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2.2.1.2 Type 1 error for the unbalanced stratified GWAMA approaches  
Next, the impact of unbalanced strata on the type 1 error of the final difference test was 
investigated. Therefore, T1ER of the 1-stage approaches [Diffαdiff] and [Overallα1 → Diffαdiff] 
(shown to be valid under the 1-stage sex-stratified GWAMA configuration) was evaluated 
based on unbalanced simulated data sets.  
Interestingly, employing an unbalanced strata design did not affect T1ER of the 
difference test (Table 2). Across all scenarios, the T1ER of the difference tests for the two 
considered 1-stage approaches remained low and ranged from 4.89% to 5.27%.  
 
 
Table 2. Simulation-based type 1 error rates (T1ER) for unbalanced stratified GWAMA 
approaches to identify stratum-difference. Shown is the T1ER of 1-stage approaches 
(validated under the sex-stratified scenario) for varying combinations of stratum-specific 
sample sizes. 
   𝑯𝟎
𝒏𝒐𝒆𝒇𝒇𝒆𝒄𝒕
 𝑯𝟎
𝒆𝒇𝒇𝒆𝒄𝒕
 
Approach nF nM #Diff- 
Tests
a
 
#Diff 
<0.05
b
 
T1ER 
 [%] 
#Diff- 
Tests
a
 
#Diff 
<0.05
b
 
T1ER 
[%] 
[Diffαdiff] 1,500 1,500 1,000,000 50,029 5.00 1,000,000 50,197 5.02 
 1,500 1,250 1,000,000 50,046 5.00 1,000,000 50,394 5.04 
 1,500 1,000 1,000,000 50,171 5.02 1,000,000 49,919 4.99 
 1,500 750 1,000,000 50,121 5.01 1,000,000 50,257 5.03 
 1,500 500 1,000,000 50,499 5.05 1,000,000 49,914 4.99 
 1,500 250 1,000,000 50,875 5.09 1,000,000 50,620 5.06 
[Overall0.05→Diffαdiff] 1,500 1,500 50,473 2,502 4.96 975,387 48,923 5.02 
 1,500 1,250 50,199 2,532 5.04 965,813 48,652 5.04 
 1,500 1,000 50,617 2,474 4.89 947,023 47,169 4.98 
 1,500 750 50,428 2,531 5.02 925,791 46,560 5.03 
 1,500 500 50,453 2,554 5.06 896,195 44,636 4.98 
 1,500 250 50,598 2,634 5.21 855,596 43,215 5.05 
a
 Number of SNPs tested for difference (i.e., number of SNPs passing the filtering steps, Mfilt) 
b
 Number of SNPs with nominal significant difference (PDiff < 0.05) 
 
 
2.2.2 Analytical power comparison  
To compare performance of approaches and to give recommendations for different stage 
designs and for different types of stratum-difference, analytical power computations were 
performed for various realistic scenarios.  
Generally, approaches that were shown to violate type 1 error requirements were 
omitted from power computations. Also, the replication-based 2-stage approach 
[Overallα1]→[Diffαdiff] was omitted from the power computations because of its obvious power 
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disadvantage compared to the combined 2-stage approach [[Overallα1]→Diffαdiff] : Both 
approaches involve the same data set for the discovery filtering, but the latter comprises a 
larger sample size (thus larger power) for the difference testing. Finally, because of the 
obvious power gain through prioritizing variants with nominally significant difference at 
discovery stage for the replication-based 2-stage approaches [Stratα1Diffα2]→[Diffαdiff] and 
[Jointα1Diffα2]→[Diffαdiff] compared to [Stratα1]→[Diffαdiff] and [Jointα1]→[Diffαdiff], the latter two 
were also omitted from the power computations.  
A systematic scheme of approaches that were compared for power is shown in 
Figure 6. 
 
 
 
Figure 6. Systematic scheme of stratified GWAMA approaches to identify stratum-difference 
considered for power comparisons (gws:= 5 x 10
-8; 1 = -level for the filtering step; 2 = -
level for the additional discovery filter on difference; Bonf = Bonferroni-corrected -level). 
 
 
Simulation-based inference of statistical dependence between tests showed that the 
difference test is independent of the overall test, but dependent of the stratified test and 
dependent of the joint test (see Appendix 9.2). This is in-line with what has already been 
seen for the type 1 error (see chapter 2.2.1.1). As a consequence, the discovery power of the 
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approach [Strat1e-5,Diff0.05]→[DiffαBonf] and of the approach [Joint1e-5,Diff0.05]→[DiffαBonf] had to 
be estimated from simulated probability distributions (see Appendix 9.3). 
For all other approaches, the power could be calculated using the derived step-
specific power formulae with equation (22). A list of applied power formulae including details 
about step-specific -levels and sample sizes is given in Table 3.  
Power comparisons were first performed under the sex-stratified GWAMA setting 
(comprising balanced stratum sizes, chapter 2.2.2.1) and then extended to the general 
setting (to investigate the impact of unbalanced stratum sizes, chapter 2.2.2.2).  
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Table 3. Analytical power formulae for the considered 1- and 2-stage sex-stratified GWAMA approaches. To calculate the Bonferroni-corrected -
level for the final difference test (Bonf = 0.05/M) of approaches that involve filtering steps, the number of independent lead SNPs tested (=M) was 
estimated from the real GIANT GENDER data set (for the sex-stratified GWAMA scenario) and from the real GIANT SMOKING data set (for the 
general stratified GWAMA scenario).  
Design Approach 
M 
(GENDER) 
M 
(SMOKING) 
Analytical power formula 
1-stage [Diff5e-8] - - 𝑃𝑤𝑟𝐷𝑖𝑓𝑓(5e-8, 𝑅1
2, 𝑅2
2, 𝑛1, 𝑓) 
[Overall1e-5→DiffαBonf] 116 70 𝑃𝑤𝑟𝑂𝑣𝑒𝑟𝑎𝑙𝑙(1e-5, 𝑅1
2, 𝑅2
2, 𝑛1, 𝑓) ∙ 𝑃𝑤𝑟𝐷𝑖𝑓𝑓(𝛼𝑏𝑜𝑛𝑓 , 𝑅1
2, 𝑅2
2, 𝑛1, 𝑓) 
[Overall5e-8→DiffαBonf] 39 18 𝑃𝑤𝑟𝑂𝑣𝑒𝑟𝑎𝑙𝑙(5e-8, 𝑅1
2, 𝑅2
2, 𝑛1, 𝑓) ∙ 𝑃𝑤𝑟𝐷𝑖𝑓𝑓(𝛼𝑏𝑜𝑛𝑓 , 𝑅1
2, 𝑅2
2, 𝑛1, 𝑓) 
2-stage 
replication-
based  
[Diff1e-5]→[DiffαBonf] 19 10 𝑃𝑤𝑟𝐷𝑖𝑓𝑓 (1e-5, 𝑅1
2, 𝑅2
2,
𝑛1
2
, 𝑓) ∙ 𝑃𝑤𝑟𝐷𝑖𝑓𝑓 (𝛼𝑏𝑜𝑛𝑓 , 𝑅1
2, 𝑅2
2,
𝑛1
2
, 𝑓) 
[Overall1e-5,Diff0.05]→[DiffαBonf] 12 10 𝑃𝑤𝑟𝑂𝑣𝑒𝑟𝑎𝑙𝑙 (1e-5, 𝑅1
2, 𝑅2
2,
𝑛1
2
, 𝑓) ∙ 𝑃𝑤𝑟𝐷𝑖𝑓𝑓 (0.05, 𝑅1
2, 𝑅2
2,
𝑛1
2
, 𝑓) ∙ 𝑃𝑤𝑟𝐷𝑖𝑓𝑓 (𝛼𝑏𝑜𝑛𝑓 , 𝑅1
2, 𝑅2
2,
𝑛1
2
, 𝑓) 
[Strat1e-5,Diff0.05]→[DiffαBonf] 18 20 𝑃𝑤𝑟𝑆𝑡𝑟𝑎𝑡∩𝐷𝑖𝑓𝑓 (1e-5, 0.05, 𝑅1
2, 𝑅2
2,
𝑛1
2
, 𝑓) ∙ 𝑃𝑤𝑟𝐷𝑖𝑓𝑓 (𝛼𝑏𝑜𝑛𝑓 , 𝑅1
2, 𝑅2
2,
𝑛1
2
, 𝑓) 
[Joint1e-5,Diff0.05]→[DiffαBonf] 19 18 𝑃𝑤𝑟𝐽𝑜𝑖𝑛𝑡∩𝐷𝑖𝑓𝑓 (1e-5, 0.05, 𝑅1
2, 𝑅2
2,
𝑛1
2
, 𝑓) ∙ 𝑃𝑤𝑟𝐷𝑖𝑓𝑓 (𝛼𝑏𝑜𝑛𝑓 , 𝑅1
2, 𝑅2
2,
𝑛1
2
, 𝑓) 
2-stage 
combined 
[[Diff1e-5]→Diff5e-8] - - 𝑃𝑤𝑟𝐷𝑖𝑓𝑓 (1e-5, 𝑅1
2, 𝑅2
2,
𝑛1
2
, 𝑓) ∙ 𝑃𝑤𝑟𝐷𝑖𝑓𝑓(5e-8, 𝑅1
2, 𝑅2
2, 𝑛1, 𝑓) 
[[Overall1e-5]→DiffαBonf] 43 54 𝑃𝑤𝑟𝑂𝑣𝑒𝑟𝑎𝑙𝑙 (1e-5, 𝑅1
2, 𝑅2
2,
𝑛1
2
, 𝑓) ∙ 𝑃𝑤𝑟𝐷𝑖𝑓𝑓(𝛼𝑏𝑜𝑛𝑓 , 𝑅1
2, 𝑅2
2, 𝑛1, 𝑓) 
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2.2.2.1 Analytical power comparison for the sex-stratified GWAMA approaches  
In the following chapter, results from power comparisons between multiple sex-stratified 
GWAMA approaches (to identify sex-difference) are presented. The sex-stratified GWAMA 
scenario assumed a total sample size of 200,000 that is equally split among strata (f = 1), 
𝑛1 = 𝑛2 = 100,000.  
To find the best approaches based on stage design, power was first compared 
between 1-stage approaches (chapter 2.2.2.1.1) and then compared between 2-stage 
approaches (chapter 2.2.2.1.2). Finally, to contrast stage designs, the recommended 1- and 
2-stage approaches were compared (chapter 2.2.2.1.3).   
2.2.2.1.1 Power for the 1-stage sex-stratified GWAMA approaches 
First, power was compared between the 1-stage approaches [Diff5e-8], [Overall1e-5→DiffαBonf] 
and [Overall5e-8→DiffαBonf] for a fixed effect size in women (defined as stratum 1; set to one of 
three realistic WHRadjBMI effects) and for varying effect sizes in men (defined as stratum 2, 
Figure 7). This strategy allowed for investigating several types of sexually dimorphic effects, 
OED, OED50%, OED25%, SSE, CED25% and CED50% effects.  
 
 
 
Figure 7. Power of the 1-stage approaches. Shown is the power to detect sex-difference 
by the three considered 1-stage approaches. The sex-difference is modelled by varying the 
effect size in men (varied on x-axis) and by fixing the effect size in women that is set to a 
known small, medium and strong genetic effect, comparable to the known WHRadjBMI effects 
near A: STAB1, B: PPARG and C: LYPLAL1, respectively. 
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As expected, the power to detect the sex-difference generally increases with the size 
of the modelled effect in women, which is reflected by the increasing area under the power 
curves when viewing panels A, B and C (Figure 7A-C).  
For a small modelled women effect (comparable to the genetic effect on WHRadjBMI 
near STAB1, 𝑅𝐹
2 = 0.014%) approach [Diff5e-8] has some power for extreme OED scenarios 
and approaches [Overall1e-5→DiffαBonf]  and [Overall5e-8→DiffαBonf]  completely lack power 
(Figure 7A). Neither small SSE nor small CED types of effects are detectable by any of the 
approaches.  
For a medium modelled women effect (comparable to the genetic effect on WHRadjBMI 
near PPARG, 𝑅𝐹
2 = 0.058%), approach [Diff5e-8] has strong power to identify any kind of OED 
effect, but breaks down once the effect in men turns towards the direction of effect in women 
(Figure 7B). In contrast, approaches [Overall1e-5→DiffαBonf]  and [Overall5e-8→DiffαBonf]  lack 
power for OED scenarios, but have sufficient or at least some power to find SSE or CED 
effects.  
For a strong modelled women effect (comparable to the genetic effect on WHRadjBMI 
near LYPLAL1,  𝑅𝐹
2 = 0.167% ), the area under the power curve of approach [Diff5e-8] 
broadens (Figure 7C). Besides the large power for OED effects, approach [Diff5e-8] displays 
increased power for SSE and CED effects. The power of the two approaches 
[Overall1e-5→DiffαBonf] and [Overall5e-8→DiffαBonf] increased for SSE effects as well as for CED 
effects.  
The lack of power for OED effects is expected for approaches that involve a-priori 
filtering on overall association. This is because the opposite sex effects are missed by the 
overall (sex-combined) test.  
Interestingly however, the initial filtering on overall association boosts the 
identification of SSE and CED signals. This is particularly interesting because such effects 
may even be the biologically most plausible types of sexually dimorphic effects. Thus, the 
commonly used GWAMA approach - that is to screen for genome-wide significant overall 
association and to follow up identified loci for sex-difference - generally performs well to find 
SSE and CED type of effects.  
Approach [Overall1e-5→DiffαBonf]  has higher power for SSE effects than approach 
[Overall5e-8→DiffαBonf], e.g., 80.7% compared to 46.7% power for the medium SSE effect. 
This suggests that a less stringent control of the overall association yields higher power for 
real SSE signals. In contrast, the more stringent the control on overall association, the 
greater is the probability to find real CED effects, e.g., 84.9% compared to 90.0% power for 
the large CED25% effect and for [Overall1e-5→DiffαBonf] and [Overall5e-8→DiffαBonf], respectively. 
Due to the larger power gain of [Overall1e-5→DiffαBonf] for SSE signals compared to the small 
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power gain of [Overall5e-8→DiffαBonf]  for CED signals, a weaker control of the overall 
association (POverall < 1 x 10
-5) can generally be recommended (in order to keep down the 
number of recommended approaches). Only if a study specifically aims at the identification of 
CED loci, a stronger control of the overall association (POverall < 5 x 10
-8) would be beneficial.  
In summary, to cover the whole range of sexually dimorphic effects, screening for 
sex-difference genome-wide ( [Diff5e-8] , for OED) in combination with the ‘liberal overall 
filtering’ approach ([Overall1e-5→DiffαBonf], for SSE and CED) can be recommended.  
2.2.2.1.2 Power for the 2-stage sex-stratified GWAMA approaches 
Next, power was compared between the six considered 2-stage approaches. Again, the 
power was depicted over a varying effect in men and set to a small, medium or large genetic 
effect in women (comparable to known effects on WHRadjBMI near STAB1, PPARG and 
LYPLAL1, respectively, Figure 8).  
 
 
 
Figure 8. Power of the 2-stage approaches. Shown is the power to detect the sex-
difference by the replication-based 2-stage (solid lines) or by the combined 2-stage (dotted 
lines) approaches. The sex-difference is modelled by varying the effect size in men (varied 
on x-axis) and by fixing the effect size in women to a known small, medium and large genetic 
effect, comparable to the known WHRadjBMI effects near A: STAB1, B: PPARG and C: 
LYPLAL1, respectively. In panel C, the orange line is completely hidden by the green line.  
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The behavior of the replication-based and the combined 2-stage approaches 
[Diff1e-5]→[DiffαBonf] and [[Diff1e-5]→Diff5e-8] is comparable to the 1-stage approach [Diff5e-8]. 
They are well powered to identify medium OED effects and break down once the effect 
direction in men turns positive (Figure 8B).  
Interestingly, the replication-based 2-stage approach [Diff1e-5]→[DiffαBonf]  and the 
combined 2-stage approach [[Diff1e-5]→Diff5e-8] perform almost identical. This suggests that 
testing sex-difference at a more relaxed -level (Bonf = 0.05/M for approach 
[Diff1e-5]→[DiffαBonf] versus gws = 5 x 10
-8 for approach [[Diff1e-5]→Diff5e-8]) compensates for 
the fewer subjects used for the final sex-difference test.  
The behavior of the replication-based 2-stage approach 
[Overall1e-5,Diff0.05]→[DiffαBonf] and the combined 2-stage approach [[Overall1e-5]→DiffαBonf] is 
comparable to the respective 1-stage approach [Overall1e-5→DiffαBonf] (Figure 8). They lack 
power for medium OED effects and display increased power for SSE and CED effects. 
Notably, for CED signals, the power of the combined 2-stage approach 
[[Overall1e-5]→DiffαBonf]  clearly surpasses the power of the replication-based 2-stage 
approach [Overall1e-5,Diff0.05]→[DiffαBonf]. This suggests that the increased sample size for the 
final sex-difference test, i.e., using the combined discovery + replication data for approach 
[[Overall1e-5]→DiffαBonf]  compared to using replication data only for approach 
[Overall1e-5,Diff0.05]→[DiffαBonf], outweighs the additional prioritization on sexually dimorphic 
SNPs in the discovery filtering of approach [Overall1e-5,Diff0.05]→[DiffαBonf]. 
Although the approaches involving the filtering on stratified or joint association, 
[Strat1e-5,Diff0.05]→[DiffαBonf] and [Joint1e-5,Diff0.05]→[DiffαBonf] , similarly lack power for small 
OED effects, they seem to be particularly advantageous for medium SSE effects (Figure 8). 
Notably, the approach [Strat1e-5,Diff0.05]→[DiffαBonf]  has lower power in the OED range 
compared to the approach [Joint1e-5,Diff0.05]→[DiffαBonf].  
In summary, if a 2-stage design has to be adopted, the replication-based approach 
[Joint1e-5,Diff0.05]→[DiffαBonf] (for OED and SSE) in combination with the combined 2-stage 
approach [[Overall1e-5]→DiffαBonf] (for CED) can be recommended.   
2.2.2.1.3 Power comparison between the best 1- and 2-stage sex-stratified GWAMA 
approaches 
As demonstrated, for a sex-stratified GWAMA project aiming at the identification of any type 
of sexually dimorphic effect and adopting a 1-stage design, a combination of approaches 
[Diff5e-8] (for OED) and [Overall1e-5→DiffαBonf] (for SSE and CED) is recommended. If a 1-
stage study specifically aims at CED loci, then the 1-stage [Overall5e-8→DiffαBonf] approach 
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involving a stronger control of the overall association is preferable. For a 2-stage design, the 
combination of the replication-based 2-stage approach [Joint1e-5,Diff0.05]→[DiffαBonf] (for OED 
and SSE) and the combined 2-stage approach [[Overall1e-5]→DiffαBonf]  (for CED) is 
recommended.   
Clearly, in cases where a 1-stage design is feasible, then this is generally preferable 
over the 2-stage design, especially for detection of OED and SSE type of effects (Table 4, 
Figure 9). The reason for this is that splitting the data into two artificial stages does not 
exploit the full possible sample size for effect discovery. For example, the power to identify a 
medium SSE effect with the best 1-stage approach [Overall1e-5→DiffαBonf] is 80.7% compared 
to 57.4% for the best 2-stage approach [Joint1e-5,Diff0.05]→[DiffαBonf]. 
Surprisingly, for CED effects, the combined 2-stage approach [[Overall1e-5]→DiffαBonf] 
showed similar or even slightly better power (e.g., +6.6% for medium CED25% effects) than 
the analogous 1-stage approach [Overall1e-5→DiffαBonf] (Table 4, Figure 9E/F). Obviously, the 
relaxed -level for the sex-difference test of approach [[Overall1e-5]→DiffαBonf] (less loci in 
follow up) had a stronger positive impact on power of  the difference test than using more 
subjects for step 1 of approach [Overall1e-5→DiffαBonf], as this yielded more SNPs in follow up 
and required a more stringent Bonferroni-corrected -level for the sex-difference test. 
Nevertheless, due to the larger power gain for SSE signals (e.g., +54.3% for medium SSE 
effects) of the 1-stage approach [Overall1e-5→DiffαBonf] compared to the 2-stage approach 
[[Overall1e-5]→DiffαBonf], the 1-stage design can generally be recommended.    
Interestingly, when depicting power over an increasing effect in women and fixing the 
effect in men to zero (to reflect SSE), the power curves of the 1-stage approaches 
[Overall5e-8→DiffαBonf]  and [Diff5e-8]  almost completely overlap (Figure 9D). Thus, the 
traditional general GWAMA approach of screening for genome-wide significant main effects 
and a follow up of detected loci for sex-difference is equally well powered to find an SSE 
effect as the genome-wide screen on sex-difference.  
Notably, none of the discussed approaches has sufficient power to detect small SSE 
effects (power < 1%), medium CED25% effects (power < 27.4%) or large CED50% effects 
(power < 28.5%) (Table 4, Figure 9). More refined methods or even larger sample sizes are 
required to find such effects (Figure 10). For example, a total overall (sex-combined) sample 
size of at least 824,000, 460,000, or 466,000 would be required to identify small SSE, 
medium CED25% or large CED50% effects, respectively, with 80% power by the best approach.  
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Table 4. Power of the best approaches. Shown is the power to identify sex-difference for 
various types of sexually dimorphic effects, all of which are based on a fixed effect size in 
women (the effect size in men is modelled accordingly). The total sample size was set to 
200,000 and was assumed to be equally split among sexes and stages.  
Approach 𝑹𝑭
𝟐 [%] Power for varying types of effects [%] 
  OED OED50% OED25% SSE CED25% CED50% 
[Diff5e-8] 0.014 (STAB1)    43.7 17.6 6.9 0.3 0 0 
0.058 (PPARG) 100 100 99.6 47.4 0.3 0 
0.167 (LYPLAL1) 100 100 100 100 18.9 0.3 
[Overall1e-5→DiffαBonf] 0.014 (STAB1) 0 0 0.1 0.7 0.4 0.2 
0.058 (PPARG) 0 0.2 4.2 80.7 19.8 2.5 
0.167 (LYPLAL1) 0 4.1 56.5 100 84.9 19.2 
[Overall5e-8→DiffαBonf] 0.014 (STAB1) 0 0 0 0.1 0.2 0.1 
0.058 (PPARG) 0 0 0.3 46.7 27.4 4.3 
0.167 (LYPLAL1) 0 0.3 19.2 100 90.0 26.7 
[Joint1e-5,Diff0.05]→[DiffαBonf] 0.014 (STAB1) 12.9 3.9 1.5 0.1 0 0 
0.058 (PPARG) 99.8 97 90.3 57.4 5.8 0.6 
0.167 (LYPLAL1) 100 100 100 100 52.8 6.2 
[[Overall1e-5]→DiffαBonf] 
 
0.014 (STAB1) 0 0 0 0.2 0.1 0.1 
0.058 (PPARG) 0 0 0.6 26.7 26.4 4.7 
0.167 (LYPLAL1) 0 0.6 11.9 98.0 90.9 28.5 
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Figure 9. Power of the best approaches over explained variance in women. Shown is 
the power to detect sex-difference over the effect size (explained variance 𝑅𝐹
2) in women and 
for various types of sexually dimorphic effects: A: OED, B: OED50%, C: OED25%, D: SSE, E: 
CED25%, and F: CED50% (the effect size in men was modelled accordingly).  
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Figure 10. Power of the best approaches over total (sex-combined) sample size. Shown 
is the power to detect sex-difference for A: a small SSE effect that is based on a small 
modelled genetic effect in women (comparable to the WHRadjBMI effect near STAB1), B: a 
medium CED25% effect that is based on a medium modelled genetic effect in women 
(comparable to the WHRadjBMI effect near PPARG), and C: a large CED50% effect that is 
based on a large modelled genetic effect in women (comparable to the WHRadjBMI effect near 
LYPLAL1).  
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2.2.2.2 Analytical power comparison for the unbalanced stratified GWAMA 
approaches  
Next, the impact of unbalanced strata designs on power was investigated. Again, a total 
sample size of 200,000 was assumed, but the proportion of stratum-specific sample sizes f 
was varied from 0.2 to 5, which corresponds to a stratum 1 sample size that is 5-times larger 
(f = 0.2) to 5-times smaller (f = 5) than stratum 2. 
Power of the considered 1- and 2-stage approaches was depicted over varying f, and 
for various types of stratum-difference (OED, OED50%, OED25%, SSE, CED25% and CED50% 
signals) that were modelled based on a given effect in stratum 1 (set to a medium genetic 
effect on WHRadjBMI, comparable to the known effect in the PPARG locus). Results are 
summarized in Figure 11 (for 1-stage approaches) and in Figure 12 (for 2-stage 
approaches).  
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Figure 11. Power of the 1-stage approaches. Shown is the power to identify stratum-
difference depicted over the proportion of stratum-specific sample sizes f = n2/n1. The total 
sample size is 200,000 and the stratum 1 effect was fixed at a medium WHRadjBMI effect 
(comparable to the known PPARG effect). Power is shown for varying scenarios of stratum-
difference: A: OED, B: OED50%, C: OED25%, D: SSE, E: CED25% and F: CED50% (the effect 
size in men was modelled accordingly). .  
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Figure 12. Power of the 2-stage approaches. Shown is the power to detect stratum-
difference depicted over the proportion of stratum-specific sample sizes f = n2/n1. The total 
sample size is 200,000 (equally split among stages). The stratum 1 effect was fixed at a 
medium WHRadjBMI effect (comparable to the known PPARG effect). Power is shown for 
varying scenarios of stratum-difference: A: OED, B: OED50%, C: OED25%, D: SSE, E: CED25% 
and F: CED50 (the effect in men was modelled accordingly).  
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For a general stratified GWAMA that does not aim at the identification of specific 
types of interaction effects, varying f did not change the combination of optimal approaches 
from the balanced strata designs: Still, the combination of approaches [Diff5e-8]  and 
[Overall1e-5→DiffαBonf] (or [Overall5e-8→DiffαBonf]) is recommended for 1-stage designs (Figure 
11), and the combination of approaches [Jointα1 , Diffα2]→[DiffαBonf] and [[Overall1e-5]→DiffαBonf] 
is recommended for 2-stage designs (Figure 12).  
 However, the optimal approach to particularly identify SSE effects changes with 
varying f: For the 1-stage design and for f > 1, the power of approach [Diff5e-8] surpasses the 
power of the overall filtering approaches (which were previously recommended for SSE 
under the balanced strata design, Figure 11D). For the 2-stage design and for f < 1, the 
power of the combined 2-stage approach [[Overall1e-5]→DiffαBonf] surpasses the power of the 
replication-based 2-stage approach [Joint1e-5, Diff0.05]→[DiffαBonf]  (which was previously 
recommended for SSE under the balanced strata design, Figure 12D).  
Interestingly, for all types of stratum-difference, the power of approaches [Diff5e-8], 
[Diff1e-5]→[DiffαBonf] and [[Diff1e-5]→DiffαBonf] (solely involving the difference test) is symmetric 
and at maximum at f = 1 (Figure 11, Figure 12). Thus, the difference test itself performs best 
if the two strata are balanced in size. For example, given the GIANT SMOKING scenario, the 
power of approach [Diff5e-8] is identical for f = 0.28 (i.e., modelled effect in the larger non-
smoker group) and f = 3.48 (i.e., modelled effect in the smaller smoker group, Table 5). 
For SSE type of effects and for approaches that involve initial filtering steps, the 
maximum power is reached at f < 1, which corresponds to a design for which the stratum 
carrying the effect (stratum 1) is larger than the stratum lacking effect (stratum 2, Figure 11, 
Figure 12). For example, given the GIANT SMOKING scenario, it is more likely to identify 
SSE signals comprising the effect in non-smokers (the larger stratum) as compared to SSE 
signals comprising the effect in smokers (the smaller stratum) (Table 5).  
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Table 5. Power of the best approaches for the unbalanced GIANT SMOKING scenario. 
Power to identify stratum-difference is shown for varying types of effects, each assuming a 
modelled and fixed effect size in stratum 1 that is set to a small (STAB1), medium (PPARG) 
or large (LYPLAL1) known effect on WHRadjBMI. For f=0.28, stratum 1 corresponds to the 
larger non-smoker stratum. For f=3.48, stratum 1 corresponds to the smaller smoker stratum. 
The effect size in stratum 1 is assumed to be given and the effect size in stratum 2 is 
modelled accordingly (e.g., set to 0 for the SSE effect).  
  Type of effect 
  f = 0.28 f = 3.48 
Approach 𝑹𝟏
𝟐 [%] OED25% SSE CED25% OED25% SSE CED25% 
[Diff5e-8] 0.014 (STAB1)    1.6 0.1 0 1.6 0.1 0 
0.058 (PPARG) 89.9 16.7 0.1 89.9 16.7 0.1 
0.167 (LYPLAL1) 100 98.5 5.0 100 98.5 5.0 
[Overall1e-5→DiffαBonf] 0.014 (STAB1) 8.7 4.5 0.7 0 0 0.1 
0.058 (PPARG) 99.7 86.4 12.6 0.4 1.9 12.5 
0.167 (LYPLAL1) 100 100 66.3 8.1 36.9 66.3 
[Overall5e-8→DiffαBonf] 0.014 (STAB1) 1.7 1.9 0.7 0 0 0 
0.058 (PPARG) 95.7 93.1 22.8 0 0.1 19.9 
0.167 (LYPLAL1) 100 100 79.3 0.7 8.6 79.3 
[Joint1e-5Diff0.05] 
→[DiffαBonf] 
0.014 (STAB1) 1.7 0.2 0 0.2 0 0 
0.058 (PPARG) 94.6 49.6 2.8 56.4 7.1 1.7 
0.167 (LYPLAL1) 100 99.1 29.4 100 90.9 29.4 
[[Overall1e-5]→DiffαBonf] 
 
0.014 (STAB1) 1.3 0.9 0.2 0 0 0 
0.058 (PPARG) 74.3 82.1 14.1 0.1 0.3 8.5 
0.167 (LYPLAL1) 100 100 68.9 1.1 6.3 69.0 
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3 Stratified GWAMA approaches to screen for G x 
AGE x SEX interaction effects 
Besides the differences in genetic effects between two strata, other – more complicated – 
scenarios may exist that involve multiple stratification variables. For example, it is well known 
that women’s body shape changes around menopause (due to the decline in estrogen levels) 
from a gynoid (more fat stored around hips) to an android body shape (more fat stored 
around waist). Thus, after menopause, the differences in body shape between men and 
women are less pronounced than before menopause. To investigate whether the age-
dependent change in sex-differences of body shape is influenced by genetic effects, one 
would particularly be interested in genetic effects that are modified by both, AGE and SEX 
(AGE as dichotomized age: younger vs older than 50 years, which reflects mean age of 
menopause).  
The overarching aim of the following chapter is to provide a systematic 
methodological evaluation of screening approaches that aim identification of 3-way G x AGE 
x SEX interaction effects and are based on an age- and sex-stratified GWAMA. The 
proposed approaches are exemplified on this specific configuration, but can readily be 
applied to any other 2 x 2 strata configuration involving two dichotomous (environmental) 
stratification variables S1 and S2 and aiming at identification of 3-way G x S1 x S2 interaction 
effects.  
  Again, an approach is defined here as a combination or concatenation of multiple 
statistical tests (i.e., steps) that are applicable to age- and sex-stratified GWAMA outcomes. 
Relevant statistical tests are introduced and a systematic scheme of approaches is 
presented.  
The performance of the approaches was compared by simulation-based estimation of 
type 1 error and by analytical computations of power. Varying realistic scenarios were 
considered and an attempt to recommend approaches - based on type of 3-way G x AGE x 
SEX interaction effect - was made.  
Herewith, a range of possible combinations of stratum-specific effects are 
distinguished (Figure 13). These include biologically plausible and relevant 3-way interaction 
effects, such as the 1-stratum interaction (e.g., effect is present in F≤50, but lacking in all 
other strata) or the 3-strata interaction (e.g., effect is only lacking in M>50), as well as less 
plausible extreme 3-way interaction effects that involve opposite directions across AGE and 
SEX. Other combinations include previously discussed 2-way interaction effects, such as 
age-difference (i.e., G x AGE, independent of SEX) or sex-difference (i.e., G x SEX, 
independent of AGE).  
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Figure 13. Examples for possible combinations of age- and sex-specific effects.  
 
3.1 Materials and Methods 
The following chapters describe the prerequisites of the methodological evaluation of age- 
and sex-stratified GWAMA approaches to identify 3-way G x AGE x SEX interaction effects.  
After presenting general assumptions (chapter 3.1.1), a statistical test for difference-
of-difference is introduced (chapter 3.1.2) that can be used to test for 3-way G x AGE x SEX 
interaction given the age- and sex-stratified GWAMA setting. Furthermore, filtering tests are 
introduced (chapter 3.1.3) and used to construct several screening approaches (chapter 
3.1.4). A systematic scheme of approaches was developed that is utilized to compare 
performance (type 1 error and power) of approaches.  
Methodological prerequisites of the simulation-based evaluation of type 1 error 
(chapter 3.1.5), the derivation of analytical power formulae as well as methodological details 
about the analytical power computations (chapter 3.1.6), are presented.  
3.1.1 Assumptions and definitions 
In the following, considerations are based on an age- and sex-stratified GWAMA model that 
is given by four stratum-specific linear regression models: 
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𝑌𝑀≤50 =∝𝑀≤50+ 𝛽𝑀≤50𝐺𝑀≤50 + 𝜀𝑀≤50,      𝜀𝑀≤50~𝑁(0, 𝜎𝑀≤50
2 ) 
𝑌𝐹≤50 =∝𝐹≤50+ 𝛽𝐹≤50𝐺𝐹≤50 + 𝜀𝐹≤50,      𝜀𝐹≤50~𝑁(0, 𝜎𝐹≤50
2 ) 
𝑌𝑀>50 =∝𝑀>50+ 𝛽𝑀>50𝐺𝑀>50 + 𝜀𝑀>50,      𝜀𝑀>50~𝑁(0, 𝜎𝑀>50
2 ) 
𝑌𝐹>50 =∝𝐹>50+ 𝛽𝐹>50𝐺𝐹>50 + 𝜀𝐹>50,      𝜀𝐹>50~𝑁(0, 𝜎𝐹>50
2 ) 
(23). 
The stratification is done by two dichotomous variables (AGE and SEX, AGE dichotomized at 
50 years of age, which reflects menopause in women) that separate each study sample into 
four subgroups: Younger men (M≤50), younger women (F≤50), older men (M>50), and older 
women (F>50). For each SNP, each study fits the stratum-specific regression models and 
obtains the stratum-specific effect estimates with standard errors. The pooled stratum-
specific genetic effect estimates bM≤50, bF≤50, bM>50 and bF>50, are obtained from stratum-
specific inverse-variance weighted meta-analyses. It is assumed that the stratified GWAMAs 
have already been conducted so that the pooled stratum-specific effect estimates with 
standard errors are already available. 
As for the 2-strata configuration, stratum-specific phenotypes are assumed to be 
continuous, and to follow equal normal distributions,  𝑌𝑖~𝑁(𝜇𝑌, 𝜎𝑌
2) where i reflects M≤50, 
F≤50, M>50, or F>50; stratum-specific additively modeled genotypes 𝐺𝑖  are assumed to 
follow equal genotype distributions; and similar populations are assumed to be involved in 
the meta-analyses (which allows ignoring the meta-analysis concept for the power and the 
type 1 error evaluations).  
Finally, to avoid overly complexity, strata are assumed to be equally balanced 
comprising identical stratum-specific sample sizes, defined as  𝑛 = 𝑛𝑀≤50 = 𝑛𝐹≤50 = 𝑛𝑀>50 =
𝑛𝐹>50 (note that the total strata-combined sample size is denoted as  𝑛𝑂𝑣𝑒𝑟𝑎𝑙𝑙). 
3.1.2 Testing for G x AGE x SEX interaction given the age- and sex-
stratified GWAMA model 
To investigate 3-way G x AGE x SEX interaction effects given the age- and sex-stratified 
GWAMA model, a difference-of-difference test is introduced that compares whether sex-
difference differs by age (𝐻0: (𝑏𝑀≤50 − 𝑏𝐹≤50) = (𝑏𝑀>50 − 𝑏𝐹>50)):  
 
𝑍𝐷𝑖𝑓𝑓𝐷𝑖𝑓𝑓 =
(𝑏𝑀≤50 − 𝑏𝐹≤50)− (𝑏𝑀>50 − 𝑏𝐹>50)
√𝑠𝑒(𝑏𝑀≤50)
2
+ 𝑠𝑒(𝑏𝐹≤50)
2 + 𝑠𝑒(𝑏𝑀>50)
2
+ 𝑠𝑒(𝑏𝐹>50)
2
~𝑁(0,1) |𝐻0 (24). 
 
Assuming the null hypothesis being true, the z statistic follows a standard normal distribution. 
The z test yields the difference-of-difference P-Value PDiffDiff. 
By re-arranging the formula or the null hypothesis, it can be shown that testing 
whether ‘sex-difference differs by age’ ( 𝐻0: (𝑏𝑀≤50 − 𝑏𝐹≤50) = (𝑏𝑀>50 − 𝑏𝐹>50) ) is 
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mathematically equivalent to testing whether ‘age-difference differs by sex’ (𝐻0: (𝑏𝑀≤50 −
𝑏𝑀>50) = (𝑏𝐹≤50 − 𝑏𝐹>50)).  
Under the assumption of independent samples, unrelated subjects and no latent 
covariate interacting with the AGE or SEX, the difference-of-difference test is mathematically 
equivalent to testing the pooled G x AGE x SEX interaction estimate bGxAGExSEX obtained from 
an interaction GWAMA model that is given by  
𝑌 = 𝛼 + 𝛽𝐺𝐺 + 𝛽𝐴𝐺𝐸𝐴𝐺𝐸 + 𝛽𝑆𝐸𝑋𝑆𝐸𝑋 + 𝛽𝐺𝑥𝐴𝐺𝐸𝐺𝑥𝐴𝐺𝐸 + 𝛽𝐺𝑥𝑆𝐸𝑋𝐺𝑥𝑆𝐸𝑋
+ 𝛽𝐴𝐺𝐸𝑥𝑆𝐸𝑋𝐴𝐺𝐸𝑥𝑆𝐸𝑋 + 𝛽𝐺𝑥𝐴𝐺𝐸𝑥𝑆𝐸𝑋𝐺𝑥𝐴𝐺𝐸𝑥𝑆𝐸𝑋 + 𝜀,      𝜀~𝑁(0, 𝜎
2) 
(25). 
3.1.3 Statistical tests to filter stratified GWAMA data sets prior to G x 
AGE x SEX interaction testing 
In order to construct age- and sex-stratified GWAMA approaches that involve initial filtering 
steps, two types of filtering tests are distinguished: (i) Directly applicable filtering tests 
(chapter 3.1.3.1), and (ii) marginal filtering tests (chapter 3.1.3.2) that are indirectly 
applicable because they require initial meta-analysis of stratum-specific results.  
3.1.3.1 Directly applicable filtering tests 
Similarly to the stratified GWAMA setting involving two strata, a stratified, an overall and a 
joint association test can directly be applied (for filtering) to the four stratum-specific effect 
estimates with standard errors:  
 A stratified test can be performed that infers whether any of the four stratum-specific 
effects is associated with the phenotype  ( 𝐻0: 𝑏𝑀≤50 = 0 ∧ 𝑏𝐹≤50 = 0 ∧ 𝑏𝑀>50 = 0 ∧
𝑏𝐹>50 = 0): The stratified test employs four stratum-specific t tests that yield stratum-
specific association P-Values PM≤50, PF≤50, PM>50, and PF>50.  Finally, the stratified 
association P-Value is defined as PStrat = 4*min(PM≤50, PF≤50, PM>50, PF>50), which is 
corrected for the multiple testing of four strata.  
 An overall test can be performed to infer whether the overall (strata-combined) effect is 
associated with the phenotype (𝐻0: 𝑏𝑂𝑣𝑒𝑟𝑎𝑙𝑙 = 0):  
 𝑇𝑂𝑣𝑒𝑟𝑎𝑙𝑙 =
𝑏𝑂𝑣𝑒𝑟𝑎𝑙𝑙
𝑠𝑒(𝑏𝑂𝑣𝑒𝑟𝑎𝑙𝑙)
~𝑡(𝑛𝑂𝑣𝑒𝑟𝑎𝑙𝑙 − 2) |𝐻0 (26), 
where nOverall is the strata-combined sample size (𝑛𝑂𝑣𝑒𝑟𝑎𝑙𝑙 = 4𝑛) and where bOverall and 
se(bOverall) are the overall genetic effect with standard error that are obtained from 
inverse-variance weighted meta-analysis of the four strata: 
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𝑏𝑂𝑣𝑒𝑟𝑎𝑙𝑙 =
∑ 𝑏𝑖/𝑠𝑒(𝑏𝑖)
2
𝑖
∑ 1/𝑠𝑒(𝑏𝑖)
2
𝑖
, 𝑠𝑒(𝑏
𝑂𝑣𝑒𝑟𝑎𝑙𝑙
) = √
1
∑ 1/𝑠𝑒(𝑏𝑖)
2
𝑖
 (27). 
Here, i iteratively refers to M≤50, M>50, F≤50 and F>50. The t test yields the overall 
association P-Value POverall.  
 A joint test can be performed to infer whether the joint (main + 2-way interaction + 3-way 
interaction) effect is associated with the phenotype (𝐻0: 𝑏𝐺 = 0 ∧ 𝑏𝐺𝑥𝐴𝐺𝐸 = 0 ∧ 𝑏𝐺𝑥𝑆𝐸𝑋 =
0 ∧ 𝑏𝐺𝑥𝐴𝐺𝐸𝑥𝑆𝐸𝑋 = 0): 
𝐶𝐽𝑜𝑖𝑛𝑡 =∑(
𝑏𝑖
𝑠𝑒(𝑏𝑖)
)
2
𝑖
~𝜒2(4) |𝐻0 (28). 
Here, i iteratively refers to M≤50, M>50, F≤50 and F>50. The chi-square test yields the 
joint-test P-Value PJoint.  
3.1.3.2 Filtering on marginal tests that require meta-analyses of age- and sex-
specific results 
In addition to the directly applicable filtering tests, the 2 x 2 age- and sex-stratified GWAMA 
scenarios offers the possibility to filter on marginal tests (Figure 14).  
 
 
 
Figure 14. Marginal tests based on age- and sex-stratified GWAMA outcomes. 
 
 
The marginal tests are based on using age-marginals (i.e., age-specific effects b≤50 
and b>50, with respective standard errors) and sex-marginals (i.e., sex-specific effects bM and 
bF, with respective standard errors) that have to be obtained from pooling the respective age- 
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and sex-specific subgroups. For example, to obtain the genetic age-marginal effect for the 
younger individuals (b≤50), a meta-analysis of genetic effects in younger men (bM≤50) and 
younger women (bF≤50) has to be performed. 
Each marginal test is a combination of a marginal age-version and a marginal sex-
version of the respective test: 
 A marginal difference test can be performed that infers whether the genetic effect differs 
by age (marginal age-difference test, independent of sex) or whether the genetic effect 
differs by sex (marginal sex-difference test, independent of age): 𝐻0: 𝑏≤50 = 𝑏>50  ∧ 𝑏𝑀 =
𝑏𝐹. The marginal difference P-Value is defined as PMarDiff = 2*min(PAgediff, PSexdiff), which is 
corrected for the multiple testing of two difference tests (see chapter 2.1.2 for the 
definition of the difference test). 
 A marginal stratified test can be performed that infers whether any of the age-marginal 
effects are associated with the phenotype (marginal age-stratified test, independent of 
sex) or whether any of the sex-marginal effects are associated with the phenotype 
(marginal sex-stratified test, independent of age): 𝐻0: 𝑏≤50 = 0 ∧ 𝑏≤50 = 0 ∧ 𝑏𝑀 = 0 ∧ 𝑏𝐹 =
0. The marginal stratified P-Value is defined as PmarStrat = 2*min(PAgestrat, PSexstrat), which is 
corrected for the multiple testing of two 2-strata stratified tests (see chapter 2.1.3 for the 
definition of the 2-strata stratified test). The marginal stratified P-Value can also be 
written as PMarStrat = 4*min(P≤50, P>50, PM, PF). 
 A marginal joint test can be performed that infers whether the age-marginal effects are 
jointly associated with the phenotype (marginal age-joint test, independent of sex) or 
whether the sex-marginal effects are jointly associated with the phenotype (marginal sex-
joint test, independent of age): 𝐻0: 𝑏𝐺 = 0 ∧ 𝑏𝐺𝑥𝐴𝐺𝐸 = 0 ∧ 𝑏𝐺𝑥𝑆𝐸𝑋 = 0. The marginal joint 
test P-Value is defined as PMarJoint = 2*min(PAgejoint, PSexjoint), which is corrected for the 
multiple testing of two 2-strata joint tests (see chapter 2.1.3 for the definition of the 2-
strata joint test). 
3.1.4 A systematic scheme of age- and sex-stratified GWAMA 
approaches to identify G x AGE x SEX interaction  
The introduced statistical tests are used to construct various age- and sex-stratified GWAMA 
approaches, each of which aims at screening for variants with significant 3-way G x AGE x 
SEX interaction effects. Generally, an approach is designed with multiple steps (statistical 
tests). The last step of each approach is to test for difference-of-difference (as a means to 
test for 3-way G x AGE x SEX interaction effects). Other statistical tests are solely employed 
for filtering the genome-wide data sets prior to the difference-of-difference testing. Multiple 
steps are implemented within a single data set (1-stage design) and – in order to avoid overly 
complexity – not extended to other stage designs. Based on the previously introduced 
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notation (see chapter 2.1.4), a systematic scheme of considered approaches was developed 
and summarized in Figure 15.  
 
 
 
Figure 15. Systematic scheme of 1-stage age- and sex-stratified GWAMA approaches to 
identify 3-way G x AGE x SEX interaction effects (gws:= 5 x 10
-8; 1 = -level for the filtering 
step; Bonf = Bonferroni-corrected -level). 
 
 
Generally, all of the considered approaches aim at using Bonferroni-corrected -
levels for the final difference-of-difference test: Bonf = 0.05/M, where M is the number of 
independent difference-of-difference tests performed.  
The most intuitive approach is to screen for difference-of-difference at a genome-wide 
significance level: Bonf = gws = 5 x 10
-8 (= 0.05/106, Bonferroni-corrected for an approximate 
number of one million independent tests) (Johnson et al., 2010).  
Further approaches are considered that involve filtering on directly applicable or on 
marginal tests. Their implementation into the 1-stage design has to be validated with regards 
to type 1 error and the impact on power of the difference-of-difference test has to be 
investigated.  
Practically (same as for the 2-strata configuration), common stratified GWAMA 
projects aim at identification of any type of 3-way interaction and it is likely that the optimal 
approach varies by type of interaction effect – necessitating multiple screening approaches. 
To avoid overly conservative correction of multiple (already conservatively controlled) 
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screening approaches, a ‘final’ multiple testing correction (for the number of outlined 
approaches) is not applied and ignored in the following.  
Technically (same as for the 2-strata configuration), genome-wide data sets are 
clumped into independent regions using a distance-based criterion (distance < 500KB, 
pairwise between SNPs of a specific region) and the region-specific lead-SNP is defined as 
the SNP with the lowest P-Value across all SNPs of a specific region. Importantly, the 
independent lead-SNPs are those that are put forward and are tested for difference-of-
difference in the final step. The total number of selected lead-SNPs is denoted as M in the 
following (as introduced before). To correct for the multiple difference-of-difference testing of 
M independent lead SNPs, the -level of the difference-of-difference test undergoes a 
Bonferroni-correction: Bonf = 0.05/M (except for approach [DiffDiffα𝑔𝑤𝑠]  that employs a 
genome-wide significant -levels for the final difference-of-difference test).  
3.1.5 Simulation based evaluation of type 1 error  
A simulation-based evaluation of type 1 error rates was performed for all considered 
approaches. Methodological details of the simulations are described in the following.  
Simulated data sets were created that follow the null hypothesis of ‘No age-difference 
in sex-difference of genetic effects’, 𝐻0: (𝑏𝑀≤50 − 𝑏𝐹≤50) = (𝑏𝑀>50 − 𝑏𝐹>50). More specifically, 
three versions of the null hypothesis were created: One assumes lack of stratum-specific 
effects (𝐻0
𝑛𝑜𝑒𝑓𝑓𝑒𝑐𝑡: 𝑏𝑀≤50 = 𝑏𝐹≤50 = 𝑏𝑀>50 = 𝑏𝐹>50 = 0), one assumes identical (unequal zero) 
stratum-specific effects (𝐻0
𝑒𝑓𝑓𝑒𝑐𝑡: 𝑏𝑀≤50 = 𝑏𝐹≤50 = 𝑏𝑀>50 = 𝑏𝐹>50 ≠ 0), and one assumes true 
sex-difference implying an opposite effect between men and women (𝐻0
𝑠𝑒𝑥𝑑𝑖𝑓𝑓: 𝑏𝑀≤50 =
𝑏𝑀>50 = −𝑏𝐹≤50 = −𝑏𝐹>50 ≠ 0). 
First, real genotypes were obtained from 750 younger men, 750 younger women, 750 
older men and from 750 older women, from the KORA study (Wichmann et al., 2005) for 
three well-imputed SNPs that cover the full allele frequency spectrum: rs6002481 (MAF = 
0.02), rs8138968 (MAF = 0.3) and rs6007738 (MAF = 0.5) (same SNPs as used before for 
the 2-strata configuration). 
Second, simulated phenotypes (for each subgroup of 750 subjects) were created 
according to Y~N(0,1) for  𝐻0
𝑛𝑜𝑒𝑓𝑓𝑒𝑐𝑡
, and according to Y|G=0~N(0,1), Y|G=1~N(b80%,1)  and 
Y|G=2~N(2*b80%,1) for  𝐻0
𝑒𝑓𝑓𝑒𝑐𝑡
. For  𝐻0
𝑠𝑒𝑥𝑑𝑖𝑓𝑓
, phenotypes for younger and older men were 
simulated according to Y|X=0~N(0,1), Y|X=1~N(b80%,1) and Y|X=2~N(2*b80%,1), and 
phenotypes for younger and older women were simulated according to Y|X=0~N(0,1), 
Y|X=1~N(-b80%,1) and Y|X=2~N(-2*b80%,1). Always, b80% reflects the minimum effect size 
detectable with 80% power by 750 samples (at  = 0.05), and G=0, G=1 or G=2 denote the 
group of individuals carrying 0, 1, or 2 minor alleles, respectively. Using G*Power, b80% was 
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estimated to be 0.514, 0.157 and 0.144 for rs6002481, rs8138968 and rs6007738, 
respectively (Faul et al., 2009). 
Third, for each null hypothesis and for each SNP, the simulated phenotypes were 
stratum-specifically tested for association with the real SNP genotypes. Age- and sex-
stratified genetic effect estimates, with standard errors and association P-Values, were 
derived.  
Next, for each null hypothesis and for each SNP, the simulation and stratum-specific 
association testing was repeated 1,000,000 times yielding 1,000,000 age- and sex-specific 
genetic effect estimates, with standard errors and association P-Values.  
Finally, for each null hypothesis and for each SNP, the age- and sex-stratified 
GWAMA approaches were applied to the respective 1,000,000 stratum-specific genetic effect 
estimates. The -level for the initial filtering was set to 1 = 0.05 (which corresponds to the 
estimation of b80%). For each approach, type 1 error rate (T1ER) of the final difference-of-
difference test was calculated by the proportion of nominal significant test results among all 
difference-of-difference tests: T1ER = #(PDiffDiff<0.05)/Mfilt (Mfilt being the number of data 
points passing the filtering, which corresponds to the previously introduced M).  
3.1.6 Analytical computation of power  
Power comparisons aim finding the best age- and sex-stratified GWAMA approach to identify 
difference-of-difference. Power formulae for the single tests were derived and then combined 
to obtain the power formulae for the approaches.  
In order to model various types of difference-of-difference, each formula was derived 
in dependence of the stratum-specific explained variances 𝑅𝑀≤50
2 , 𝑅𝐹≤50
2 , 𝑅𝑀>50
2  and 𝑅𝐹>50
2 .  
3.1.6.1 Power formulae for the directly applicable statistical tests 
In the following, power formulae for the directly applicable statistical tests are presented.  
Difference-of-difference test: 
The difference test involves the z statistic 𝑍𝐷𝑖𝑓𝑓𝐷𝑖𝑓𝑓 (given by equation (24)). The power of 
the difference-of-difference test is given by  
𝑃𝑤𝑟𝐷𝑖𝑓𝑓𝐷𝑖𝑓𝑓(𝛼) = 𝑃 (𝑍𝐷𝑖𝑓𝑓𝐷𝑖𝑓𝑓 ≤ 𝑧𝛼
2
|𝐻𝐴) + 𝑃 (𝑍𝐷𝑖𝑓𝑓𝐷𝑖𝑓𝑓 ≥ 𝑧1−𝛼2
|𝐻𝐴)
= Φ(−𝑧
1−
𝛼
2
−
(𝑏𝑀≤50 − 𝑏𝐹≤50) − (𝑏𝑀>50 − 𝑏𝐹>50)
√𝑠𝑒(𝑏𝑀≤50)2 + 𝑠𝑒(𝑏𝐹≤50)2 + 𝑠𝑒(𝑏𝑀>50)2 + 𝑠𝑒(𝑏𝐹>50)2
)
+ Φ(−𝑧
1−
𝛼
2
+
(𝑏𝑀≤50 − 𝑏𝐹≤50) − (𝑏𝑀>50 − 𝑏𝐹>50)
√𝑠𝑒(𝑏𝑀≤50)2 + 𝑠𝑒(𝑏𝐹≤50)2 + 𝑠𝑒(𝑏𝑀>50)2 + 𝑠𝑒(𝑏𝐹>50)2
) 
(29), 
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where, Φ  denotes the cumulative standard normal distribution and 𝑧𝑞  denotes the q-th 
quantile of Φ. Utilizing equations (10) and (11) yields (note that n is the sample size of a 
single stratum): 
𝑃𝑤𝑟𝐷𝑖𝑓𝑓𝐷𝑖𝑓𝑓(𝛼, 𝑅𝑀≤50
2 , 𝑅𝐹≤50
2 , 𝑅𝑀>50
2 , 𝑅𝐹>50
2 , 𝑛)
= Φ
(
 −𝑧
1−
𝛼
2
− √𝑛
|𝑅𝑀≤50| − |𝑅𝐹≤50| − |𝑅𝑀>50| + |𝑅𝐹>50|
√4 − 𝑅𝑀≤50
2 − 𝑅𝑀>50
2 − 𝑅𝐹≤50
2 − 𝑅𝐹>50
2
)
 
+Φ
(
 −𝑧
1−
𝛼
2
+ √𝑛
|𝑅𝑀≤50| − |𝑅𝐹≤50| − |𝑅𝑀>50| + |𝑅𝐹>50|
√4 − 𝑅𝑀≤50
2 − 𝑅𝑀>50
2 − 𝑅𝐹≤50
2 − 𝑅𝐹>50
2
)
  
(30). 
Stratified test: 
The stratified test involves four stratum-specific t tests that are performed simultaneously. 
The power of a single stratum-specific t test in dependence of the stratum-specific explained 
variance and sample size is given by equation (16). To obtain the power of the stratified test 
(combination of four stratum-specific t tests), the power formulae of the stratum-specific t 
tests have to be combined and the stratum-specific -levels have to be corrected for the 
multiple testing of four stratum-specific t tests. Leveraging independence of stratum-specific t 
tests (due to using independent subjects), the power of the stratified test is given as follows: 
𝑃𝑤𝑟𝑆𝑡𝑟𝑎𝑡(𝛼, (𝑅𝑀≤50
2 , 𝑅𝐹≤50
2 , 𝑅𝑀>50
2 , 𝑅𝐹>50
2 ), 𝑛) = 1 −∏(1 − 𝑃𝑤𝑟𝑡 (
𝛼
4
, 𝑅𝑖
2, 𝑛))
𝑖
 (31), 
where i  is iteratively expressed as M≤50, F≤50, M>50 and F>50 and n is the sample size of 
a single stratum. 
Overall test: 
The overall test involves the t test statistic 𝑇 = 𝑏𝑂𝑣𝑒𝑟𝑎𝑙𝑙/𝑠𝑒(𝑏𝑂𝑣𝑒𝑟𝑎𝑙𝑙). The power formula for 
the overall test is based on using bOverall, se(bOverall) and nOverall in the power formula of the t 
test (given by equation (15)). Expressing the overall parameters in terms of stratum-specific 
parameters (see equation (27), and with nOverall = 4n) and utilizing equations (10) and (11) 
yields:  
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𝑃𝑤𝑟𝑂𝑣𝑒𝑟𝑎𝑙𝑙(𝛼, (𝑅𝑀≤50
2 , 𝑅𝐹≤50
2 , 𝑅𝑀>50
2 , 𝑅𝐹>50
2 ), 𝑛) =
= 𝑡4𝑛−2
(
 
 
 
−𝑡
4𝑛−2,1−
𝛼
2
−√𝑛 
∑
|𝑅𝑖|
(1 − 𝑅𝑖
2)𝑖
√∑
1
(1 − 𝑅𝑖
2)𝑖
)
 
 
 
+ 𝑡4𝑛−2
(
 
 
 
−𝑡
4𝑛−2,1−
𝛼
2
+ √𝑛 
∑
|𝑅𝑖|
(1 − 𝑅𝑖
2)𝑖
√∑
1
(1 − 𝑅𝑖
2)𝑖
)
 
 
 
 
(32), 
where i is iteratively expressed as M≤50, F≤50, M>50 and F>50.  
 Joint test: 
The joint test involves a chi-square test statistic 𝐶𝐽𝑜𝑖𝑛𝑡 (see equation (28)). The power of the 
joint test is given by  
𝑃𝑤𝑟𝐽𝑜𝑖𝑛𝑡(𝛼) = 𝑃(𝐶𝐽𝑜𝑖𝑛𝑡 ≥ 𝜒4,1−𝛼|𝐻𝐴) = 1 − Χ4,𝜆
2 (𝜒4,1−𝛼) (33), 
where 𝜒4,𝑞 is the q-th quantile of a chi-square distribution with 4 df and Χ4,𝜆
2  is the cumulative 
distribution function of a non-central chi-square distribution with 4 df and non-centrality 
parameter 𝜆 that can be calculated as follows:𝜆 = ∑ (
𝑏𝑖
𝑠𝑒(𝑏𝑖)
)
2
𝑖 , where i is iteratively expressed 
as M≤50, F≤50, M>50 and F>50. Utilizing equations (10) and (11) yields   
𝜆((𝑅𝑀≤50
2 , 𝑅𝐹≤50
2 , 𝑅𝑀>50
2 , 𝑅𝐹>50
2 ), 𝑛) =∑
𝑛𝑅𝑖
2
1 − 𝑅𝑖
2
𝑖
 (34), 
where i is iteratively expressed as M≤50, F≤50, M>50 and F>50 and n is the sample size of a 
single stratum. Thus, the power for the joint test is given as follows: 
𝑃𝑤𝑟𝐽𝑜𝑖𝑛𝑡(𝛼, (𝑅𝑀≤50
2 , 𝑅𝐹≤50
2 , 𝑅𝑀>50
2 , 𝑅𝐹>50
2 ), 𝑛) = 1 − Χ4,𝜆((𝑅𝑀≤502 ,𝑅𝐹≤502 ,𝑅𝑀>502 ,𝑅𝐹>502 ),𝑛)
2 (𝜒4,1−𝛼) (35). 
3.1.6.2 Power formulae for the marginal tests 
Each of the marginal tests is a combination of an age- and a sex-version of the respective 
test. For example, the marginal difference test simultaneously conducts a marginal age-
difference test (to compare age-marginal effects b≤50 and b>50) and a marginal sex-difference 
test (to compare sex-marginal effects bM and bF). To obtain the power formula for a marginal 
test (in dependence of stratum-specific explained variances of the four strata), power 
formulae for the respective age- and the sex-version of the test have to be derived, and then 
have to be combined. The derivations of power formulae are exemplified on the age-versions 
and can easily be transferred to the respective sex-version.  
Marginal age-difference test: 
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The marginal age-difference test involves the z statistic 𝑍𝐴𝑔𝑒𝑑𝑖𝑓𝑓 that corresponds to a basic 
stratum-difference test statistic (as given by equation (5)). The power formula for the 
marginal age-difference test is based on using the age-marginal effects b≤50, b>50 with se(b≤50) 
and se(b>50) in the power formula of the difference test (equation (13)). Expressing the age-
marginal parameters in terms of stratum-specific parameters (see equation (8), and with 
n≤50 = n>50 = 2n) and utilizing equations (10) and (11) yields: 
𝑃𝑤𝑟𝐴𝑔𝑒𝑑𝑖𝑓𝑓(𝛼, (𝑅𝑀≤50
2 , 𝑅𝐹≤50
2 , 𝑅𝑀>50
2 , 𝑅𝐹>50
2 ), 𝑛)
= Φ
(
 
 
 
 
 
 
 
−𝑧
1−
𝛼
2
− √𝑛
∑
|𝑅𝑗|
(1 − 𝑅𝑗
2)𝑗
∑
1
(1 − 𝑅𝑗
2)𝑗
−
∑
|𝑅𝑘|
(1 − 𝑅𝑘
2)𝑘
∑
1
(1 − 𝑅𝑘
2)𝑘
√∑
1
(1 − 𝑅𝑗
2)𝑗
+ ∑
1
(1 − 𝑅𝑘
2)𝑘
)
 
 
 
 
 
 
 
+Φ
(
 
 
 
 
 
 
 
−𝑧
1−
𝛼
2
+ √𝑛
∑
|𝑅𝑗|
(1 − 𝑅𝑗
2)𝑗
∑
1
(1 − 𝑅𝑗
2)𝑗
−
∑
|𝑅𝑘|
(1 − 𝑅𝑘
2)𝑘
∑
1
(1 − 𝑅𝑘
2)𝑘
√∑
1
(1 − 𝑅𝑗
2)𝑗
+ ∑
1
(1 − 𝑅𝑘
2)𝑘
)
 
 
 
 
 
 
 
 
(36), 
where j is iteratively expressed as M≤50 and F≤50, and k is iteratively expressed as M>50 
and F>50. The formula can equally be used to derive the power of the marginal sex-
difference test, in what case, j is iteratively expressed as M≤50 and M>50, and k is iteratively 
expressed as F≤50 and F>50. 
Marginal age-stratified test: 
The marginal age-stratified test involves two age-marginal t test statistics 𝑇≤50 =
𝑏≤50
𝑠𝑒(𝑏≤50)
 
and  𝑇>50 =
𝑏>50
𝑠𝑒(𝑏>50)
. Since each of the age-marginal effects is obtained from pooling two 
respective stratum-specific effects (e.g., 𝑏≤50 is obtained from meta-analysis of 𝑏𝑀≤50  and 
𝑏𝐹≤50), the power of a single age-marginal t test in dependence of respective stratum-specific 
explained variances is similar to the power of the 2-strata overall test (which is also a meta-
analysis of two strata): 𝑃𝑤𝑟≤50(𝛼, (𝑅𝑀≤50
2 , 𝑅𝐹≤50
2 ), 𝑛) = 𝑃𝑤𝑟𝑂𝑣𝑒𝑟𝑎𝑙𝑙(𝛼, 𝑅𝑀≤50
2 , 𝑅𝐹≤50
2 , 𝑛, 0.5); and 
𝑃𝑤𝑟>50(𝛼, (𝑅𝑀>50
2 , 𝑅𝐹>50
2 ), 𝑛) = 𝑃𝑤𝑟𝑂𝑣𝑒𝑟𝑎𝑙𝑙(𝛼, 𝑅𝑀>50
2 , 𝑅𝐹>50
2 , 𝑛, 0.5). To obtain the power of the 
marginal age-stratified test (combination of the two age-marginal t tests), the power formulae 
of the two age-marginal t tests have to be combined and the -levels have to be corrected for 
the multiple testing of two t tests. Leveraging independence of the age-marginal t tests (due 
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to using independent subjects), the power of the marginal age-stratified test is given as 
follows: 
𝑃𝑤𝑟𝐴𝑔𝑒𝑠𝑡𝑟𝑎𝑡(𝛼, 𝑅𝑀≤50
2 , 𝑅𝐹≤50
2 , 𝑅𝑀>50
2 , 𝑅𝐹>50
2 , 𝑛)
= 𝑃𝑤𝑟𝑂𝑣𝑒𝑟𝑎𝑙𝑙 (
𝛼
2
, 𝑅𝑀≤50
2 , 𝑅𝐹≤50
2 , 𝑛, 0.5) + 𝑃𝑤𝑟𝑂𝑣𝑒𝑟𝑎𝑙𝑙 (
𝛼
2
, 𝑅𝑀>50
2 , 𝑅𝐹>50
2 , 𝑛, 0.5)
− 𝑃𝑤𝑟𝑂𝑣𝑒𝑟𝑎𝑙𝑙 (
𝛼
2
, 𝑅𝑀≤50
2 , 𝑅𝐹≤50
2 , 𝑛, 0.5) 𝑃𝑤𝑟𝑂𝑣𝑒𝑟𝑎𝑙𝑙 (
𝛼
2
, 𝑅𝑀>50
2 , 𝑅𝐹>50
2 , 𝑛, 0.5) 
(37). 
The formula can equally be used to derive the power of the marginal sex-stratified test, in 
what case the subgroups for the overall power have to be defined by sex instead of by age 
group. 
Marginal age-joint test: 
The marginal age-joint test involves the chi-square statistic 𝐶𝐴𝑔𝑒𝑗𝑜𝑖𝑛𝑡 that corresponds to a 
basic 2-stata joint test statistic (given by equation (9)). The power formula for the marginal 
age-joint test is based on using the age-marginal effects b≤50, b>50 with se(b≤50) and se(b>50) in 
the power formula of the 2-strata joint test (equation (19)). Expressing the age-marginal 
parameters in terms of stratum-specific parameters (see equation (8), and with n≤50 = n>50 = 
2n) and utilizing equations (10) and (11) yields: 
𝑃𝑤𝑟𝐴𝑔𝑒𝑗𝑜𝑖𝑛𝑡(𝛼, (𝑅𝑀≤50
2 , 𝑅𝐹≤50
2 , 𝑅𝑀>50
2 , 𝑅𝐹>50
2 ), 𝑛)
= 1 − Χ2,𝜆((𝑅𝑀≤502 ,𝑅𝐹≤502 ,𝑅𝑀>502 ,𝑅𝐹>502 ),𝑛)
2 (𝜒2,1−𝛼) 
(38) 
, with non-centrality parameter  that is given by  
𝜆((𝑅𝑀≤50
2 , 𝑅𝐹≤50
2 , 𝑅𝑀>50
2 , 𝑅𝐹>50
2 ), 𝑛) = 𝑛
(
 
 
 ∑
|𝑅𝑗|
(1 − 𝑅𝑗
2)𝑗
√∑
1
(1 − 𝑅𝑗
2)𝑗
)
 
 
 
2
+ 𝑛
(
 
 
 ∑
|𝑅𝑘|
(1 − 𝑅𝑘
2)𝑘
√∑
1
(1 − 𝑅𝑘
2)𝑘
)
 
 
 
2
 (39), 
where j is iteratively expressed as M≤50 and F≤50, and k is iteratively expressed as M>50 
and F>50. The formula can equally be used to derive the power of the marginal sex-joint test, 
in what case, j is iteratively expressed as M≤50 and M>50, and k is iteratively expressed as 
F≤50 and F>50. 
Combining marginal age- and marginal sex-specific power formulae: 
The power for the marginal difference, the marginal stratified, and the marginal joint test is 
derived by combining the age- and the sex-version of the respective test using an OR 
relationship, while correcting the -levels of the age- and the sex-version for the multiple 
testing of two versions:  
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𝑃𝑤𝑟𝑀𝑎𝑟𝐷𝑖𝑓𝑓(𝛼, 𝑅𝑀≤50
2 , 𝑅𝐹≤50
2 , 𝑅𝑀>50
2 , 𝑅𝐹>50
2 , 𝑛) = 𝑃𝑤𝑟𝐴𝑔𝑒𝑑𝑖𝑓𝑓∪𝑆𝑒𝑥𝑑𝑖𝑓𝑓 (
𝛼
2
,… )
= 𝑃𝑤𝑟𝐴𝑔𝑒𝑑𝑖𝑓𝑓 (
𝛼
2
,… ) + 𝑃𝑤𝑟𝑆𝑒𝑥𝑑𝑖𝑓𝑓 (
𝛼
2
,… ) − 𝑃𝑤𝑟𝐴𝑔𝑒𝑑𝑖𝑓𝑓∩𝑆𝑒𝑥𝑑𝑖𝑓𝑓 (
𝛼
2
, … ) 
(40) 
𝑃𝑤𝑟𝑀𝑎𝑟𝑆𝑡𝑟𝑎𝑡(𝛼, 𝑅𝑀≤50
2 , 𝑅𝐹≤50
2 , 𝑅𝑀>50
2 , 𝑅𝐹>50
2 , 𝑛) = 𝑃𝑤𝑟𝐴𝑔𝑒𝑠𝑡𝑟𝑎𝑡∪𝑆𝑒𝑥𝑠𝑡𝑟𝑎𝑡 (
𝛼
2
,… )
= 𝑃𝑤𝑟𝐴𝑔𝑒𝑠𝑡𝑟𝑎𝑡 (
𝛼
2
,… ) + 𝑃𝑤𝑟𝑆𝑒𝑥𝑠𝑡𝑟𝑎𝑡 (
𝛼
2
,… ) − 𝑃𝑤𝑟𝐴𝑔𝑒𝑠𝑡𝑟𝑎𝑡∩𝑆𝑒𝑥𝑠𝑡𝑟𝑎𝑡 (
𝛼
2
,… ) 
(41) 
𝑃𝑤𝑟𝑀𝑎𝑟𝐽𝑜𝑖𝑛𝑡(𝛼, 𝑅𝑀≤50
2 , 𝑅𝐹≤50
2 , 𝑅𝑀>50
2 , 𝑅𝐹>50
2 , 𝑛) = 𝑃𝑤𝑟𝐴𝑔𝑒𝑗𝑜𝑖𝑛𝑡∪𝑆𝑒𝑥𝑗𝑜𝑖𝑛𝑡 (
𝛼
2
, … )
= 𝑃𝑤𝑟𝐴𝑔𝑒𝑗𝑜𝑖𝑛𝑡 (
𝛼
2
,… ) + 𝑃𝑤𝑟𝑆𝑒𝑥𝑗𝑜𝑖𝑛𝑡 (
𝛼
2
,… ) − 𝑃𝑤𝑟𝐴𝑔𝑒𝑗𝑜𝑖𝑛𝑡∩𝑆𝑒𝑥𝑗𝑜𝑖𝑛𝑡 (
𝛼
2
,… ) 
(42) 
The power can be computed analytically if the age- and the sex-version of the test are 
statistically independent. For example, assuming independence of the marginal age-
difference and the marginal sex-difference test, the power of the intersection can be 
computed as follows: 𝑃𝑤𝑟𝐴𝑔𝑒𝑑𝑖𝑓𝑓∩𝑆𝑒𝑥𝑑𝑖𝑓𝑓 = 𝑃𝑤𝑟𝐴𝑔𝑒𝑑𝑖𝑓𝑓 ∙ 𝑃𝑤𝑟𝑆𝑒𝑥𝑑𝑖𝑓𝑓. The simulated data sets 
(initially created for the type 1 error evaluation of approaches) were utilized to evaluate 
whether the respective age- and sex-versions of the marginal tests are dependent or 
independent. In case of dependence, the power of the intersection has to be obtained from 
simulated probability distributions. 
3.1.6.3 Power formulae for the approaches 
To obtain the power formula for an approach, the derived power formulae for the single 
statistical tests (i.e., steps implemented in the approach) have to be combined.  
As for the 2-strata configuration, for independent steps, the power of an approach is a 
product of the power of the implemented steps (see equation (22)). However, for dependent 
steps, the power for the intersection of dependent steps has to be obtained from simulated 
probability distributions. Again, the simulated data sets (initially created for the type 1 error 
evaluation of approaches) were utilized to evaluate statistical dependence of steps. 
3.1.6.4 Details of the power comparisons 
Analytical power formulae were derived for the considered approaches. In order to compute 
the power, assumptions about stratum-specific sample sizes, explained variances and -
levels have to be made. Generally, the parameters were defined to reflect realistic power 
computation scenarios that are similar to the GIANT consortium age- and sex-stratified 
GWAMA scenario.  
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A total balanced sample size of 200,000 was assumed to be equally distributed 
among the four age- and sex-specific strata. 
Different types of age- and sex-specific effects were modelled based on known and 
realistic genetic effect sizes taken from GIANT consortium GWAMAs on WHRadjBMI: A small 
(rs6784615 near STAB1), a medium (rs4684854 near PPARG) and a large (rs2820443 near 
LYPLAL1) genetic effect on WHRadjBMI that explained 0.014%, 0.058% and 0.167% of the 
WHRadjBMI variation in women, respectively (Heid et al., 2010; Randall et al., 2013).  
The -levels for the filtering tests were arbitrarily set to 1 = 1 x 10
-5. For each 
approach that involves filtering, the number of independent lead-SNPs passing the filtering 
(=M) had to be estimated from the real GIANT AGE x SEX data set (see chapter 4.1.4 for 
details) (Winkler et al, in revision). This was required to obtain the Bonferroni-corrected -
level for the final difference-of-difference test (Bonf = 0.05/M). 
3.2 Results 
The following chapters show results from the structured methodological comparison of age- 
and sex-stratified GWAMA approaches to identify 3-way G x AGE x SEX interaction effects. 
First, approaches were validated with regards to type 1 error (using simulation, chapter 3.1.5) 
and second, approaches were compared with regards to power (using analytical 
computations, chapter 3.2.2).  
3.2.1 Simulation-based evaluation of type 1 error 
To evaluate approaches with regards to type 1 error, simulation-based estimations of type 1 
error rates were performed.  
As for the 2-strata configuration, prior to investigating type 1 error of the approaches, 
the simulated data sets were validated, i.e., shown to truly reflect the implied null hypotheses 
of ‘No age-difference in sex-difference of genetic effects’ (see Appendix 9.4).  
Type 1 error rate (T1ER) of an approach was estimated by calculating the number of 
nominally significant difference-of-difference test results among all conducted difference-of-
difference tests. Assuming the null hypothesis of ‘No age-difference in sex-difference of 
genetic effects’ and a 5% -level one would expect that 5% of difference-of-difference tests 
reach nominal significance. Increased numbers of nominally significant test outcomes 
pinpoint invalid approaches.  
As for the 2-strata configuration, filtering on overall association did not inflate T1ER, 
but the stratified and the joint test increased the T1ER of the difference-of-difference test (for 
all modelled scenarios, Table 6).  
3. Screening for 3-way G x AGE x SEX interaction 
66 
 Surprisingly, approaches that involve filtering on marginal tests yielded valid T1ER for 
the difference-of-difference test (for all of the modelled scenarios, Table 6). Obviously, 
comparing marginal effects (marginal age-effects, independent of sex; or marginal sex-
effects, independent of age) cannot negatively impact T1ER of the difference-of-difference 
test. The impact of marginal filtering tests on power of the difference-of-difference test has to 
be investigated.  
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Table 6. Simulation-based type 1 error rates (T1ER) for the age- and sex-stratified GWAMA approaches. 
   𝑯𝟎
𝒏𝒐𝒆𝒇𝒇𝒆𝒄𝒕
 𝑯𝟎
𝒆𝒇𝒇𝒆𝒄𝒕
 𝑯𝟎
𝒔𝒆𝒙𝒅𝒊𝒇𝒇
 
Approach SNP MAF 
#DiffDiff- 
Testsa 
#DiffDiff 
<0.05b 
T1ER 
[%] 
#DiffDiff- 
Testsa 
#DiffDiff 
<0.05b 
T1ER 
[%] 
#DiffDiff- 
Testsa 
#DiffDiff 
<0.05b 
T1ER 
[%] 
[DiffDiffαDiffDiff] rs6002481 0.05 1,000,000 50,044 5.00 1,000,000 50,464 5.05 1,000,000 50,258 5.03 
 rs8138968 0.3 1,000,000 49,996 5.00 1,000,000 49,872 4.99 1,000,000 49,920 4.99 
 rs6007738 0.5 1,000,000 49,986 5.00 1,000,000 50,044 5.00 1,000,000 50,398 5.04 
[Overall0.05→DiffDiffαDiffDiff] rs6002481 0.05 50,596 2,623 5.18 999,795 50,448 5.05 82,331 4,119 5.00 
 rs8138968 0.3 50,499 2,522 4.99 999,848 49,869 4.99 53,353 2,634 4.94 
 rs6007738 0.5 50,578 2,604 5.15 999,863 50,036 5.00 53,192 2,736 5.14 
[Strat0.05→DiffDiffαDiffDiff] rs6002481 0.05 50,119 13,193 26.32 976,618 50,416 5.16 973,883 50,215 5.16 
 rs8138968 0.3 49,934 13,140 26.31 977,357 49,845 5.10 977,206 49,894 5.11 
 rs6007738 0.5 49,673 12,979 26.13 978,424 50,029 5.11 975,798 50,374 5.16 
[Joint0.05→DiffDiffαDiffDiff] rs6002481 0.05 50,924 15,831 31.09 997,193 50,451 5.06 996,886 50,250 5.04 
 rs8138968 0.3 50,693 15,780 31.13 997,792 49,870 5.00 997,763 49,910 5.00 
 rs6007738 0.5 50,714 15,648 30.86 997,981 50,044 5.01 997,601 50,395 5.05 
[MarDiff0.05→DiffDiffαDiffDiff] rs6002481 0.05 49,414 2,570 5.20 49,568 2,499 5.04 999,288 50,221 5.03 
 rs8138968 0.3 50,115 2,595 5.18 49,884 2,538 5.09 999,549 49,891 4.99 
 rs6007738 0.5 49,756 2,555 5.14 49,765 2,640 5.30 999,531 50,380 5.04 
[MarStrat0.05→DiffDiffαDiffDiff] rs6002481 0.05 45,080 2,298 5.10 996,997 50,304 5.05 992,370 49,846 5.02 
 rs8138968 0.3 45,384 2,348 5.17 997,447 49,759 4.99 994,216 49,590 4.99 
 rs6007738 0.5 45,216 2,299 5.08 997,642 49,923 5.00 993,903 50,127 5.04 
[MarJoint0.05→DiffDiffαDiffDiff] rs6002481 0.05 41,773 2,118 5.07 998,569 50,390 5.05 997,897 50,147 5.03 
 rs8138968 0.3 41,986 2,195 5.23 998,900 49,818 4.99 998,462 49,831 4.99 
 rs6007738 0.5 41,687 2,098 5.03 999,026 49,994 5.00 998,424 50,317 5.04 
a
 Number of SNPs tested for difference-of-difference (i.e., number of SNPs passing the filtering steps, Mfilt) 
b
 Number of SNPs with nominal significant difference-of-difference (PDiffDiff < 0.05) 
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3.2.2 Analytical power comparison  
To compare performance of approaches and to give recommendations for specific types of 
3-way G x AGE x SEX interaction effects, analytical power computations were performed for 
various realistic scenarios.  
Approaches that were shown to violate type 1 error requirements were omitted from 
power computations. A systematic scheme of approaches that were compared for power is 
shown in Figure 16. 
 
 
Figure 16. Systematic scheme of age- and sex-stratified GWAMA approaches to identify 3-
way G x AGE x SEX interaction effects that are considered for the power comparisons (gws:= 
5 x 10-8; 1 = -level for the filtering step; Bonf = Bonferroni-corrected -level). 
 
 
Simulation-based inference of statistical dependence between tests showed 
independence (i) between the difference-of-difference and the overall test, and (ii) between 
the marginal age-difference and the marginal sex-difference test (see Appendix 9.5). As a 
consequence, equation (22) could be used to calculate power of approaches 
[Overall1e-5→DiffDiffαBonf]  and [MarDiff1e-5→DiffDiffαBonf] . In contrast, the marginal age-
stratified and the marginal sex-stratified test, as well as the marginal age-joint and the 
marginal sex-joint test were shown to be dependent. Thus, simulated probability distributions 
had to be utilized to estimate the power of the intersection of tests 𝑃𝑤𝑟𝐴𝑔𝑒𝑆𝑡𝑟𝑎𝑡∩𝑆𝑒𝑥𝑆𝑡𝑟𝑎𝑡 and 
𝑃𝑤𝑟𝐴𝑔𝑒𝐽𝑜𝑖𝑛𝑡∩𝑆𝑒𝑥𝐽𝑜𝑖𝑛𝑡 (see Appendix 9.6). 
A list of power formulae including details about step-specific -levels and sample 
sizes is shown in Table 7.  
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Table 7. Analytical power formulae for the considered age- and sex-stratified GWAMA approaches. To calculate the Bonferroni-corrected -level 
for the final difference-of-difference test (Bonf = 0.05/M) of approaches that involve filtering steps, the number of independent lead SNPs tested 
(=M) was estimated from the real GIANT AGExSEX data set. 
Approach 
M 
(AGExSEX) Analytical power formula 
[DiffDiff5e-8] - 𝑃𝑤𝑟𝐷𝑖𝑓𝑓𝐷𝑖𝑓𝑓(5e-8, 𝑅𝑀≤50
2 , 𝑅𝐹≤50
2 , 𝑅𝑀>50
2 , 𝑅𝐹>50
2 , 𝑛) 
[Overall1e-5→DiffDiffαBonf] 135 𝑃𝑤𝑟𝑂𝑣𝑒𝑟𝑎𝑙𝑙(1e-5, 𝑅𝑀≤50
2 , 𝑅𝐹≤50
2 , 𝑅𝑀>50
2 , 𝑅𝐹>50
2 , 𝑛) ∙ 𝑃𝑤𝑟𝐷𝑖𝑓𝑓𝐷𝑖𝑓𝑓(𝛼𝑏𝑜𝑛𝑓 , 𝑅𝑀≤50
2 , 𝑅𝐹≤50
2 , 𝑅𝑀>50
2 , 𝑅𝐹>50
2 , 𝑛) 
[MarDiff1e-5→DiffDiffαBonf] 22 𝑃𝑤𝑟𝑀𝑎𝑟𝐷𝑖𝑓𝑓(1e-5, 𝑅𝑀≤50
2 , 𝑅𝐹≤50
2 , 𝑅𝑀>50
2 , 𝑅𝐹>50
2 , 𝑛) ∙ 𝑃𝑤𝑟𝐷𝑖𝑓𝑓𝐷𝑖𝑓𝑓(𝛼𝑏𝑜𝑛𝑓 , 𝑅𝑀≤50
2 , 𝑅𝐹≤50
2 , 𝑅𝑀>50
2 , 𝑅𝐹>50
2 , 𝑛) 
     with:  𝑃𝑤𝑟𝑀𝑎𝑟𝐷𝑖𝑓𝑓(𝛼, … ) = 𝑃𝑤𝑟𝐴𝑔𝑒𝐷𝑖𝑓𝑓 (
𝛼
2
, … ) + 𝑃𝑤𝑟𝑆𝑒𝑥𝐷𝑖𝑓𝑓 (
𝛼
2
, … ) − 𝑃𝑤𝑟𝐴𝑔𝑒𝐷𝑖𝑓𝑓(
𝛼
2
, … ) ∙ 𝑃𝑤𝑟𝑆𝑒𝑥𝐷𝑖𝑓𝑓(
𝛼
2
, … ) 
[MarStrat1e-5→DiffDiffαBonf] 95 𝑃𝑤𝑟𝑀𝑎𝑟𝑆𝑡𝑟𝑎𝑡(1e-5, 𝑅𝑀≤50
2 , 𝑅𝐹≤50
2 , 𝑅𝑀>50
2 , 𝑅𝐹>50
2 , 𝑛) ∙ 𝑃𝑤𝑟𝐷𝑖𝑓𝑓𝐷𝑖𝑓𝑓(𝛼𝑏𝑜𝑛𝑓 , 𝑅𝑀≤50
2 , 𝑅𝐹≤50
2 , 𝑅𝑀>50
2 , 𝑅𝐹>50
2 , 𝑛) 
      with:  𝑃𝑤𝑟𝑀𝑎𝑟𝑆𝑡𝑟𝑎𝑡(𝛼, … ) = 𝑃𝑤𝑟𝐴𝑔𝑒𝑆𝑡𝑟𝑎𝑡 (
𝛼
2
, … ) + 𝑃𝑤𝑟𝑆𝑒𝑥𝑆𝑡𝑟𝑎𝑡 (
𝛼
2
, … ) − 𝑃𝑤𝑟𝐴𝑔𝑒𝑆𝑡𝑟𝑎𝑡∩𝑆𝑒𝑥𝑆𝑡𝑟𝑎𝑡(
𝛼
2
, … ) 
[MarJoint1e-5→DiffDiffαBonf] 120 𝑃𝑤𝑟𝑀𝑎𝑟𝐽𝑜𝑖𝑛𝑡(1e-5, 𝑅𝑀≤50
2 , 𝑅𝐹≤50
2 , 𝑅𝑀>50
2 , 𝑅𝐹>50
2 , 𝑛) ∙ 𝑃𝑤𝑟𝐷𝑖𝑓𝑓𝐷𝑖𝑓𝑓(𝛼𝑏𝑜𝑛𝑓 , 𝑅𝑀≤50
2 , 𝑅𝐹≤50
2 , 𝑅𝑀>50
2 , 𝑅𝐹>50
2 , 𝑛) 
      with:  𝑃𝑤𝑟𝑀𝑎𝑟𝐽𝑜𝑖𝑛𝑡(𝛼,… ) = 𝑃𝑤𝑟𝐴𝑔𝑒𝐽𝑜𝑖𝑛𝑡 (
𝛼
2
, … ) + 𝑃𝑤𝑟𝑆𝑒𝑥𝐽𝑜𝑖𝑛𝑡 (
𝛼
2
, … ) − 𝑃𝑤𝑟𝐴𝑔𝑒𝐽𝑜𝑖𝑛𝑡∩𝑆𝑒𝑥𝐽𝑜𝑖𝑛𝑡(
𝛼
2
, … ) 
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First, power was compared for the biologically most plausible 1-stratum and for 3-
strata interaction effects. To accomplish this, power for the five considered approaches was 
depicted over an increasing modelled effect size: To reflect the 1-stratum interaction, the 
modeled effect was set to be present in the F≤50 group and lacking in all other strata, and to 
reflect the 3-strata interaction, the modeled effect was set to be equally present in the F≤50, 
M≤50 and F>50 groups and lacking in M>50 (Figure 17).  
Surprisingly, the marginal filtering approaches [MarStrat1e-5→DiffDiffαBonf]  and 
[MarJoint1e-5→DiffDiffαBonf] performed best for both types of interaction effects. In comparison, 
approach [Overall1e-5→DiffDiffαBonf] displayed similar power for 3-strata interaction effects, but 
lower power for 1-stratum interaction effects.  
Notably, only 1-stratum and 3-strata interaction effects involving large stratum-specific 
genetic effect sizes (comparable to the genetic effect on WHRadjBMI near LYPLAL1, 𝑅2 =
0.167%) can be detected efficiently by the given setting (e.g., power = 85.1% to find large 1-
stratum interaction with approach [MarJoint1e-5→DiffDiffαBonf], Table 8).  
For a medium modelled effect size (comparable to the genetic effect on WHRadjBMI 
near PPARG, 𝑅2 = 0.058%), none of the approaches displayed sufficient power to identify 
plausible 3-way interaction effects (power < 22%, Table 8).  
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Figure 17. Power to detect plausible 3-way interaction effects. A: Power to detect 1-stratum 
interaction over modeled effect size in F≤50 and assuming no effect in all other strata. B: 
Power to detect 3-strata interaction over modeled and identical effect sizes in F≤50, F>50 
and M≤50 and assuming no effect in M>50. 
 
Table 8. Power to detect plausible 3-way interaction effects (total sample size = 200,000). 
  Power 
Approach Modeled 𝑹
𝟐  
[%] 
1-stratum 
interaction 
3-strata  
interaction 
[DiffDiffαgws] 0.014 (STAB1) 0 0 
0.058 (PPARG) 0.3 0.3 
0.167 (LYPLAL1) 18.9 19.0 
 [Overall1e-5→DiffDiffαBonf] 0.014 (STAB1) 0 0.4 
0.058 (PPARG) 0.8 19.3 
0.167 (LYPLAL1) 47.5 84.4 
 [MarStrat1e-5→DiffDiffαBonf] 0.014 (STAB1) 0 0.4 
0.058 (PPARG) 6.3 22.0 
0.167 (LYPLAL1) 85.8 86.6 
[MarJoint1e-5→DiffDiffαBonf] 
 
0.014 (STAB1) 0 0.6 
0.058 (PPARG) 6.0 20.2 
0.167 (LYPLAL1) 85.1 85.2 
[MarDiff1e-5→DiffDiffαBonf] 
 
0.014 (STAB1) 0 0 
0.058 (PPARG) 0 0 
0.167 (LYPLAL1) 2.1 2.1 
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To further investigate the characteristics of approaches in greater detail and to 
illustrate their performance for other 3-way interaction effects, power was depicted in 
heatplots (Figure 18). For each heatplot, the effect size in F≤50 was set to a realistic genetic 
effect size and the effect size in M>50 was set to zero. The effect sizes in M≤50 and F>50 
were varied on the x- and y-axis, respectively. This strategy allowed to depict power for a 
range of interesting types of interaction effects (see Figure 18A for a map of interesting 
heatplot regions).  
The figure shows that for a medium modelled genetic effect (comparable to the 
genetic effect on WHRadjBMI in the PPARG region), the power of approaches 
[Overall1e-5→DiffDiffαBonf]  and [MarDiff1e-5→DiffDiffαBonf]  is low for any type of 3-way 
interaction effect.  
The genome-wide screening approach [DiffDiffαgws]  has good power to identify 
extreme 3-way interaction effects (see 3rd quadrant of Figure 18B) but lacks power for any 
other types.  
The behavior of approaches   [MarStrat1e-5→DiffDiffαBonf]  and 
[MarJoint1e-5→DiffDiffαBonf]  is similar across all types of 3-way interaction effects (Figure 
18E/F). However, approach [MarJoint1e-5→DiffDiffαBonf] shows slightly better power in the 2
nd, 
3rd and 4th quadrant. For example, the power to identify an effect that is positive in F≤50, 
negative in M≤50 and lacking in the other two strata, is 67.6% for approach 
[MarJoint1e-5→DiffDiffαBonf] and 34.8% for approach [MarStrat1e-5→DiffDiffαBonf].  
In summary, the power computations found approach [DiffDiffαgws] to be optimal for 
extreme 3-way interaction effects (see 3rd quadrant of the heatplots) and approach 
[MarJoint1e-5→DiffDiffαBonf]  to be optimal for plausible 1-stratum and 3-strata interaction 
effects (see regions a) and b) in the heatplots) as well as for the less extreme 3-way 
interaction effects (see 2nd and 4th quadrant in the heatplots). 
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Figure 18. Power heatplots. Shown is the power to identify 3-way interaction for the five 
considered age- and sex-stratified GWAMA approaches. Power is drawn for a fixed effect 
size in F≤50 (set to the medium genetic effect on WHRadjBMI, near PPARG), a fixed effect size 
in M>50 (set to zero) and over varying effect sizes in M≤50 (y-axis) and F>50 (x-axis). A: 
Regions of interest: a) 1-stratum interaction, b) 3-strata interaction, c) 2-way age-differential 
SSE (effect in younger, none in older), d) 2-way sexually dimorphic SSE (effect in women, 
none in men), and e) extreme 3-way interaction. Power is displayed for B: [DiffDiffαgws], C: 
 [Overall1e-5→DiffDiffαBonf]. D: [MarDiff1e-5→DiffDiffαBonf], E: [MarJoint1e-5→DiffDiffαBonf], and F: 
[MarStrat1e-5→DiffDiffαBonf]. 
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4 Application to stratified GWAMAs for obesity 
traits  
In order to explore the performance of approaches using real data and to systematically 
screen for potential stratum-difference in the genetic effects of central obesity, the best 
approaches were applied to real stratified GWAMA data sets for WHRadjBMI from the GIANT 
consortium.  
 First, in order to identify sex-difference in genetic effects for WHRadjBMI, the best 
approaches were applied to the balanced sex-stratified GIANT GENDER project data set for 
WHRadjBMI (Randall et al., 2013). Results were compared between best approaches and 
related to the reported results as well as to the originally applied approaches (Randall et al., 
2013).  
 Second, to explore approaches using a real unbalanced data set and to identify 
difference in genetic effects for WHRadjBMI between smokers and non-smokers, the best 
approaches were applied to the smoking-status stratified GIANT SMOKING project data set 
for WHRadjBMI (Justice et al, in progress).  
 Third, to identify 3-way G x AGE x SEX interaction effects for WHRadjBMI between, 
best 3-way approaches were applied to the age- and sex-stratified GIANT AGE x SEX 
project data set for WHRadjBMI (Winkler et al, in revision).  
4.1 Materials and Methods 
Except using different stratification variables (i.e., sex for GIANT GENDER, smoking-status 
for GIANT SMOKING, and dichotomized age and sex for GIANT AGE x SEX), similar 
statistical methods were employed for the conduct of the stratified GWAMAs (see chapter 
4.1.1). Descriptions of the project-specific data sets as well as an overview on the applied 
approaches are given in chapter 4.1.2 (for GIANT GENDER), chapter 4.1.3 (for GIANT 
SMOKING) and chapter 4.1.4 (for GIANT AGE x SEX).  
4.1.1 Statistical analysis for the stratified GWAMA projects of the GIANT 
consortium 
Generally, each project involved three consecutive steps: Study-specific GWAS testing, 
central quality-control of GWAS summary results and central GWAMAs.  
First, study-specific stratified GWAS were conducted. In order to obtain comparable 
summary GWAS results across studies and strata, an analysis plan was developed by the 
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consortium analysts and sent out to the study analysts. The plan detailed instructions about 
phenotype transformations, genotype models and GWAS testing.  
Each study analyst stratified the study data by the respective stratification variable, 
i.e., by sex, by smoking-status or by age and sex (age dichotomized at the age of 50 years). 
For studies with a case-control design, a further stratification by cases and controls was 
applied. For each stratum separately, waist-hip ratio (WHR) phenotypes were adjusted for 
age, age2 and BMI. To accomplish this, residuals were calculated from a non-linear 
regression model for WHR that included age, age2 and BMI. Finally, to obtain homogenously 
distributed phenotypes across strata and across studies, the stratum-specific residuals were 
inverse-normal transformed yielding a standard-normal distributed phenotype, defined as 
WHRadjBMI. 
Next, for each stratum, additively modeled SNP genotypes were tested for 
association with WHRadjBMI via linear regression using MACH2QTL (Y. Li, Willer, Ding, 
Scheet, & Abecasis, 2010), SNPTEST (Marchini, Howie, Myers, McVean, & Donnelly, 2007), 
ProbABEL (Aulchenko, Struchalin, & van Duijn, 2010), GenABEL (Aulchenko, Ripke, Isaacs, 
& van Duijn, 2007), Merlin (Abecasis & Wigginton, 2005), PLINK (Purcell et al., 2007) or 
QUICKTEST (Kutalik et al., 2011). The obtained stratum-specific GWAS summary results 
were provided to the consortium analysts via upload to an ftp server.  
Second, the collected study-specific GWAS results were validated centrally using an 
extensive quality control (QC) procedure (Winkler, Day, et al., 2014). The QC involved 
general file checks, such as checks for issues with phenotype transformations or issues with 
allele frequencies, as well as exclusion of low quality SNPs, such as exclusion of SNPs with 
poor imputation quality or with low minor allele count (see chapter 5.2 for details).  
Third, for each stratum separately, an inverse-variance weighted meta-analysis 
assuming a fixed effect model was performed using metal (Willer, Li, & Abecasis, 2010). In 
order to ensure proper results, each meta-analysis was conducted by two analysts 
simultaneously, followed by a comparison of results. Again, results were validated using an 
extensive meta-analysis quality control (QC) procedure (see chapter 5.2 and (Winkler, Day, 
et al., 2014) for details).   
4.1.2 Utilizing the GIANT GENDER data for WHRadjBMI to screen for 
stratum-difference under a balanced design 
The GIANT GENDER data for WHRadjBMI reflects a balanced 2-stage sex-stratified GWAMA 
results data set that was created according to the methods described in chapter 4.1.1 
(Randall et al., 2013). 
The discovery stage included sex-stratified GWAS results from 46 HapMap imputed 
studies (each analyzing up to 2.8M SNPs) and comprised up to 60,586 men and 73,137 
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women of European descent. Randall and colleagues selected SNPs from discovery stage 
and followed them up in additional 48 independent replication studies that comprised up to 
62,395 men and 74,657 women. The replication data set contained both HapMap imputed 
studies as well as studies that were genotyped using the custom MetaboChip array 
(analyzing up to ~195K SNPs)(Voight et al., 2012). The two separate stages of the GIANT 
GENDER data were directly applicable to the considered 2-stage approaches. To 
additionally make the GIANT GENDER data applicable to 1-stage approaches, sex-specific 
inverse-variance weighted meta-analyses of the GIANT GENDER discovery and replication 
data sets were conducted using metal (Willer et al., 2010).  
The best 1-stage approaches, [Diff5e-8] and [Overall1e-5→DiffαBonf] as well as the best 
2-stage approaches [Joint1e-5,Diff0.05]→[DiffαBonf] and [[Overall1e-5]→DiffαBonf] were applied to 
the GIANT GENDER data for WHRadjBMI. For each approach, a list of independent lead SNPs 
with significant sex-differences was extracted according to the technical procedure described 
in chapter 2.1.4. Results were compared between the best approaches and related to the 
power computation results.  
Moreover, results of the best approaches were related to originally applied 
approaches and to the reported results (Randall et al., 2013). Since the original systematic 
screen for sex-difference conducted by Randall and colleagues considered nine 
anthropometric traits in parallel, the results were not directly comparable to the here applied 
approaches that focus on WHRadjBMI. Thus (in order to improve comparability), the Randall-
like 2-stage approaches [Stratα1 ,Diffα2] → [Diffαdiff] and [Diffα1] → [Diffαdiff] were applied to the 
WHRadjBMI data set and results were compared with the best approaches. 
4.1.3 Utilizing the GIANT SMOKING data for WHRadjBMI to screen for 
stratum-difference under an unbalanced design 
The GIANT SMOKING data for WHRadjBMI reflects an unbalanced smoking-status stratified 
GWAMA results data set that was created according to the methods described in chapter 
4.1.1.  
In total, results from 88 HapMap imputed or typed MetaboChip GWA studies were 
included that comprised up to 37,300 smokers and up to 129,926 non-smokers of European 
descent. This reflected an unbalanced stratified GWAMA design that implies f = 3.48 
(proportion of non-smokers to smokers, i.e., smokers as stratum 1) or f = 0.28 (proportion of 
smokers to non-smokers, i.e., non-smokers as stratum 1). Due to adopting both, 1- and 2-
stage approaches in the GIANT SMOKING project analyses, the data sets were directly 
applicable to all of the here considered approaches. 
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Here, the best 1-stage approaches, [Diff5e-8] and [Overall1e-5→DiffαBonf] as well as the 
best 2-stage approaches [Joint1e-5,Diff0.05]→[DiffαBonf]  and [[Overall1e-5]→DiffαBonf]  were 
applied to the GIANT SMOKING data for WHRadjBMI. For each approach, a list of independent 
lead SNPs with significant differences in genetic effects between smokers and non-smokers 
was extracted according to the technical procedure described in chapter 2.1.4. Results were 
compared between the best approaches and related to the power computation results.  
4.1.4 Utilizing the GIANT AGE x SEX data for WHRadjBMI to screen for G x 
AGE x SEX interaction 
The GIANT AGE x SEX data for WHRadjBMI reflects an age- and sex-stratified GWAMA 
results data set that was created according to the methods described in chapter 4.1.1. 
For WHRadjBMI, age- and sex-stratified GWAS results from 84 HapMap imputed or 
typed MetaboChip studies were analyzed that comprise up to 216,654 individuals of 
European descent. Due to adopting a 1-stage design in the GIANT AGE x SEX project 
analyses, the data set was directly applicable to the here considered 1-stage approaches. 
The best approaches, [DiffDiff5e-8] and [MarJoint1e-5→DiffDiffαBonf] were applied to the 
GIANT AGE x SEX data for WHRadjBMI. For each approach, a list of independent lead SNPs 
with significant 3-way G x AGE x SEX interaction effects was extracted according to the 
technical procedure described in chapter 3.1.4. Results were compared between the 
considered approaches and related to the power computation results.  
4.2 Results 
To explore difference in genetic effects on WHRadjBMI between men and women (chapter 
4.2.1), between smokers and non-smokers (chapter 4.2.2), as well as to identify 3-way G x 
AGE x SEX interaction effects for WHRadjBMI (chapter 4.2.3), selected approaches were 
applied to real stratified GWAMA results data for WHRadjBMI from the GIANT consortium.   
4.2.1 Identification of sex-differences in genetic effects for WHRadjBMI  
In order to screen for genetic effects for WHRadjBMI that are significantly different between 
men and women, the best 1-stage approaches [Diff5e-8] (for OED) and [Overall1e-5→DiffαBonf] 
(for SSE and CED, chapter 4.2.1.1) as well as the best 2-stage approaches 
[Joint1e-5,Diff0.05]→[DiffαBonf] (for OED and SSE) and [[Overall1e-5]→DiffαBonf] (for CED, chapter 
4.2.1.2) were applied to the GIANT GENDER data set for WHRadjBMI.  
Furthermore, results were compared between stage designs (chapter 4.2.1.3) and 
compared to approaches [Strat1e-5,Diff0.05] → [DiffαBonf]  and [Diff1e-5] → [DiffαBonf]  that are 
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similar to the originally employed approaches by Randall and colleagues (chapter 4.1.4) 
(Randall et al., 2013). 
4.2.1.1 The best 1-stage approaches  
In total, the best 1-stage approaches [Diff5e-8]  and  [Overall1e-5→DiffαBonf]  identified 10 
independent loci with significant sex-differences in the genetic effects for WHRadjBMI (Table 
9). Nine of the 10 loci showed a stronger effect in women: Seven being women SSE signals 
that completely lack association in men (near SLC30A10, COBLL1, PPARG, PLXND1, 
TNFAIP8, VEGFA, NKX3-1) and two being women CED signals that show an effect in 
women accompanied by a less pronounced (but nominally significant and concordant) effect 
in men (near ADAMTS9, ITPR2). One of the 10 loci displayed significant effects in both men 
and women, yet with opposite effect directions (near LRRC69).  
Consistent with the results from the power computations, the two CED signals were 
only identified by approach [Overall1e-5→DiffαBonf] and the OED signal was only detected by 
approach [Diff5e-8]. While four of the seven women SSE signals were found by both 1-stage 
approaches, the other three SSE signals were only detected by [Overall1e-5→DiffαBonf]. This is 
again consistent with the power comparison results that demonstrated that approach 
[Overall1e-5→DiffαBonf] is advantageous over [Diff5e-8] for SSE signals.  
The here identified loci include all of the six sexually dimorphic WHRadjBMI loci 
reported by Randall and colleagues as well as four novel sexually dimorphic loci (near 
PLXND1, NKX3-1, LRRC69, ITPR2) that were missed by Randall and colleagues (Randall et 
al., 2013). This can be attributed to the more optimal approaches but also to the different 
SNP selection method applied by Randall and colleagues that involved a False-Discovery-
Rate (FDR) approach to correct for the multiple testing of nine considered anthropometric 
and obesity phenotypes (thus results were not directly comparable).  
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Table 9. Ten loci with sexually dimorphic effects for WHRadjBMI detected by the best 1-stage approaches [Diff5e-8] (Diff) and [Overall1e-5→DiffαBonf] 
(OverallDiff). To indicate loci detected by both approaches but with different lead SNPs, independent loci are distinguished by alternating shading. 
The table is sorted by chromosome and position. 
        Men Women 
Gene
a
 SNP Approach Type EA
b
 EAF
c
 PSexdiff POverall Beta P N Beta P N 
SLC30A10 chr1:217820132 Diff 
OverallDiff 
SSE T 0.72 1.2E-16 1.2E-23 0.005 0.37 76,626 0.064 4.6E-37 98,352 
COBLL1 chr2:165236870
d
 OverallDiff SSE G 0.60 6.5E-16 2.7E-17 3.0E-04 0.95 75,573 0.054 1.8E-31 97,142 
 chr2:165247907
d
 Diff SSE T 0.59 1.0E-16 1.4E-14 -0.003 0.61 76,594 0.052 2.0E-29 98,322 
PPARG chr3:12463882 OverallDiff SSE C 0.43 2.2E-06 2.1E-09 0.004 0.41 74,653 0.037 4.2E-14 96,473 
PLXND1* chr3:130816923
e
 OverallDiff SSE A 0.79 3.2E-07 1.4E-09 0.003 0.68 74,655 0.044 7.5E-15 96,056 
 chr3:130822305
e
 Diff SSE T 0.79 5.3E-09 1.5E-07 -0.007 0.33 44,701 0.048 2.4E-14 73,628 
ADAMTS9 chr3:64676186 OverallDiff CED A 0.70 4.1E-05 4.9E-20 0.018 9.4E-04 75,590 0.047 5.3E-21 97,150 
TNFAIP8 chr5:118757185 OverallDiff SSE C 0.71 5.2E-06 2.6E-08 0.003 0.55 75,584 0.037 7.9E-13 97,136 
VEGFA chr6:43872529 Diff 
OverallDiff 
SSE T 0.47 7.1E-12 1.6E-22 0.010 0.05 75,704 0.060 2.4E-31 97,269 
NKX3-1* chr8:23659269 OverallDiff SSE A 0.77 6.5E-07 3.8E-07 -5.0E-04 0.94 75,598 0.038 3.4E-12 97,157 
LRRC69* chr8:92217371 Diff OED T 0.67 4.1E-08 0.95 -0.026 4.4E-05 44,792 0.019 5.4E-04 73,744 
ITPR2* chr12:26361436 OverallDiff CED T 0.25 1.4E-04 2.1E-13 0.013 0.02 74,269 0.042 4.4E-15 95,750 
a 
Nearest gene; 
 b 
Effect allele: Chosen to reflect the WHRadjBMI increasing allele in women; 
c 
Effect allele frequency calculated from the sex-combined sample; 
 d 
r
2
 
between COBLL1 lead SNPs is 0.94; 
e
 r
2
 between PLXND1 lead SNPs is 1.00. * Novel locus compared to Randall and colleagues. 
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4.2.1.2 The best 2-stage approaches  
In total, the best 2-stage approaches [Joint1e-5,Diff0.05]→[DiffαBonf] and [[Overall1e-5]→DiffαBonf] 
identified seven loci with significant sex-differences in the genetic effects on WHRadjBMI 
(Table 10).  
Of the seven loci, four loci were identified by both approaches (near SLC30A10, 
COBLL1, ADAMTS9, VEGFA) and three have only been detected by approach 
[[Overall1e-5]→DiffαBonf]  (near PLXND1, ITPR2, HOXC13). Two of the latter three can be 
categorized as CED effects, which supports the power analysis result that recommended 
approach [[Overall1e-5]→DiffαBonf] for CED effects. The remaining five loci can be classified as 
SSE effects, with one locus being a borderline SSE/CED locus (near ADAMTS9). No OED 
loci were identified.  
While four of the seven identified loci overlap with results reported by Randall and 
colleagues, three novel loci were identified by approach [[Overall1e-5]→DiffαBonf]  (near 
PLXND1, ITPR2, HOXC13) (Randall et al., 2013). Notably, two of the loci identified by 
Randall and colleagues were completely missed by the here conducted analysis. The main 
reason for this may be that Randall and colleagues applied a different SNP selection method 
that involved a FDR approach to correct for the multiple testing of nine considered 
anthropometric and obesity phenotypes (thus results were not directly comparable). 
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Table 10. Seven sexually dimorphic loci for WHRadjBMI detected by the best 2-stage approaches [Joint1e-5,Diff0.05]→[DiffαBonf] (Joint2Diff), and 
[[Overall1e-5]→DiffαBonf] (Overall2Diff). Independent loci are distinguished by alternating shading. The table is sorted by chromosome and position. 
          MEN WOMEN 
Gene
a
 SNP Approach Type EA
b
 EAF
c
 Stage PSexdiff POverall PSexjoint Beta P N Beta P N 
SLC30A10 chr1:217815441
d
 Joint2Diff SSE C 0.72 Disc 1.2E-07 3.4E-12 4.5E-17 0.009 0.23 34,599 0.064 8.5E-18 42,732 
 
 
    Repl 1.1E-09 2.6E-11 2.9E-18 -2.0E-04 0.98 40,935 0.064 1.4E-19 53,799 
 
 
    Comb 3.1E-16 4.2E-22 9.3E-35 0.005 0.39 75,534 0.064 1.7E-35 96,530 
 chr1:217820132
d
 Overall2Diff SSE T 0.72 Disc 1.2E-07 1.2E-12 1.7E-17 0.010 0.19 34,601 0.064 3.7E-18 42,735 
 
 
    Repl 3.2E-10 5.0E-12 1.8E-19 -6.0E-04 0.94 42,025 0.064 1.8E-20 55,617 
 
 
    Comb 1.2E-16 1.2E-23 1.1E-36 0.005 0.37 76,626 0.064 4.6E-37 98,352 
COBLL1 chr2:165221337
e
 Overall2Diff SSE T 0.59 Disc 3.0E-06 1.1E-10 2.8E-14 0.009 0.20 34,579 0.053 6.3E-15 42,708 
 
 
    Repl 1.9E-11 2.3E-07 4.4E-16 -0.012 0.12 40,091 0.054 1.3E-16 53,347 
 
 
    Comb 6.5E-16 3.2E-16 1.2E-28 -7.0E-04 0.90 74,670 0.053 6.6E-30 96,055 
 chr2:165265564
e
 Joint2Diff SSE C 0.62 Disc 1.5E-07 6.5E-08 8.6E-13 0.001 0.89 34,572 0.052 9.1E-14 42,712 
 
 
    Repl 2.3E-10 1.1E-06 2.2E-14 -0.011 0.15 40,998 0.052 4.9E-15 54,425 
 
 
    Comb 1.5E-16 4.1E-13 3.5E-26 -0.005 0.37 75,569 0.052 3.8E-27 97,136 
ADAMTS9 chr3:64679931
f
 Overall2Diff CED T 0.70 Disc 0.04 4.0E-08 4.0E-08 0.018 0.02 34,601 0.038 1.1E-07 42,735 
 
 
    Repl 7.4E-04 3.1E-13 1.1E-14 0.018 0.02 40,995 0.053 1.8E-14 54,422 
 
 
    Comb 8.6E-05 8.2E-20 6.3E-22 0.018 7.9E-04 75,595 0.046 3.5E-20 97,156 
 chr3:64686944
f
 Joint2Diff SSE C 0.75 Disc 3.3E-04 2.0E-05 2.4E-07 0.004 0.62 34,589 0.042 3.8E-08 42,708 
 
 
    Repl 2.1E-03 7.4E-12 6.4E-13 0.019 0.03 40,997 0.052 1.1E-12 54,424 
 
 
    Comb 1.2E-06 3.6E-15 5.1E-19 0.011 0.06 75,586 0.048 2.9E-19 97,132 
PLXND1* chr3:130788609 Overall2Diff SSE T 0.90 Disc 8.2E-06 1.7E-06 8.1E-10 0.003 0.83 34,520 0.074 9.9E-11 42,670 
 
 
    Repl 0.25 3.0E-03 6.4E-03 0.014 0.27 42,004 0.032 2.9E-03 55,613 
 
 
    Comb 7.8E-05 3.6E-08 1.6E-10 0.008 0.36 76,524 0.052 3.8E-11 98,283 
VEGFA chr6:43872529 Joint2Diff SSE T 0.47 Disc 3.0E-05 1.5E-10 2.9E-13 0.012 0.11 34,594 0.057 1.1E-13 42,727 
 
 
Overall2Diff    Repl 6.2E-08 2.4E-13 1.4E-18 0.009 0.22 41,110 0.062 2.8E-19 54,542 
 
 
    Comb 7.1E-12 1.6E-22 4.1E-31 0.010 0.05 75,704 0.060 2.4E-31 97,269 
ITPR2* chr12:26354349 Overall2Diff CED C 0.25 Disc 9.4E-04 8.3E-08 3.1E-09 0.011 0.14 34,601 0.046 1.2E-09 42,735 
 
 
    Repl 0.08 2.2E-06 3.0E-06 0.015 0.07 40,916 0.034 2.3E-06 54,373 
 
 
    Comb 3.2E-04 1.2E-12 2.4E-14 0.013 0.02 75,517 0.040 2.9E-14 97,108 
HOXC13* chr12:52628951 Overall2Diff CED A 0.24 Disc 6.3E-04 1.8E-07 4.6E-09 0.011 0.18 34,599 0.048 1.4E-09 42,735 
 
 
    Repl 0.09 1.4E-06 2.1E-06 0.016 0.05 41,112 0.035 2.0E-06 54,536 
 
 
    Comb 2.9E-04 1.2E-12 2.1E-14 0.013 0.02 75,711 0.041 3.0E-14 97,271 
a 
Nearest gene; 
 b 
Effect allele: WHRadjBMI increasing allele in women; 
c 
Effect allele frequency from the sex-combined sample; 
 d 
r
2
 between SLC30A10 lead SNPs 
is 0.96; 
e 
r
2
 between COBLL1 lead SNPs is 0.69; 
f 
r
2
 between ADAMTS9 lead SNPs is 0.74. * Novel locus compared to Randall and colleagues. 
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4.2.1.3 Comparison between the 1- and 2-stage approaches  
As expected, the 1-stage approaches outperformed the 2-stage approaches (10 versus 
seven identified loci).  
Consistent with the expectation that the power gain of the 1-stage approach 
 [Overall1e-5→DiffαBonf] for SSE loci outweighs the small power loss for CED loci compared to 
the 2-stage approach [[Overall1e-5]→DiffαBonf], three SSE loci were detected by the 1-stage 
approach [Overall1e-5→DiffαBonf] (and missed by any 2-stage approach), but only one CED 
locus (near ITPR2) was detected by the 2-stage approach [[Overall1e-5]→DiffαBonf]  (and 
missed by any 1-stage approach).  
The general recommendation for adopting a 1-stage design is further supported by 
the fact that the only identified OED locus (near LRRC69) was completely missed by the 2-
stage approaches.  
4.2.1.4 Comparison with re-analyzed GIANT GENDER project approaches   
In order to improve comparability between the here applied best 1- and 2-stage approaches 
(focused on WHRadjBMI and employed Bonferroni-corrected -levels) and the originally 
applied approaches by Randall and colleagues (considered nine anthropometric and obesity 
traits in parallel and employed a FDR approach to correct for the multiple testing), Randall-
like approaches were applied to the GIANT GENDER data set for WHRadjBMI. More 
specifically, the replication-based 2-stage approaches [Strat1e-5,Diff0.05]→[DiffαBonf]  and 
[Diff1e-5]→[DiffαBonf]  were applied because these are similar to the originally employed 
screening approaches (Randall et al., 2013).    
 In total, the two Randall-like approaches identified four independent loci with 
significant sex-difference (Table 11). All four loci were similarly identified by the best 1- and 
2-stage approaches, which however, additionally identified another six and three loci, 
respectively. More specifically, the Randall-like approach [Strat1e-5,Diff0.05]→[DiffαBonf] 
identified the exact same set of loci as approach [Joint1e-5,Diff0.05]→[DiffαBonf], but missed the 
three loci that were only identified by the combined 2-stage approach [[Overall1e-5]→DiffαBonf]. 
This is consistent with the power analyses that demonstrated equal power of approaches 
[Strat1e-5,Diff0.05]→[DiffαBonf]and [Joint1e-5,Diff0.05]→[DiffαBonf] for SSE and CED effects, but 
increased power of approach [[Overall1e-5]→DiffαBonf] for CED effects. 
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Table 11. Four sexually dimorphic loci for WHRadjBMI detected by the re-analyzed Randall-like 2-stage approaches [Strat1e-5,Diff0.05]→[DiffαBonf] 
(Strat2Diff) and [Diff1e-5]→[DiffαBonf] (Diff2Diff). Independent loci are distinguished by alternating shading. The table is sorted by chromosome and 
position. 
         MEN WOMEN 
Genea SNP Approach Type EAb EAFc Stage PSexdiff PSexstrat Beta P N Beta P N 
SLC30A10 chr1:217815441 Strat2Diff SSE C 0.72 Disc 1.2E-07 1.7E-17 0.009 0.23 34,599 0.064 8.5E-18 42,732 
 
 
Diff2Diff    Repl 1.1E-09 2.8E-19 -2.0E-04 0.98 40,935 0.064 1.4E-19 53,799 
COBLL1 chr2:165265564 Strat2Diff SSE C 0.62 Disc 1.5E-07 1.8E-13 0.001 0.89 34,572 0.052 9.1E-14 42,712 
 
 
Diff2Diff    Repl 2.3E-10 9.8E-15 -0.011 0.15 40,998 0.052 4.9E-15 54,425 
ADAMTS9 chr3:64686944 Strat2Diff SSE C 0.75 Disc 3.3E-04 7.6E-08 0.004 0.62 34,589 0.042 3.8E-08 42,708 
 
 
    Repl 2.1E-03 2.1E-12 0.019 0.03 40,997 0.052 1.1E-12 54,424 
VEGFA chr6:43872529 Strat2Diff SSE T 0.47 Disc 3.0E-05 2.2E-13 0.012 0.11 34,594 0.057 1.1E-13 42,727 
 
 
    Repl 6.2E-08 5.5E-19 0.009 0.22 41,110 0.062 2.8E-19 54,542 
a Nearest gene;  b Effect allele: WHRadjBMI increasing allele in women; 
c Effect allele frequency from the sex-combined sample 
 
4. Application to stratified GWAMAs for WHRadjBMI 
 
84 
4.2.2 Identification of differences between smokers and non-smokers in 
genetic effects for WHRadjBMI     
In order to screen for genetic effects for WHRadjBMI that are significantly different between 
smokers and non-smokers, the best 1-stage approaches [Diff5e-8] and [Overall1e-5→DiffαBonf] 
as well as the best 2-stage approaches [Joint1e-5,Diff0.05]→[DiffαBonf]  and 
[[Overall1e-5]→DiffαBonf]  were applied to the unbalanced GIANT SMOKING data set for 
WHRadjBMI, and results were compared.  
 In total, three loci were identified that display significant differences in genetic effects 
between non-smokers and smokers (near SOX11, MYT1L and EYA4) (Figure 19). All of the 
three loci were identified by the 1-stage approach [Overall1e-5→DiffαBonf] . The 2-stage 
approach [[Overall1e-5]→DiffαBonf]  missed the locus near EYA4. Approaches [Diff5e-8]  and 
[Joint1e-5,Diff0.05]→[DiffαBonf] did not identify any loci.  
 All of the identified loci are categorized as non-smoker-specific SSE loci displaying an 
effect in non-smokers while lacking effect in smokers. This is consistent with the power 
comparisons that suggested that power to detect SSE effects carrying the effect in the larger 
subgroup (non-smokers, f < 1) is larger than power to detect SSE effects carrying the effect 
in the smaller subgroup (smokers, f > 1). Clearly, larger sample sizes – in particular more 
smokers - are needed to increase power to detect subtle smoker-specific SSE effects.  
 The identification of SSE signals by the approaches that include a-priori filtering on 
overall association further supports the power computations results.  
Same as for the smoker-specific SSE effects, larger sample sizes are needed to 
identify realistic CED effects. However, given the large power to identify OED effects (power 
was shown to be comparable to the power of SSE f < 1 signals), the lack of OED25% loci 
suggests that such loci may simply not exist for the WHRadjBMI.  
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Figure 19. Betas in non-smokers compared to betas in smokers. The plots contrast 
betas (pooled genetic effects) between non-smokers (y-axes) and smokers (x-axes). A: 1-
stage approaches: Shown are independent lead SNPs for loci that survived the 1-stage 
filtering criterion POverall < 1 x 10
-5. The orange highlighted loci displayed significant difference 
between smokers and non-smokers and were identified by approach [Overall1e-5→DiffαBonf]. 
B: 2-stage approaches: Shown are discovery + replication data set results for independent 
lead SNPs for loci that survived the discovery filtering criterion POverall < 1 x 10
-5. The green 
loci displayed significant difference between smokers and non-smokers and were identified 
by approach [[Overall1e-5]→DiffαBonf]. 
 
 
4.2.3 Identification of G x AGE x SEX interaction for WHRadjBMI   
In order to screen for 3-way G x AGE x SEX interaction effects for WHRadjBMI, the best 
approaches [DiffDiffαDiffDiff] and [MarJoint1e-5→DiffDiffαDiffDiff] were applied to the GIANT AGE x 
SEX data set for WHRadjBMI, and results were compared.  
No significant 3-way G x AGE x SEX interaction effects were identified (Figure 20). 
Given the large power to find extreme 3-way interaction effects involving medium genetic 
effect sizes (comparable to the known genetic effect on WHRadjBMI near PPARG, power > 
80%) suggests that such effects may simply not exist and supports the prior believe that 
such extreme interaction effects are implausible.  
However, lack of biologically plausible 3-way interaction effects may be due to low 
power. With the current GIANT AGE x SEX setting, only 1-stratum and 3-strata interaction 
effects could have been identified that involve large genetic effect sizes. Thus, larger sample 
sizes would be needed to efficiently identify plausible 3-way interaction effects that involve 
medium or even smaller effect sizes. For example, identification of a medium 1-stratum 
interaction effect (comparable to the known PPARG effect that is present in one stratum and 
lacking in the other three) with 80% power would require a total sample size of 536,000; and 
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identification of a medium 3-strata interaction effect (comparable to the known PPARG effect 
that is present in three and lacking in one stratum) with 80% power would require a total 
sample size of 528,000. 
 
 
 
Figure 20. QQ plot depicting distribution of difference-of-difference P-Values (PDiffDiff) for all 
SNPs genome-wide (magenta) and for a subset of SNPs that passed filtering on marginal 
joint association (PMarJoint < 1 x 10
-5) (green). No significant difference-of-difference P-Values 
were observed. 
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5 The Easy R packages  
Large-scale GWAMA consortia nowadays gather data from hundreds of single GWAS 
studies. Often, consortia are evaluating a multitude of phenotypes in parallel and specific 
requirements, such as stratified analyses, further increase the overall complexity.  
For example, recent stratified GWAMAs from the GIANT consortium involved multiple 
obesity traits (e.g., BMI, waist circumference and waist-hip ratio), multiple stratification 
variables (e.g., smoking, physical activity, age and sex) and included up to 320,000 
individuals from hundreds of single GWA studies (Justice et al, in progress; Winkler et al, in 
revision). In total, more than 3,000 single GWAS result files were evaluated, each of which 
contained ~2.8M rows of SNP-specific association results. Proper conduct of the stratified 
GWAMAs necessitated an extensive quality control (QC) procedure and software that was 
able to deal with the large number of large GWAS result files.  
In addition, a further software tool was required to evaluate stratified GWAMA results, 
i.e., to apply the here defined screening approaches, to extract significant results and to 
generate graphical summaries.  
Two R packages were developed that facilitate conduct, QC and evaluation of 
stratified GWAMAs (Figure 21). The R package EasyQC was originally developed for QC of 
large numbers of general large scale GWAS and GWAMA data sets, but can readily be 
applied to stratified GWAS and stratified GWAMA data sets (Winkler, Day, et al., 2014). The 
R package EasyStrata is tailored for the statistical and graphical evaluation of stratified 
GWAMA results data (Winkler, Kutalik, et al., 2014).  
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Figure 21. Integration of EasyQC and EasyStrata into a sex-stratified GWAMA pipeline. 
EasyQC is applied for the QC of the study-specific GWAS results and EasyStrata is applied 
to evaluate the sex-stratified GWAMA results, e.g., to apply the screening approach, to 
extract independent loci with significant sex-difference effects or to create graphical 
presentations of results. 
 
5.1 The Easy framework 
Both packages were implemented into the Easy framework. The framework only exports a 
single function, either EasyQC() or EasyStrata(). To start the program, the function is called 
from the R command line with a single parameter that is the path to a customized ecf-file, 
e.g., EasyStrata(“/path2ecf/pipeline.ecf”). The ecf-file is a plain text file that consists of two 
parts: a configuration-section at the beginning that defines data input and output, and a 
scripting interface that defines the commands to be executed. The scripting interface allows 
aligning multiple statistical, graphical and general data handling functions in a flexible 
fashion. The ecf-file concept and the Easy framework simplify data-handling and allow the 
user to easily develop customized QC or evaluation pipelines. Customized ecf-pipelines to 
facilitate GWAMA QC and evaluation of stratified GWAMA results were developed and can 
be downloaded from the website www.genepi-regensburg.de/software. An example 
EasyStrata ecf-pipeline to evaluate sex-stratified GWAMA results is shown in Appendix 9.7.  
5.1.1 Object oriented programming 
In order to use a structured object oriented programming technique, each of the exported 
EasyQC or EasyStrata commands was integrated as separate class. Class definitions were 
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similarly structured and provide variables and functions specifically for the respective 
command. Each command class contains functions to (i) to translate the scripting interface 
parameters into class variables; (ii) conduct validity checks, e.g., to ensure that the stated 
parameters are applicable with the command and with the current input data; and (iii) to 
execute the actual command-specific algorithm. This object-oriented programming technique 
allows the developer to easily update the package by new functionality or commands that are 
automatically exported to the scripting interface. 
5.1.2 Big data  
To efficiently handle large data-sets, the Easy framework utilizes the data.table package that 
provides state-of-the-art functions to handle big data in R. Objects of type data.table are an 
extension to the commonly used data.frames, but provide a much faster and more efficient 
aggregation and combination of data. The data.table concept was implemented in a specific 
data type called GWADATA that was developed to supply general data handling and data 
manipulation functions and that is utilized throughout the whole package implementation.  
5.1.3 Requirements and performance  
Since the Easy framework inherits functionality from the graphical R packages Cairo, plotrix 
and data.table, these packages have to be available prior to installation of EasyQC or 
EasyStrata. Extracting independent loci using LD-based thresholds requires the software 
PLINK to be installed (Purcell et al., 2007).  
For GWAS or stratified GWAMA results based on HapMap imputed data (~2.8M 
SNPs) (International HapMap et al., 2010), it is recommended to have at least 4GB of 
Random-Access Memory (RAM) available (see Table 12 for an evaluation of runtime and 
memory requirements for a standard evaluation pipeline). While the package was primarily 
developed for HapMap imputed data sets, it is also applicable to data sets that are based on 
1000 Genomes imputation (~40M SNPs), which are increasingly being implemented in meta-
analysis projects (Genomes Project et al., 2010). To execute standard evaluation pipelines 
with 1000 Genomes imputed data sets, at least ~20GB of RAM have to be available (Table 
12). 
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Table 12. Runtime and memory requirements for a standard EasyStrata evaluation. The 
table is based on Supplementary Table 3 from (Winkler, Kutalik, et al., 2014). 
GWAMA data set #SNPs 
Maximum RAM  
allocated* 
Computational  
Time* 
Typed MetaboChip 185,648 256 MB 10 s 
HapMap Imputed 2,515,652 3.0 GB 3 min 4 s 
1000 Genomes Imputed 19,395,227 19.8 GB 24 min 39 s 
* The presented values represent average values, gathered from 10 identical EasyStrata runs using the pipeline 
shown in Appendix 9.7, R version 2.15.3 on a Linux Server with a 3.07GHz Intel Xeon CPU and 96GB RAM. 
 
5.2 EasyQC 
GWAMA consortium analysts often have to deal with thousands of individual big GWAS 
result data sets, a circumstance that necessitates extensive quality control (QC) and requires 
software that is able to handle such large numbers of big GWAS result data sets.  
To accomplish this, a powerful tool called EasyQC was developed that facilitates QC 
of multiple study-specific GWAS results as well as of meta-analyzed GWAMA results. A 
typical workflow of GWAMA conduct and QC was developed and is illustrated in Figure 22.  
 
 
Figure 22. Workflow of conduct and QC of a typical GWAMA. The figure is based on Figure 
1 from Winkler et al (Winkler, Day, et al., 2014). 
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Assume study-specific GWAS results have been collected centrally by a team of 
consortium analysts. The typical GWAMA conduct and QC can be divided into four major 
steps that are outlined consecutively: File-level QC, Meta-level QC, Meta-analysis and Meta-
analysis QC.  
At file-level QC, each study-specific GWAS result file is cleaned and checked. File 
cleaning involves multiple steps such as harmonization of column names, file formats, or 
marker names or exclusion of low quality SNPs: For example, in GIANT consortium 
GWAMAs, SNPs were excluded due to low minor allele count (mac ≤ 6, mac defined as 
2*MAF*N), low imputation quality (< 0.3, <0.4 or <0.8, respectively for MACH, IMPUTE or 
PLINK imputed data sets) or due to low genotype quality (call-rate < 0.95 or out of Hardy-
Weinberg equilibrium: PHWE < 10
-5). File checking involves sanity checks, such as checking 
overall descriptive statistics of the results or the number of SNP exclusions. The task is 
typically outlined for each study separately and aims at identification of study-specific issues 
and at exclusion of poor quality data. 
At meta-level QC, summary statistics are compared across studies. The aim of this 
step is to identify study-specific issues that have yet been undetected by file-level QC. Meta-
level QC involves checking for a range of analytical issues, such as issues with trait 
transformations (checked by creating so-called SE-N plots that contrast median standard 
errors with sample sizes across studies), issues with allele frequencies or strand (checked by 
plotting the study allele frequencies against reference frequencies), or issues with population 
stratification (checked by creating QQ plots and by calculating genomic-control (GC) inflation 
factors; note that the actual GC correction is applied during meta-analysis (Devlin & Roeder, 
1999)).  
Meta-analysis denotes the stage at which the actual meta-analysis is conducted. To 
limit potential errors with regards to study in- or exclusion or other failures in the meta-
analysis scripts, this task is typically outlined by two analysts independently and in parallel. In 
order to correct for potential population stratification issues, a GC correction is applied to 
each single GWAS result during meta-analysis (this can be accomplished by the metal 
function GENOMICCONTROL ON).  
Finally, meta-analysis QC stands for checking the meta-analysis results. This involves 
the comparison of results between the two meta-analysis performed by the different analysts;  
and the QC of the meta-analysis result itself. For example, meta-analysis result QC involves 
checking for issues with between-study heterogeneity or checking the meta-analysis GC 
inflation factor.  
Customized EasyQC pipelines have been developed to accomplish file-level, meta-
level and meta-analysis QC and can be downloaded from www.genepi-
regensburg.de/software.  
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5.3 EasyStrata 
After the conduct of the actual stratified GWAMA itself, analysts still have to deal with big 
GWAMA data sets that contain pooled association results for millions of SNPs and for 
multiple strata. Application of the here discussed statistical tests or approaches, and 
extraction of significant results, requires customized software.  
To facilitate this, EasyStrata was developed as a pipelining tool that combines state-
of-the-art statistical and graphical methods to evaluate large-scale stratified GWAMA results 
data.  
The prerequisite of an EasyStrata evaluation is that the stratified GWAMAs itself have 
already been conducted by meta-analytical software programs such as metal (Willer et al., 
2010) or GWAMA (Magi & Morris, 2010) (Figure 21). Although EasyStrata was primarily 
developed for evaluation of stratified GWAMAs based on continuous trait GWAS that involve 
linear regression models on the study-level, it also provides an extended applicability for 
other GWAMA configurations (see Appendix 9.8).  
A multitude of EasyStrata evaluation pipelines for stratified GWAMA results, e.g. to 
graphically display and to extract independent significant sexually dimorphic loci from sex-
stratified GWAMA outcomes, have been developed and can be accessed from www.genepi-
regensburg.de/software. An example EasyStrata ecf-pipeline to evaluate sex-stratified 
GWAMA results is shown in Appendix 9.7. 
5.3.1 Statistical Functionality 
EasyStrata has implemented handling of (i) stratum-specific inverse-variance weighted 
GWAMA outcomes, i.e., for each SNP the stratum-specific pooled genetic estimate with 
standard error (Cox & Hinkley, 1979), and (ii) stratum-specific sample size weighted Z-score 
based GWAMA outcomes, i.e., for each SNP the stratum-specific pooled Z-score and 
accumulated sample size (Stouffer, 1949). A summary of implemented statistics tailored for 
evaluation of stratified GWAMA outcomes is given in Table 13. Other statistical methods that 
are capable to general GWAMA settings, such as multiple testing or genomic control 
correction, are described in Appendix 9.8. 
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Table 13. EasyStrata functions for the statistical analysis of stratified GWAMA results. The table is based on Supplementary Table 2 from Winkler 
et al (Winkler, Kutalik, et al., 2014). The given probability distributions assume that the null hypothesis of the respective test is true.  
Function #Strata                                                   Test-Statistics    References 
  Inverse-variance weighted GWAMA; 
𝑤𝑖 = 1/𝑆𝐸𝑖
2 
Sample size weighted z-score based GWAMA;  
𝑤𝑖 = √𝑁𝑖* 
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i=1…m 𝛽𝑂𝑣𝑒𝑟𝑎𝑙𝑙 =
∑ 𝛽𝑖𝑤𝑖𝑖
∑ 𝑤𝑖𝑖
 ;   𝑆𝐸𝑂𝑣𝑒𝑟𝑎𝑙𝑙 = √
1
∑ 𝑤𝑖𝑖
 
𝑍𝑂𝑣𝑒𝑟𝑎𝑙𝑙 =
𝛽𝑂𝑣𝑒𝑟𝑎𝑙𝑙
𝑆𝐸𝑂𝑣𝑒𝑟𝑎𝑙𝑙
~𝑁(0,1) 
𝑁𝑂𝑣𝑒𝑟𝑎𝑙𝑙 = ∑ 𝑁𝑖𝑖 ,     𝑍𝑂𝑣𝑒𝑟𝑎𝑙𝑙 =
∑ 𝑍𝑖𝑤𝑖𝑖
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2
𝑖
~𝑁(0,1) 
(Cox & Hinkley, 1979; 
Stouffer, 1949) 
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𝑖
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~𝜒𝑚
2  (Aschard et al., 2010) 
CALCPDIFF 2 𝑍𝐷𝑖𝑓𝑓 =
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√𝑆𝐸1
2 + 𝑆𝐸2
2
~𝑁(0,1) 
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𝑍𝐷𝑖𝑓𝑓 =
𝛽1 − 𝛽2
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§
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𝑍1 √𝑁1 − 𝑍2 √𝑁2 ⁄⁄
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(Magi, Lindgren, & 
Morris, 2010; Randall 
et al., 2013) 
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~𝑁(0,1) (Winkler et al, in 
revision) 
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*
for dichotomous traits, with unequal numbers of controls and cases, we suggest using the total effective sample size Neff = 4/(1/Ncases+ 1/Ncontrols), which can be calculated in 
EasyStrata by the ADDCOL function: “ADDCOL --rcdAddCol 4/(1/NCASES+ 1/NCONTROLS) --colOut Neff”, given columns NCASES and NCONTROLS in the input data set. §
 
calculated as the Spearman rank correlation coefficient across all SNPs 
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5.3.2 Graphical Functionality 
To facilitate extended graphical presentation of stratified GWAMA results data, commonly 
used graphical functions like Quantile-Quantile-(QQ), scatter- and Manhattan-plots were 
implemented.  
A particular functionality of EasyStrata is tailored for comparison of stratified GWAMA 
results within single plots. Standard Manhattan plots display SNP-specific association P-
Values over respective chromosomal base-positions. EasyStrata introduces so-called Miami 
plots that contrast two Manhattan plots in a single graph (Figure 23). This is particularly 
useful for a locus-wise comparison of two stratified GWAMA results.  
A general comparison of the association strength between multiple strata can be 
obtained by the EasyStrata functionality to draw multiple QQ plot curves into a single graph.  
Scatterplots are one of the most simple and practical tools to investigate the 
relationship between two variables. EasyStrata can create scatterplots comparing two types 
of statistics and allows adding further dimensions by applying user-defined colors, symbols 
and symbol-sizes. For example, this can be helpful when comparing effect sizes from two 
strata. 
EasyStrata provides many other helpful extended graphical features, such as locus 
highlighting, exclusion of less significant SNPs to increase plotting speed or breaking up 
axes scales to properly display highly significant results (see Appendix 9.8). These features 
may also be helpful for the interpretation of general GWAMA data.  
  
5. The Easy R packages 
95
 
Figure 23. Example Miami-plot contrasting women- and men-specific GWAMA results for 
WHRadjBMI. The plot shows discovery stage results from the GIANT GENDER project (Randall 
et al., 2013). The coloring highlights WHRadjBMI loci that were previously established for 
overall association by Lindgren and colleagues (green)(Lindgren et al., 2009) and by Heid 
and colleagues (orange)(Heid et al., 2010). Since identical samples have been utilized in the 
sex-combined screen conducted by Heid and colleagues as compared to the sex-difference 
screen conducted by Randall and colleagues, the plot nicely shows that two additional 
genome-wide significant loci on chromosome 3 could have been identified by Heid and 
colleagues, if an additional sex-stratified screen would have been conducted.  
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6 Discussion 
6.1 Summary of main results 
In the following chapters a summary of results is presented for each of the initial objectives. 
Based on a systematic methodological evaluation, optimized stratified GWAMA methods to 
screen for stratum-difference in genetic effects between two strata were developed 
(summary in chapter 6.1.1), considerations were extended to stratified GWAMA methods to 
screen for 3-way G x AGE x SEX interaction effects (summary in chapter 6.1.2), 
recommended methods were applied to real GIANT consortium stratified GWAMA data sets 
for WHRadjBMI (summary in chapter 6.1.3) and software tools were developed that facilitate 
conduct and evaluation of large-scale stratified GWAMAs (summary in chapter 6.1.4).  
6.1.1 Optimal stratified GWAMA approaches to screen for stratum-
difference 
First, several stratified GWAMA approaches to identify difference in the genetic effects 
between two strata were defined. A systematic scheme of approaches was developed that 
incorporated different statistical filtering methods. 
Simulation-based evaluations of type 1 error rates as well as analytical comparisons 
of power were performed and optimal approaches were recommended for specific types of 
stratum-difference and for various stage designs - including 1-stage and 2-stage designs as 
well as balanced strata (equal stratum sizes) and unbalanced strata (unequal stratum sizes) 
designs (Table 14). 
 
 
Table 14. Optimal stratified GWAMA approaches to identify stratum-difference. 
Type of  
stratum-differencea 
Stage Design 
1-stage 2-stage 
Opposite effect 
direction (OED) 
[Diff5e-8] [Joint1e-5,Diff0.05]→[DiffαBonf] 
Single-stratum 
effect (SSE) 
[Overall1e-5→Diffαdiff] [Joint1e-5,Diff0.05]→[DiffαBonf] 
for f > 1.5b: [Diff5e-8]  for f < 0.66
b: [[Overall1e-5]→DiffαBonf] 
Concordant effect 
direction (CED) 
[Overall5e-8→Diffαdiff] [[Overall1e-5]→DiffαBonf] 
a 
assuming a given effect in stratum 1; 
b 
proportion of stratum 
 
2 sample size to stratum 1 sample size 
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For stratified GWAMAs with a balanced 1-stage design, (i) the intuitive approach of 
testing for difference at a genome-wide significant level is optimal for OED effects, and (ii) 
testing for difference with a priori filtering for overall association is optimal for SSE and CED 
effects (Table 14).  
For example, assuming a total sample size of 200,000, the power to identify the 
difference between a medium-sized genetic effect on WHRadjBMI in women and no effect in 
men was 80.7% and 47.4%, with and without filtering for overall association, respectively. 
Interestingly, filtering for weaker overall association (POverall < 1 x 10
-5) was beneficial for SSE 
effects, while a more stringent threshold (POverall < 5 x 10
-8) was beneficial for CED effects. 
However, because the power gain of the weaker control for SSE effects was larger than the 
power loss for CED effects, generally a weaker control of the overall association is 
recommended.  
Remarkably, simulations demonstrated inflated type 1 error for the difference test for 
SNPs that were filtered for stratified or joint association. As a consequence, filtering for 
stratified or joint association necessitated an independent data set to perform the difference 
test and can only be implemented in a 2-stage stratified GWAMA design. 
For stratified GWAMAs with a balanced 2-stage design, (i) testing for difference using 
the replication stage data while focusing on SNPs that were filtered for joint association as 
well as for nominally significant difference in the discovery stage data is optimal for OED and 
SSE effects, and (ii) testing for difference using the combined (discovery + replication) stage 
data while focusing on SNPs that were filtered for overall association in the discovery stage 
data is optimal for CED effects (Table 14). 
When comparing stage designs, the 1-stage approaches generally displayed larger 
power to identify stratum-difference than the 2-stage approaches.  
For unbalanced strata designs, the optimal approach did only change for SSE effects 
(Table 14). Interestingly, the power comparisons also highlighted that it is generally more 
likely to identify stratum-difference that exhibits a stronger effect in the larger stratum. For 
example, for an analysis that contains more non-smokers than smokers, the power to detect 
stratum-difference with effect in non-smokers (and a less pronounced or no effect in 
smokers) is higher than the power to detect stratum-difference with effect in smokers (and a 
less pronounced or no effect in non-smokers).  
6.1.2 Optimal stratified GWAMA approaches to screen for G x AGE x 
SEX interaction  
Methodological considerations were extended to age- and sex-stratified GWAMAs that are 
based on two dichotomous stratification variables (SEX: men vs women; AGE: younger vs 
older than 50 years of age, which reflects mean age of menopause in women). A difference-
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of-difference test was introduced that can be used to test for 3-way G x AGE x SEX 
interaction effects given an age- and sex-stratified GWAMA model. Several approaches to 
identify 3-way G x AGE x SEX interaction effects under a balanced 1-stage design were 
defined and a systematic scheme of approaches was developed. 
As for the 2-strata configuration, simulations demonstrated inflated type 1 error rates 
for the difference-of-difference test for SNPs that were filtered for stratified or joint 
association, but valid type 1 error rates for SNPs that were filtered for overall (strata-
combined) association. Surprisingly, filtering data for marginal tests (using age-marginal and 
sex-marginal effects, obtained from meta-analysis of respective strata), also displayed valid 
type 1 error rates for the difference-of-difference test, when this is calculated for the filtered 
SNPs and within the filtering data set.  
Analytical power formulae were derived and power of the validated age- and sex-
stratified GWAMA approaches was compared for varying realistic scenarios. Power 
computations demonstrated that testing for difference-of-difference at a genome-wide 
significance level is optimal for extreme 3-way interaction effects. Surprisingly, filtering for 
marginal joint association and testing the filtered SNPs for difference-of-difference resulted in 
highest power for biologically plausible 3-way interaction effects that imply an effect in one 
stratum (e.g., younger women) and no effect in the other three, or an identical effect in three 
strata and no effect in one stratum. 
6.1.3 Application to stratified GWAMAs for obesity traits 
The optimal approaches were applied to real GIANT consortium sex-stratified, smoking-
status stratified and age- and sex-stratified GWAMA results for WHRadjBMI.  
Ten loci were identified that displayed significant sex-differences in genetic effects on 
WHRadjBMI. Nine of the ten loci showed a significant effect on WHRadjBMI in women and no or 
less pronounced (but concordant) effect in men, and one locus displayed an opposite effect 
on WHRadjBMI between men and women.  
Three loci showed significantly stronger genetic effects on WHRadjBMI in non-smokers 
as compared to smokers. Given the larger sample size in non-smokers, this was consistent 
with the power computation result that concluded that it is more likely to identify stratum-
difference with larger effect in the larger stratum.  
No loci displayed significant 3-way G x AGE x SEX interaction effects, which may 
however be attributable to low power of the study to identify biological plausible 1-stratum or 
3-strata interaction effects involving medium genetic effects. 
Generally, the application of approaches underscored the power computation results 
and demonstrated that significant differences in genetic effects for WHRadjBMI exist between 
men and women, as well as between smokers and non-smokers.  
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6.1.4 Software for conduct and evaluation of stratified GWAMAs  
Finally, two software packages, EasyQC and EasyStrata, were developed that facilitate (i) 
conduct and quality control of stratified GWAMAs, and (ii) statistical evaluation and graphical 
presentation of stratified GWAMA results as well as application of the here defined statistical 
screening approaches to identify significant stratum-differences. Both packages can easily 
be integrated into the workflow of large scale stratified GWAMA projects and are increasingly 
being utilized by various GWAMA consortia.  
6.2 Stratified GWAMA methods to tackle gene-environment 
interaction effects  
The here discussed stratified GWAMA approaches aim at the identification of stratum-
difference and were specifically evaluated for continuous outcomes Y, additively modelled 
genotypes and for the meta-analytical framework. Testing for stratum-difference under a 
stratified model is mathematically equivalent to testing gene-strata (G x S) interaction effects 
under an interaction model (under the assumption of unrelated subjects and no covariate 
interacting with G or S). G x S interaction effects involve a dichotomous environmental 
(stratification) variable S and – as such - are a specific form of general gene-environment (G 
x E) interaction effects (that may also involve continuous or categorical E).  
In the literature, reported statistical methods can be distinguished into those that (i) 
aim at identifying SNP effects while accounting for potential G x E interaction, or (ii) aim at 
identifying G x E interaction as such (Hutter et al., 2013). In the following, these methods and 
their applicability to the stratified GWAMA setting (involving continuous Y and dichotomous 
S) are discussed (chapter 6.2.1 and chapter 6.2.2). Moreover, advantages and 
disadvantages of stratified compared to interaction modelling are discussed (chapter 6.2.3).  
6.2.1 Reported methods to account for G x E interaction effects 
Over the past years a number of methods have been developed that aim at the identification 
of novel SNP effects while accounting for potential G x E interaction effects (Aschard et al., 
2010; Dai et al., 2012; Kraft et al., 2007; Manning et al., 2011) (and including own work 
(Behrens et al., 2011). A summary can be found in Table 15. 
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Table 15. Reported methods for gene-environment interaction effects. 
Reference Type of test Outcome Y Exposure E Step 1 filter 
Applicability to meta-
analysis summary 
statistics shown 
Applicability to  
continuous Y 
shown 
Testing for SNP effects while accounting for GxE interaction effects 
(Kraft et al., 2007) joint  bin / cont bin / cont NA Yes Yes 
(Aschard et al., 2010) 
stratified joint meta-
analysis 
bin / cont bin NA Yes Yes 
(Manning et al., 2011) joint meta-analysis bin / cont bin / cont NA Yes Yes 
(Behrens et al., 2011) stratified bin / cont bin NA Yes Yes 
(Dai et al., 2012) 
simultaneous marginal + 
interaction 
bin bin NA No No 
Testing for  G x E interaction effects 
(Piegorsch et al., 1994) Case-only bin categorical  NA  No No 
(Kooperberg & Leblanc, 2008) 2-step bin SNP  POverall No Yes 
(Mukherjee et al., 2008) Empirical Bayes bin bin NA No No 
(D. Li & Conti, 2009) Bayes model averaging bin bin NA No No 
(Murcray, Lewinger, & Gauderman, 
2009) 
2-step bin bin PG-E No No 
(Murcray, Lewinger, Conti, Thomas, & 
Gauderman, 2011) 
2-step bin bin / cont POverall + PG-E No No 
(Hsu et al., 2012) 2-step bin bin POverall + PG-E No No 
(Gauderman, Zhang, Morrison, & 
Lewinger, 2013) 
2-step bin bin POverall + PG-E No No 
This work 2-step  cont bin POverall / Pjoint / 
PStrat / PDiff 
Yes Yes 
bin = binary; cont = continuous; 2-step denotes consecutive filtering and interaction tests; NA = not applicable 
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The most straightforward way to account for potential G x S interaction effects is to 
conduct stratum-specific analyses and to screen for associated variants within each stratum 
separately, called the stratified screen in the following (Behrens et al., 2011).  
Another method to generally account for potential G x E interaction effects is the joint 
test screen that simultaneously tests the main and the interaction effect. While the original 
version of the joint test had solely been developed for single-study G x E interaction models 
(Kraft et al., 2007), recent versions have integrated the joint test into the interaction GWAMA 
setting (Manning et al., 2011) as well as into the stratified GWAMA setting (Aschard et al., 
2010).  
Both, stratified and joint test screens have commonly and successfully been 
employed to identify associated variants for many different traits (Hamza et al., 2011; 
Hancock et al., 2012; Manning et al., 2012; Simino, Sung, Kume, Schwander, & Rao, 2013; 
Taylor et al., 2013; Winham et al., 2014). However, to distinguish whether the highlighted 
genetic effects are significantly different between strata, or whether the highlighted loci were 
detected for main or for interaction effects, one would need to additionally test the highlighted 
variants for stratum-difference or for interaction. Neither the stratified nor the joint test can be 
used to establish the interaction as such. 
In this work, stratified and joint tests have been considered as methods to filter data 
sets prior to difference testing. Via simulation, it has been demonstrated that SNPs that were 
filtered for stratified or joint association cannot be tested for difference (or for G x S 
interaction) within the same data set. Thus, the many GWAMA projects employing stratified 
or joint test approaches require independent data sets to test the discovered variants for 
difference or interaction.  
6.2.2 Reported methods to detect G x E interaction effects 
Similarly, a multitude of methods specifically tailored to identify G x E interaction effects were 
released over the past years (Table 15).  
These include case-only approaches (Piegorsch et al., 1994), data adaptive methods 
(D. Li & Conti, 2009; Mukherjee et al., 2008) as well as hedge methods that involve initial 
filtering steps on marginal gene-disease association, gene-environmental exposure 
correlation, or both (Gauderman et al., 2013; Hsu et al., 2012; Kooperberg & Leblanc, 2008; 
Murcray et al., 2011; Murcray et al., 2009).  
All of the reported methods were developed for single-study analyses, for interaction 
models and for dichotomous disease outcomes. It is not clear at all whether or how the 
presented methods can be transferred into the meta-analysis framework, into the stratified 
setting or whether they can be extended to continuous outcomes. While some of the reported 
methods may indeed be applicable to continuous outcomes (still to be demonstrated), others 
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were specifically developed for disease outcomes (e.g., those that involve case-only 
approaches) and are not extendible to continuous outcomes.  
Notably, no methods have been reported that consider 3-way G x E1 x E2 interaction 
effects so far.  
This work is the first structured methodological evaluation of approaches to identify G 
x S interaction effects, focusing on continuous outcomes, stratified modelling and on an 
implementation into the meta-analytical framework. Moreover this is the first work to consider 
3-way G x S1 x S2 interaction effects at all.  
6.2.3 Relating stratified modelling to interaction modelling  
The stratified GWAMA approach to identify gene-strata (G x S) interaction (measured as 
stratum-difference) has some important advantages and disadvantages compared to 
GWAMAs based on study-specific G x S interaction modeling.  
A disadvantage of the here discussed stratified GWAMA approaches to identify G x S 
effects is that they are limited to dichotomous (environmental) stratification variables S, 
whereas the interaction modelling as such is extendible to categorical or continuous 
environmental variables E. However, any continuous E can generally be dichotomized into 
two strata (by applying a specific threshold that separates E into two groups). It depends on 
the respective scenario as to whether the continuous or the dichotomized version is to be 
preferred. For example, women’s body shape changes after menopause (due to hormonal 
changes) and for some G x E interaction effects, fitting the interaction model with 
dichotomized age (younger vs older than 50 years of age) might be beneficial over fitting 
continuous age.  
For categorical E (>2 categories), the stratified GWAMA per se would be 
straightforward (one meta-analysis per category). However more refined methods, such as 
trend tests for ordinal categorical variables, would have to be evaluated using the pooled 
category-specific summary effect estimates. Such methods are not yet available for genome-
wide summary statistics and have not been considered so far, thus being a research topic of 
future efforts  
Another disadvantage of the stratified model is that it cannot model family structures 
that may be present across strata. For example, a sex-stratified analysis may not properly 
control for the relatedness across sexes when brothers and sisters would be analyzed 
separately. For the stratum-difference test, a covariance correction has been introduced that 
is supposed to control for such relatedness (Randall et al., 2013). However a structured 
methodological evaluation to investigate this in detail has not yet been performed and similar 
corrections for other employed tests (e.g., overall or joint tests) are not yet available.  
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One advantage of the stratified modelling - compared to interaction modelling - is that 
it provides better control for confounding and can avoid model misspecification. Typically in 
genetic association studies, additional covariables C, such as AGE, are added to the 
regression models in order to avoid confounding and to increase power to find the genetic 
association. Many published G x E interaction studies added co-variables to the interaction 
model yet missed the modelling of potential gene-covariable (G x C) and environment-
covariable (E x C) interaction effects. Missing these interaction terms leads to model 
misspecification and can create spurious G x E interaction effects (Keller, 2014). The reason 
for missing these interaction terms is not merely lack of knowledge, but mostly the fact that 
commonly used software programs (to facilitate genome-wide G x E interaction studies) lack 
the functionality to properly account for G x C and E x C interaction effects. For example the 
software program PLINK cannot model E x C terms (Purcell et al., 2007) and ProbABEL 
cannot account for G x C or E x C effects at all (Aulchenko et al., 2010). In contrast, the 
stratified model is not affected by such model misspecification issues because it provides 
proper control of confounding by adding covariables to each of the stratified ‘main effect’ 
models separately.  
A big advantage of stratified modelling is larger power for a very practical reason: 
Especially in the context of large scale GWAMA projects that combine data from hundreds of 
studies, the stratified GWAMA will tend to comprise a larger total sample size – thus resulting 
in larger power. One simple reason for this is that some studies can be expected to lack 
individuals for a specific stratum. Women-only studies may contribute to the women-specific 
meta-analysis, but a G x SEX interaction model cannot be fitted due to the lack of men in the 
study. For example, the GIANT consortium sex-stratified GWAMA from 2013 involved >7,000 
men from five men-only studies and >30,000 women from six women-only studies that would 
have been missed by the interaction modelling (Randall et al., 2013).  
Another reason for the larger sample size is that the stratified model generally reflects 
a straightforward model that can be implemented on the study-level without requiring 
specialized GWAS tools - other than those that are commonly applied for main effect GWAS 
and that are familiar to study analysts. For example in the GIANT analyses to study gene-
smoking interaction, the sample size of the smoking-stratified GWAMA was ~10% larger than 
the sample size of the GWAMA based on G x SMOKING interaction modelling, just because 
some of the studies were not able to contribute genome-wide interaction model results due to 
increased computational burdens (Justice et al, in progress). 
Finally, a further advantage of the stratified approach with regards to modelling is that 
it already allows for investigating 3-way G x S1 x S2 interaction effects (however limited to 
dichotomous S1 and S2). Prior to this work, there has no GWAS software tool or method been 
available that allows for fitting a 3-way interaction model on a genome-wide scale.  
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6.3 Stratum-specific effects in the genetics of obesity 
Over the past years, several stratified GWAMAs have highlighted biologically relevant 
differences in genetic effects on obesity measures between men and women, between 
smokers and non-smokers or between age-groups.  
In the following chapters a chronological review of identified sex-differences in genetic 
effects for body fat distribution is given and the observed sex-specific (chapter 6.3.1), 
smoking-status-specific (chapter 6.3.2) and age-specific effects (chapter 6.3.3) in the 
genetics of obesity are discussed.  
6.3.1 Sex-differences in genetic effects for body fat distribution 
Over the past years, several GIANT consortium GWAMA projects have increasingly identified 
sexually dimorphic genetic effects for WHRadjBMI (as a measure of body fat distribution). 
In 2009, the very first round of GIANT consortium GWAMAs for WHRadjBMI – including 
up to 37,670 individuals in the discovery stage - was published (Lindgren et al., 2009). This 
work primarily aimed at the identification of associated loci. To accomplish this, overall (sex-
combined) as well as sex-specific GWAMAs were performed. A single locus (near LYPLAL1) 
was identified to be associated with WHRadjBMI in women only. This was the first locus in the 
genetics of WHRadjBMI to display significant differences between sexes.  
 In 2010, a second round of GIANT consortium GWAMAs for WHRadjBMI – now 
including up to 77,167 individuals in discovery stage - was conducted (Heid et al., 2010). 
Again, this work primarily aimed at the identification of overall (sex-combined) associated 
loci. In total, 14 loci displayed genome-wide significant overall effects on WHRadjBMI (including 
the previously reported LYPLAL1 locus and 13 novel associated loci). Interestingly, seven of 
the 14 loci displayed significant sex-differences, all of which showed effects in women and no 
or less pronounced effects in men.  
The first systematic screen for sex-difference in the genetics of nine anthropometric 
traits (including WHRadjBMI) was published in 2013 (Randall et al., 2013). Randall and 
colleagues conducted 2-stage sex-stratified GWAMAs based on sex-specific GWAS results 
that comprised up to 77,598 individuals in discovery stage. Variants were filtered for sex-
specific association in the discovery stage and tested for sex-difference in an independent 
replication stage. Despite the increased multiple testing burdens (considering nine 
anthropometric traits in parallel), two novel sexually dimorphic (women-specific) loci for 
WHRadjBMI were identified.  
Importantly, the here presented power computations showed that Randall and 
colleagues did not implement the optimal approach. In the here presented work, application 
of the recommended 1-stage (or 2-stage) approaches to the Randall et al data sets showed 
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that four (or three) additional sexually dimorphic loci could have been identified. Figure 24 
illustrates that the additionally highlighted loci cover most of the sex-difference that was left 
undetected by Randall and colleagues. In particular, the recommended combination of 1-
stage approaches (genome-wide screen for difference in combination with testing SNPs for 
difference that were filtered for overall association), exploit the underlying sex-difference 
much better than the analysis strategy conducted by Randall and colleagues.  
 
 
 
Figure 24. QQ plot for WHRadjBMI sex-difference P-Values from the combined (discovery + 
replication) stage data from Randall and colleagues: All genome-wide SNPs (black), after 
excluding the six loci reported by Randall and colleagues (green), after excluding the seven 
loci detected by the best 2-stage approaches (purple), and after excluding the 10 loci 
detected by the best 1-stage approaches (orange). The green curve reflects the sex-
difference that was left undetected by Randall and colleagues. The 1-stage approaches 
detected the sex-difference most efficiently. 
 
 
In 2015, a third round of GIANT consortium GWAMAs for WHRadjBMI – now including 
up to 224,459 individuals - was published (Shungin et al., 2015). Again, this work primarily 
aimed at the identification of associated loci and successfully identified 49 independent loci 
with genome-wide significant effects on WHRadjBMI. Consistent with previous work, strong 
sexual dimorphism in genetic effects for WHRadjBMI was observed among the overall 
associated variants: 19 of the 49 loci displayed stronger effects in women (and less 
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pronounced or no effects in men), and (for the first time) one locus displayed a men-specific 
effect (with no effect in women). The identification of such particular types of sexually 
dimorphic effects is consistent with the here presented power computations that showed that 
filtering for overall association prior to difference testing is optimal for SSE and CED type of 
effects. 
Currently, a second systematic screen for sex-difference in the genetics of WHRadjBMI 
is well underway (Winkler et al, in revision). In this work, age- and sex-stratified GWAMAs 
were conducted that include up to 216,654 individuals for WHRadjBMI. Based on the here 
presented power computations, the best approaches were applied that aim at the 
identification of 2-way (G x AGE or G x SEX) or 3-way (G x AGE x SEX) interaction effects. 
For WHRadjBMI, 44 loci were identified for significant sex-differences and the number of known 
sexually dimorphic effects was more than doubled (from 21 to 48, four were missed by the 
current study).  
In summary, of the 48 identified sexually dimorphic WHRadjBMI loci, 32 exhibited a 
stronger effect on WHRadjBMI in women, five a stronger effect on WHRadjBMI in men and 11 
were classified as opposite effect loci.  
A chronological overview on the identified sexually dimorphic loci for WHRadjBMI from 
GIANT analyses is given in Table 16. 
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Table 16. Overview of applied approaches and number of sexually dimorphic loci identified for WHRadjBMI by the GIANT consortium. 
   Sample size Number of identified loci (novel loci) 
Reference Description Approach Discovery  Replication 
Sex-
difference  
Women-
specific  
Men-
specific  
Opposite 
effect  
(Lindgren et al., 2009) Overall GWAMA to 
identify main effects 
for WHRadjBMI 
Overall5e-8→Diff𝑏𝑜𝑛𝑓 37,670  61,612 1 (1) 1 (1) - - 
(Heid et al., 2010) Overall GWAMA to 
identify main effects 
for WHRadjBMI 
Overall5e-8→Diff𝑏𝑜𝑛𝑓 77,167 113,636 7 (6) 7 (6) - - 
(Randall et al., 2013) Systematic screen for 
sex-difference for nine 
anthropometric traits 
(incl. WHRadjBMI) 
DiffFDR5% 
+ 
StratFDR5%→DiffFDR5% 
77,598 108,832 6 (2) 6 (2) - - 
(Shungin et al., 2015) Overall GWAMA to 
identify main effects 
for WHRadjBMI 
Overall5e-8→Diff𝑏𝑜𝑛𝑓 224,459  - 20 (12) 19 (11) 1 (1) - 
(Winkler et al, in 
revision) 
Systematic screen for 
age-difference, sex-
difference, and for 3-
way G x AGE x SEX 
interaction effects for 
two obesity traits (incl. 
WHRadjBMI) 
DiffFDR5% 
+ 
Overall1e-5→Diff𝐹𝐷𝑅5% 
216,654  - 44 (27) 28 (12) 5 (4) 11 (11) 
 Total number of sexually dimorphic loci identified: 48 32 5 11 
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The enrichment of women-specific loci (32 among 48 loci with sex-difference, PBinom = 
0.015) is consistent with heritability analyses that showed a significantly higher heritability of 
WHRadjBMI in women than in men (Shungin et al., 2015; Zillikens et al., 2008). Using the 
Framingham Heart study, family-based heritability of WHRadjBMI in women was estimated to 
be 46% as compared to 19% for men (Shungin et al., 2015). Similar trends were observed in 
unrelated subjects and using all 2.5 million variants (Winkler et al, in revision). Moreover, 
variants found for overall association explained a significantly larger fraction of WHRadjBMI 
variance in women than in men (2.4% explained variation in women, 0.8% in men, Winkler et 
al, in revision) (Shungin et al., 2015).  
However, the identified sexually dimorphic effects explained only few of the missing 
heritability of WHRadjBMI. A substantial fraction of the missing heritability may still be hidden in 
missed rare variant genetic effects, for which the current analyses were underpowered. For 
example, the most recent overall GIANT scan only identified main effect variants down to 5% 
allele frequency (Shungin et al., 2015) and the most recent systematic sex-difference scan 
only identified sex-specific effects (except for some opposite effects) down to 20% allele 
frequency (Winkler et al, in revision) (Figure 25). Thus, even larger sample sizes are needed 
to identify sex-difference for less common or rare variants or sex-difference that is based on 
even smaller – but realistic – genetic effect sizes.  
 
 
 
Figure 25. Effect sizes versus allele frequencies: Effect size of the 44 sexually dimorphic 
WHRadjBMI loci detected from the GIANT AGE x SEX meta-analyses, are depicted over allele 
frequency. A: Shown on the y-axis is the stronger sex-specific effect size of the 33 detected 
SSE and CED loci (red: 28 with stronger effect in women; blue: five with stronger effect in 
men). The curves reflect the power to find an SSE effect with the approach 
[Overall1e-5→DiffαBonf] for varying total sample sizes. B: Shown on the y-axis is the effect 
difference for the 11 detected OED loci. The curves reflect the power to find an OED effect 
with the approach [Diff5e-8] for varying total sample sizes. 
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Remarkably, many of the identified sexually dimorphic variants are located in 
biologically interesting regions.  
For example, one locus found for its women-specific association with WHRadjBMI is 
located in vicinity of the GRB14 gene, of which the encoded protein has a reported role in 
insulin sensitivity and lipid metabolism (Goenaga et al., 2009; Ridker et al., 2009). The 
identified WHRadjBMI variant showed a similar sex-specific and directionally consistent 
association pattern with HDL-cholesterol, triglycerides, fasting insulin and type 2 diabetes 
(Randall et al., 2013) as well as a significant (although not sex-specific) association with 
increased GRB14 expression levels in human subcutaneous adipose tissue. In addition, a 
significant sexually dimorphic association of GRB14 with lower expression in brown fat of 
female mice was observed that was lacking in male mice. Due to the reported role of brown 
fat in triglyceride metabolism, this is consistent with the reported women-specific association 
on HDL-cholesterol and triglycerides.  
Another particularly interesting region is the women-specific association with 
WHRadjBMI near PPARG, which is well-known for its relevant role in type 2 diabetes therapy. 
The encoded protein PPARγ regulates white adipocyte differentiation and influences 
adipogenesis, obesity as well as insulin sensitivity (Lehrke & Lazar, 2005; Nakagami, 2013). 
Follow-up analyses highlighted a significantly higher expression of PPARG in liver of female 
mice that was lacking in male mice (Randall et al., 2013). Interestingly, PPARG is predicted 
to bind at a transcription factor binding site that is in high LD with the lead SNP of another 
region (near HSD17B4) that was also found for its women-specific association on WHRadjBMI. 
The enzyme HSD17B4 itself is an interesting candidate because it converts the hormone 
estradiol into estrone and influences steroid metabolism as well as fatty acid oxidation 
(Leenders et al., 1996; Thompson, Dzubur, Wade, & Tomaszycki, 2011).  
In summary, the identification of sexually dimorphic WHRadjBMI regions supports the 
hypothesis that sex-differences in body fat distribution are regulated by a complex interplay 
of autosomal genetic factors.  
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6.3.2 Differences in genetic effects for obesity measures between 
smokers and non-smokers 
Preliminary results from a smoking-status stratified GWAMA for obesity traits (Justice et al, in 
progress, own work), including BMI, waist circumference adjusted for BMI (WCadjBMI) and 
waist-hip ratio adjusted for BMI (WHRadjBMI), highlight a number of loci with significant 
differences in genetic effects between smokers and non-smokers. 
For example, a variant near PRNP displayed a genome-wide significant difference in 
genetic effects on WCadjBMI between smokers and non-smokers. The WCadjBMI increasing 
allele in smokers showed a decreasing effect in non-smokers, which is consistent with the 
fact that smokers exhibit on average larger waist circumference than non-smokers. PRNP is 
highly expressed throughout the central nervous system (as are many obesity genes) and 
influences oxidative stress response (Kachiwala et al., 2005; Zomosa-Signoret, Arnaud, 
Fontes, Alvarez-Martinez, & Liautard, 2008). Taken together, this makes it a strong biological 
candidate gene for obesity and interaction with smoking.  
Another interesting gene-smoking interaction effect has been identified for BMI and is 
located near CHRNB4 (Cholinergic Nicotine Receptor B4), which confirms previous work 
(Freathy et al., 2011). The CHRNB4 locus with a reported role in nicotine addiction (Picciotto 
& Kenny, 2013) is also an interesting finding from a methodological point of view. It was 
recently described that spurious gene-environment interaction can occur for a proxy marker if 
the true causal genetic variant is associated with the environmental exposure (Dudbridge & 
Fletcher, 2014). In the case of CHRNB4, the dependence of a potentially causal variant with 
the environmental factor smoking might be given through the reported association with 
nicotine addiction. Therefore, the observed gene-smoking interaction has to be interpreted 
with care and sensitivity analyses are required to establish the finding.  
6.3.3 Age- and sex-specific genetic effects for obesity measures 
Given that overall and central obesity measures change over time makes age another 
important factor that may influence genetic effects on obesity. Since changes in obesity 
measures differ between men and women, some genetic effects may possibly even be 
modified by both, age and sex simultaneously.  
To systematically screen for 2-way G x SEX (sex-differences, independent of AGE), 
G x AGE (age-differences, independent of SEX) and 3-way G x AGE x SEX interaction 
effects, recently, a large-scale age- and sex-stratified GWAMAs were conducted that 
included up to 320,485 individuals for BMI and up to 216,654 individuals for WHRadjBMI 
(Winkler et al, in revision). Herewith, age was dichotomized at a threshold of 50 years of age 
that reflects the mean age of menopause in women. 
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In summary, the study highlighted (i) 44 sex-dependent effects for WHRadjBMI with 
predominantly larger effects in women (as noted and discussed before), and (ii) 15 age-
dependent effects for BMI with predominantly larger effects in younger individuals. Although 
the study was well powered for any 2-way interaction effects, no age-difference was 
observed for WHRadjBMI and no sex-difference was observed for BMI. Furthermore, no 3-way 
G x AGE x SEX interaction effects were discovered at all, which may however be attributable 
to low power of the study for plausible 1-stratum or 3-strata interaction effects.  
The highlighted age-dependent BMI loci included some biologically interesting 
candidates, such as the most prominent BMI loci near FTO and near MC4R. The age-
specifity of many of the identified loci is supported by longitudinal studies (den Hoed et al., 
2010; Elks et al., 2012; Graff et al., 2013; Hardy et al., 2010; Hertel et al., 2011; Sovio et al., 
2011).  
The enrichment of loci showing stronger BMI effects in the younger subgroup (11 of 
the 15 loci) may mirror an accumulation of environmental and lifestyle factors over life that 
mask the genetic effect on obesity in the older group. Interestingly, the four loci exhibiting 
stronger effects in the older subgroup have a reported role on related diseases, such as type 
2 diabetes or coronary heart disease, and may reflect disease relevant processes that are 
distinct from other BMI loci.  
Admittedly, the age-dependency may also reflect a cohort effect that could have been 
introduced by the stratification of age into younger and older individuals - yielding different 
environmental or genetic make overs. For example, the increased exposure to high caloric 
food intake over the past 30 years may have influenced younger individuals differently than 
older individuals. Indeed, assuming no cohort effect, significant differences in genetic effects 
on BMI between two age groups imply change of BMI at some point during life. Yet, large-
scale longitudinal studies are required to improve accuracy of age-dependent genetic effect 
estimates and to define the time in life with greater precision at which the genetic loci 
contribute to BMI changes.    
6.4 Relevance of the developed Easy software packages 
Due to the lack of software packages tailored for quality control and evaluation of large-scale 
stratified GWAMA data sets, two R packages called EasyQC and EasyStrata were 
developed. EasyQC provides extended features for quality control of multiple single-study 
GWAS results, as well as for stratified GWAMA results (Winkler, Day, et al., 2014). 
EasyStrata provides extended statistical and graphical features for the evaluation of stratified 
GWAMA results and can be utilized to apply the here discussed screening approaches and 
to extract significant results (Winkler, Kutalik, et al., 2014). 
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The two software packages have specifically been developed for GIANT consortium 
GWAMA projects. They were applied for the quality control of study-specific GWAS or 
GWAMA results data sets as well as for evaluation of stratified GWAMA results for the most 
recent rounds of GIANT consortium meta-analyses (Locke et al., 2015; Shungin et al., 2015; 
Wood et al., 2014)(Winkler et al, in revision; Justice et al, in progress).  
Both packages were integrated into the (specifically developed) Easy framework that 
contains efficient methods to handle big data and provides a scripting interface. The scripting 
interface makes the programs easy to use and simplifies handling of hundreds of large scale 
GWAS or GWAMA data sets. This diminishes computational burdens and allows less 
computationally experienced analysts to outline pre-defined quality control or statistical 
evaluation pipelines.  
Notably, there are other tools available for GWAS data, which however only provide 
some parts of the quality control, graphical features or statistical functionality as captured by 
the two Easy packages (Table 17). Most of the other tools are either applicable for single 
study genotype files or for conducting meta-analyses of multiple GWAS.  
Remarkably, EasyStrata is the only tool available to date that was specifically 
designed and developed for evaluation of stratified GWAMA results data, and is the only tool 
that provides the joint test (based on stratified outcomes) or the 3-way difference-of-
difference test.  
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Table 17. Comparison of GWAS software tools.  
 QC functionality Plotting functionality Statistical functionality  
Software 
File-
level
1 
Meta-
level 
Meta-
anal. 
level 
QQ 
plot 
Manhattan 
plot 
Miami 
plot 
Scatter 
plot 
Meta-
anal. 
Joint 
test 
Diff 
test 
Diff- 
Diff 
Test 
Hetero-
geneity Reference 
Haploview no no no no yes no no no no no no no (Barrett, Fry, Maller, & Daly, 2005) 
PLINK no no no no no no no yes no yes no yes  (Purcell et al., 2007) 
GenABEL no no no yes yes no yes yes
4
 no no no no (Aulchenko et al., 2007) 
metal no no no no no no no yes no no no yes (Willer et al., 2010) 
GWAMA no no no yes
2
 yes
2
 no no yes yes
3
 no no yes
3
 (Magi & Morris, 2010) 
GWASpi no no no yes yes no no no no no no no (Muniz-Fernandez, Carreno-Torres, Morcillo-
Suarez, & Navarro, 2011) 
GWAtoolbox yes yes no yes no no no no no no no no (Fuchsberger, Taliun, Pramstaller, Pattaro, & 
consortium, 2012) 
GWASTools yes no no yes yes no no no no no no no (Gogarten et al., 2012) 
EasyStrata no no no yes yes yes yes yes yes yes yes yes (Winkler, Kutalik, et al., 2014) 
EasyQC yes yes yes yes no no yes yes no no no no (Winkler, Day, et al., 2014) 
1
 File-level QC denotes QC of GWAs summary results data, not QC of the raw genotype data. 
2
 Plots are available through separate R scripts.
 
3
 The software GWAMA provides an option “--sex” that allows for running a gender-differentiated analysis, that is similar to the joint test of two groups (i.e. men and women), and 
that allows for testing for heterogeneity between the sexes. Both methods are limited to two subgroups (sexes) and are not applicable to analyses involving more than two strata. 
4
 Meta-analysis available through the MetABEL software. 
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6.5 Strengths and Limitations 
In the following chapter, important strength and limitations of this work are discussed.  
The major strength of this work is that it fills an important research gap for a specific 
study design configuration: It is the first structured methodological evaluation of genome-
wide screening approaches to identify gene-strata (G x S) interaction effects for continuous 
outcomes, given a stratified model and a meta-analysis framework. In contrast, other 
methodological work has - so far - focused on single-study gene-environment (G x E) 
interaction methods for binary outcomes and for interaction models. Moreover, this is the first 
methodological work to consider 3-way G x S1 x S2 interaction effects at all.  
Although this work focused on continuous phenotypes, the methodological results 
can readily be extended to stratified GWAMAs involving dichotomous phenotypes, such as 
binary disease outcomes. By log-transformation, the pooled genetic odds ratios and 
confidence intervals – as obtained from stratified GWAMAs for dichotomous phenotypes – 
can easily be transferred into pooled effect estimates and standard errors, and then be 
applied to the discussed screening approaches.   
A specific strength is that the methodological work is accompanied by easy-to-use 
software packages that are able to deal with large-scale GWAMA results data and that make 
the methods easily accessible for other scientists.  
Finally, evaluated methods and the developed software were applied and exemplified 
using unpublished and unique real sex-stratified, smoking-status-stratified or age- and sex-
stratified GWAMA data sets from the GIANT consortium.  
Admittedly, there are also some limitations to this work, most of which are related to 
assumptions made for the power computations.  
First, power formulae were derived based on the assumption of equal phenotype 
distributions between strata. Due to requesting uniformly transformed phenotypes for each 
stratum, this assumption is always fulfilled in the GIANT consortium analyses. Notably, other 
GWAMA consortia may employ unequal phenotype distributions between strata.  
Second, power formulae were derived based on the assumption of equal genotype 
distributions between strata, an assumption that builds upon random mating between strata. 
Random mating between men and women is fulfilled and is not an issue for comparisons 
between younger and older individuals. However, the concept of random mating might be 
violated for example between smokers and non-smokers, because smokers might rather 
mate smokers and non-smokers might rather mate non-smokers. The impact of non-random 
mating is largely ignored in GWAMA methodology altogether.  
Third, power computations assumed similar populations, i.e., homogenous genotype 
distributions and equal genetic effects across studies. Given these assumptions, it has been 
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shown that a fixed effect meta-analysis of GWAS summary statistics from multiple studies 
yields approximatively identical results as one large GWAS including all individuals 
(Evangelou & Ioannidis, 2013). Similarly, meta-analysis of multiple study-specific interaction 
estimates have been demonstrated to yield approximatively identical results as fitting an 
interaction model in one large study (Sung et al., 2014). This assumption might be violated 
for large-scale meta-analyses that include diverse populations, such as multiple ethnicities 
across studies.  
In principle, violation to any of these three assumptions necessitates adapting the 
analytical power formulae. However, on average, one can assume that the overall message 
would still be valid.  
To avoid overly complexity, the methodological evaluation of approaches for 3-way 
interaction effects was limited to balanced 1-stage designs. Nevertheless, the methodological 
results were particularly interesting and may be an important start for future methodological 
work on 3-way interaction effects that may involve unbalanced and 2-stage designs.  
Similarly, this work was limited to additively modelled genotypes and it was not 
evaluated how or whether the results transfer to recessive or dominant genotype effects. 
Typically, GWAMA projects focus on additively modelled genotypes because those are 
considered to be the best compromise to identify different types of genotype-phenotype 
effects. 
Finally, the discussed stratified GWAMA approaches were limited to identify 
interaction with dichotomous environmental variables. However, it was already noted that 
continuous environmental variables can always be dichotomized and that in some instances, 
this might even be a better model fit to the reality than utilizing the continuous variable.  
6.6 Conclusion and Outlook 
In conclusion, a structured methodological evaluation of stratified GWAMA approaches to 
identify difference in genetic effects between strata has been outlined, its value has been 
documented using GIANT consortium data, and software to implement the approaches has 
been developed.   
First, a systematic scheme of stratified GWAMA approaches to identify stratum-
difference was developed. Simulation-based evaluations of type 1 error rates as well as 
analytical comparisons of power were performed and approaches were recommended for 
specific types of stratum-difference as well as for 1- or 2-stage study designs. For example, 
testing variants for stratum-difference that were initially filtered for overall (strata-combined) 
association, yielded valid type 1 error rates and displayed the largest power to identify 
variants that exhibited an effect in one stratum but lacked effect or showed a less 
pronounced effect in the other stratum. 
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The methodological evaluation was extended to stratified GWAMAs involving two 
dichotomous stratification variables: AGE (younger vs older than 50 years of age, which 
reflects menopause in women) and SEX (men vs women). A statistical test for difference-of-
difference was introduced that can be utilized to test for 3-way G x AGE x SEX interaction 
effects given a stratified GWAMA model. Again, multiple approaches to identify 3-way G x 
AGE x SEX interaction effects were defined and compared with regards to type 1 error and 
power. Recommendations have been given for specific types of 3-way G x AGE x SEX 
interaction effects. For example, testing variants for difference-of-difference that were pre-
filtered for marginal joint association yielded valid type 1 error rates and displayed the largest 
power to identify variants that exhibit an effect in one stratum (e.g., younger women) but lack 
effect in all other strata, or variants that exhibit an identical effect in three strata but lack 
effect in one stratum. Although only balanced 1-stage age- and sex-stratified GWAMA 
designs were considered, these results may be an important start for follow up 
methodological work on 3-way interaction effects.   
Application of the stratified GWAMA approaches to obesity traits has proven to 
successfully pinpoint biologically relevant stratum-differences, such as interactions with sex, 
age or smoking status. For example, significant sex-differences were observed at 48 
independent loci for WHRadjBMI (as a measure of central obesity), and significant age-
differences were observed at 15 independent loci for BMI (as a measure of overall obesity). 
Vice versa, no age-difference was observed for WHRadjBMI and no sex-difference was 
observed for BMI. Adding to the reported separation of central versus overall obesity 
genetics into adipose or insulin-related versus central nervous system related biology (Locke 
et al., 2015; Shungin et al., 2015), this further separates obesity genetics into central obesity 
genetics being sex-specific but not affected by age versus overall obesity genetics being 
age-specific, but not affected by sex.  
Notably, many of the highlighted stratum-differences in genetic effects of obesity 
measures have been identified at disease-relevant loci, a circumstance that may be an 
important start to guide and to improve personalized treatment options. Generally, 
identification of genes that influence obesity and whose effects are modified by 
environmental factors will help understanding the complex interplay between genetic 
susceptibility, environmental factors, obesity and obesity-related diseases. Yet, more 
functional follow-up analyses are required to further unravel likely causal candidates and to 
elucidate the genetic functions affecting stratum-differences in obesity measures. 
Despite the recent success, power computations also demonstrated that even larger 
sample sizes are required to identify stratum-differences for rare variants, stratum-differences 
comprising even smaller effect sizes, or biologically plausible 3-way G x AGE x SEX 
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interaction effects. The upcoming 1000 Genomes initiative of the GIANT consortium 
including up to 1 million subjects is expected to – at least in part - fill in that gap. 
Besides the stratification by relevant dichotomous environmental factors, future 
studies may also be interested in stratification by disease status. For example, one may be 
interested in whether the genetic effect on obesity differs significantly between healthy 
individuals and individuals with type 2 diabetes. Such efforts can similarly be implemented 
into the stratified GWAMA setting and the here discussed approaches can directly be 
employed to investigate potential gene-disease interaction effects.   
Two software packages – called EasyQC and EasyStrata – were developed that 
facilitate quality control and statistical or graphical evaluation of stratified GWAMA data. Both 
packages are increasingly being used by various GWAMA consortia and an implementation 
of EasyQC into a cloud-computing framework is already in work.  
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7 Summary 
While genome-wide association meta-analyses (GWAMA) have largely contributed to the 
understanding of the genetics of complex diseases, such as obesity, little has been known 
about whether or not the genetic effects differ between strata, such as between men and 
women, or between smokers and non-smokers. Thus, this work focused on stratified 
GWAMA screening approaches to identify variants with significant stratum-difference in 
genetic effects.  
A structured methodological evaluation of approaches to identify differences in 
genetic effects between two strata with regard to type 1 error and power was performed. This 
evaluation differentiated between situations where one data set was available (1-stage 
approaches) or where two independent data sets were to be utilized (2-stage approaches). 
For 1-stage designs, (i) as expected, a genome-wide screen for difference is the best 
approach to detect variants with opposite effect directions among strata, and (ii) surprisingly, 
the naive approach of filtering for overall (strata-combined) association followed by a test for 
difference is the best approach for variants with no or less pronounced (but concordant) 
effect in one stratum. Remarkably, filtering for joint association violated the type 1 error of the 
difference test when both steps are conducted in the same data set. For 2-stage designs, (i) 
filtering for joint association and for nominally significant difference in the discovery stage 
followed by a test for difference in the replication stage is the best approach for variants with 
no effect in one stratum or variants with opposite effect directions among strata; and (ii) 
filtering for overall association in the discovery stage followed by a test for difference using 
the combined (discovery + replication) stage data is the best approach for variants with less 
pronounced (but concordant) effect in one stratum. Interestingly, unequal stratum sizes did 
not impact the type 1 error of the difference test, but power computations showed that it is 
generally more likely to identify variants with stronger effect in the larger stratum. 
The methodological evaluation was extended to GWAMAs stratified by AGE (younger 
vs older than 50 years of age, which reflects menopause) and by SEX (men vs women) 
aiming at the identification of 3-way G x AGE x SEX interaction effects. A difference-of-
difference test was introduced that can be employed to test for 3-way G x AGE x SEX 
interaction effects under a stratified GWAMA setting. As expected, a genome-wide screen for 
difference-of-difference is the best approach for extreme 3-way interaction effects that 
involve opposite effect directions across AGE and SEX. Surprisingly, filtering for marginal 
joint association followed by a test for difference-of-difference turned out to be the best 
approach for biologically more plausible 3-way interaction effects that involve an effect in one 
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stratum (e.g., younger women) and no effect in the other three, or that involve an identical 
effect in three strata and no effect in one.  
Application of recommended approaches to stratified GWAMA data sets for waist-hip 
ratio (adjusted for BMI) from the GIANT consortium underscored the power computations 
results, and highlighted a number of biologically interesting differences in common genetic 
effects between sexes (predominantly larger effects in women) or between smokers and 
non-smokers. Most likely, due to the low power to detect plausible 3-way interaction effects, 
no 3-way G x AGE x SEX interaction effects were identified. Still, larger sample sizes are 
required to efficiently identify stratum-difference for rare variants, or to identify plausible 3-
way interaction effects.  
Two powerful and easy-to-use software packages called EasyQC and EasyStrata 
were developed that facilitate conduct, quality control and evaluation of stratified GWAMAs. 
The software packages are already utilized by GIANT consortium analysts as well as by 
other genetic research consortia.  
In summary, the methodological results, supported by the application to GIANT 
consortium data and the provided software implementation may guide and help the conduct 
of future stratified GWAMAs aiming at the identification of gene-strata interaction effects. A 
better understanding of stratum-specific genetic effects for diseases and disease-related 
traits will ultimately lead to improved knowledge of etiology of the diseases and pinpoint 
novel treatment options.  
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8 Zusammenfassung 
Genomweite Assoziations Meta-Analysen (GWAMAs) haben wesentlich zum besseren 
Verständnis der Genetik von komplexen Krankheiten, wie z.B. Adipositas, beigetragen. 
Allerdings ist wenig darüber bekannt, ob sich genetische Effekte zwischen Subgruppen, wie 
z.B. zwischen Männern und Frauen oder zwischen Rauchern und Nichtrauchern, 
unterscheiden. Die vorliegende Arbeit befasste sich daher mit stratifizierten GWAMA 
Ansätzen zum Identifizieren von genetischen Varianten, deren Effekte sich signifikant 
zwischen Subgruppen unterscheiden.  
 Zunächst wurde eine strukturierte, methodische Evaluierung von stratifizierten 
GWAMA Ansätzen zum Detektieren von Unterschieden zwischen zwei Gruppen, in Bezug 
auf Typ 1 Fehler und Power, durchgeführt. Hierbei wurde zwischen Situationen 
unterschieden, in denen entweder ein Datensatz (1-Phasen Design) oder zwei unabhängige 
Datensätze (Discovery + Replication, 2-Phasen Design) verwendet wurden.  
Für 1-Phasen Designs zeigte sich die genomweite Suche nach Effekt-Unterschied als 
am besten geeignet für Varianten deren Effekte zwischen den zwei Subgruppen in 
unterschiedliche Richtungen zeigen. Überaschenderweise zeigte sich der naive Ansatz, 
zuerst für allgemeine (subgruppen-kombinierte) Effekte zu filtern und dann auf Effekt-
Differenz zu testen, als am besten geeignet für Varianten die keinen oder einen kleineren 
(aber gleichgerichteten) Effekt in einer Subgruppe zeigen. Bemerkenswert war, dass das 
Filtern für Joint-Assoziation eine Erhöhung des Typ 1 Fehlers des Effekt-Differenz Tests zur 
Folge hatte, wenn dieser im gleichen Datensatz durchgeführt wird.  
Für 2-Phasen Designs zeigte sich der Ansatz, im Discovery-Datensatz für Joint-
Assoziation sowie für nominal signifikante Effekt-Differenz zu filtern und im Replication-
Datensatz auf Effekt-Differenz zu testen, als am besten geeignet für Varianten deren Effekte 
zwischen den zwei Subgruppen in unterschiedliche Richtungen zeigen und für Varianten die 
keinen Effekt in einer Subgruppe zeigen. Des Weiteren zeigte sich der Ansatz, im Discovery-
Datensatz für allgemeine (subgruppen-kombinierte) Assoziation zu filtern und im 
kombinierten (Discovery + Replication) Datensatz auf Differenz zu testen, als am besten 
geeignet für Varianten die einen kleineren (aber gleichgerichteten) Effekt in einer Subgruppe 
zeigen.  
Interessanterweise hatten ungleiche Subgruppengrößen keinen Einfluss auf den Typ 
1 Fehler des Effekt-Differenz Tests. Powerberechnungen zeigten jedoch, dass es im 
Allgemeinen wahrscheinlicher ist Varianten zu finden, deren stärkerer Effekt in der größeren 
Subgruppe vorkommt.  
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Die methodische Evaluierung wurde auf alters- und geschlechts-stratifizierte 
GWAMAs erweitert, welche auf die Identifizierung von 3-fach G x AGE x SEX Interaktionen 
abzielen (mit SEX = Geschlecht, AGE = Alter dichotomisiert bei 50 Jahren, entspricht 
Menopause bei Frauen). Ein Differenz-Differenz Test wurde eingeführt, welcher zum Testen 
auf 3-fach G x AGE x SEX Interaktionen innerhalb einer stratifizierten Auswertung verwendet 
werden kann. Wie zu erwarten war, zeigte sich die genomweite Suche nach Differenz-
Differenz als am besten geeignet für Varianten mit extremen 3-fach Interaktionen, die mit 
unterschiedlichen Richtungen hinsichtlich AGE und SEX einhergehen. Überraschenderweise 
zeigte sich der Ansatz zuerst für marginale Joint-Effekte zu filtern und dann auf Differenz-
Differenz zu testen als am besten geeignet für biologisch plausible 3-fach Interaktionen, 
welche entweder einen Effekt in einer Subgruppe (z.B. in jungen Frauen) und keinen Effekt 
in allen anderen zeigen, oder einen identischen Effekt in drei Subgruppen und keinen Effekt 
in einer Subgruppe zeigen.  
Die Anwendung der besten Ansätze auf reale stratifizierte GWAMA Datensätze für 
Taille-Hüft-Verhältnis (adjustiert für BMI) aus dem GIANT Konsortium unterstrich die 
Ergebnisse der Powerberechnungen und identifizierte eine Reihe von häufig-
vorkommenden, biologisch interessanten, genetischen Effekt-Differenzen zwischen 
Geschlechtern (mit überwiegend stärkeren Effekten bei Frauen), als auch zwischen 
Rauchern und Nichtrauchern. Wahrscheinlich wurden wegen zu geringer Power keine 
biologisch plausiblen 3-fach Interaktionen gefunden. Um Effekt-Differenzen für seltene 
Varianten oder plausible 3-fach Interaktionen detektieren zu können, werden noch größere 
Stichprobenumfänge gebraucht.  
 Zwei leistungsfähige und einfach zu verwendende Software-Pakete namens EasyQC 
und EasyStrata wurden entwickelt, welche die Durchführung, Qualitätskontrolle und 
Auswertung von stratifizierten GWAMAs ermöglichen. Die Softwarepakete werden bereits 
von Analysten des GIANT-Konsortiums als auch von anderen genetischen 
Forschungskonsortien verwendet.   
 Zusammenfassend lässt sich sagen, dass die methodischen Ergebnisse, bestätigt 
durch die Anwendung auf Daten des GIANT Konsortiums, und die zur Verfügung gestellte 
Softwareimplementierung, die Durchführung zukünftiger stratifizierter GWAMA 
Auswertungen zum Detektieren von Gen-Subgruppen Interaktionen, unterstützen und 
anleiten können. Ein besseres Verständnis der subgruppen-spezifischen genetischen 
Effekten von Krankheiten und krankheits-relevanten Merkmalen wird letztendlich zu einem 
besseren Verständnis der Ursachen und Entstehung von Krankheiten beitragen.   
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9 Appendix 
9.1 Validation of simulated data sets used for evaluation of 
type 1 error of approaches involving two strata 
9.1.1 Validation of simulated data sets for 1-stage approaches 
Prior to investigating type 1 error of the various 1-stage approaches, the simulated data sets 
were validated (Appendix Table 1). For each SNP, the sex-specific data sets – simulated 
under 𝐻𝑜
𝑛𝑜𝑒𝑓𝑓𝑒𝑐𝑡
– were shown to reflect non-associated sex-specific data sets (False-positive 
rate < 5.02%). Likewise, for each SNP, the sex-specific data sets – simulated under 𝐻𝑜
𝑒𝑓𝑓𝑒𝑐𝑡
 – 
were shown to reflect true associated sex-specific data sets that imply an effect that can 
approximately be detected with 80% power (True-positive rate > 71.6%). Further, the 
simulated data was shown to truly reflect the two implied sex-difference null hypotheses 
𝐻𝑜
𝑛𝑜𝑒𝑓𝑓𝑒𝑐𝑡: 𝑏𝑀 = 𝑏𝑀 = 0 (no sex-difference, no sex-specific effect) and 𝐻𝑜
𝑒𝑓𝑓𝑒𝑐𝑡: 𝑏𝑀 = 𝑏𝑀 ≠ 0 
(no sex-difference, identical sex-specific effects). For each of the two implied null hypotheses 
and for each SNP, the type 1 error rate of the sex-difference test was estimated to be < 
5.01% (Appendix Table 1). Further, no inflation of sex-difference P-values could be 
observed in the QQ plots (Appendix Figure 1). Contrariwise to the fact that identification of 
sex-difference from unassociated sex-specific data (given by 𝐻𝑜
𝑛𝑜𝑒𝑓𝑓𝑒𝑐𝑡
) obviously is 
impossible, this suggests that significantly identified sex-difference automatically implies 
significant association in at least one of the sexes. 
 
 
Appendix Table 1. The table shows observed false-positive rates for the sex-specific data 
sets that were simulated under 𝐻𝑜
𝑛𝑜𝑒𝑓𝑓𝑒𝑐𝑡
 (no sex-specific effects), observed true-positive 
rates for the sex-specific data sets that were simulated under 𝐻𝑜
𝑒𝑓𝑓𝑒𝑐𝑡
 (with sex-specific 
effects), and type 1 error rates (T1ER) for the resulting sex-difference test.  
  𝑯𝒐
𝒏𝒐𝒆𝒇𝒇𝒆𝒄𝒕
 𝑯𝒐
𝒆𝒇𝒇𝒆𝒄𝒕
 
  False-Positive Rate T1ER True-Positive Rate T1ER 
SNP MAF Men Women Sexdiff Men Women Sexdiff 
rs6002481 0.02 5.00 5.02 5.01 71.6 82.0 5.00 
rs8138968 0.30 4.99 5.01 5.01 78.5 80.0 4.99 
rs6007738 0.50 5.01 5.02 5.01 79.3 79.3 4.98 
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Appendix Figure 1. QQ plots showing the distribution of 1,000,000 sex-difference P-Values 
that are based on 1,500 men and 1,500 women from the KORA study. The distributions are 
depicted for each of the three SNPs, rs6002481 (blue), rs8138968 (purple) and rs6007738 
(red) and for each of the two implied null hypotheses, A: 𝐻𝑜
𝑛𝑜𝑒𝑓𝑓𝑒𝑐𝑡
, and B: 𝐻𝑜
𝑒𝑓𝑓𝑒𝑐𝑡
. 
 
 
9.1.2 Validation of simulated data sets for 2-stage approaches 
Again, prior to investigating type 1 error of the 2-stage approaches, the simulated data sets 
were validated. The sex-specific data sets simulated under 𝐻𝑜
𝑛𝑜𝑒𝑓𝑓𝑒𝑐𝑡
 reflected true non-
associated sex-specific data sets: False-positive rates for the sex-specific association tests 
ranged from 4.99 to 5.08% across SNPs and stages. The sex-specific data sets simulated 
under 𝐻𝑜
𝑒𝑓𝑓𝑒𝑐𝑡
 reflected true associated sex-specific data sets that imply an effect that can 
approximately be detected with 80% power: True-positive rates for the sex-specific 
association tests ranged from 62.0 to 85.5% across SNPs and stages. Further, the simulated 
data was shown to truly reflect the implied sex-difference null hypotheses 𝐻𝑜
𝑛𝑜𝑒𝑓𝑓𝑒𝑐𝑡: 𝑏𝑀 =
𝑏𝑀 = 0 (no sex-difference, no sex-specific effect) or 𝐻𝑜
𝑒𝑓𝑓𝑒𝑐𝑡: 𝑏𝑀 = 𝑏𝑀 ≠ 0 (no sex-difference, 
identical sex-specific effects): Across stages, SNPs and null hypotheses, the type 1 error rate 
of the sex-difference test ranged from 4.97 to 5.09% and no inflation of sex-difference P-
values could be observed in the QQ plots (Appendix Figure 2). 
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Appendix Figure 2. QQ plots showing the distribution of 1,000,000 sex-difference P-Values, 
each based on 750 men and 750 women from the KORA study. The distributions are 
depicted for each SNP, rs6002481 (blue), rs8138968 (purple) and rs6007738 (red), for each 
stage, discovery (circles) and replication (squares) and for each of the two implied null 
hypotheses, A: 𝐻𝑜
𝑛𝑜𝑒𝑓𝑓𝑒𝑐𝑡
and B: 𝐻𝑜
𝑒𝑓𝑓𝑒𝑐𝑡
. 
 
 
9.2 Simulation-based inference of statistical dependence 
between filtering and difference tests  
Prior to computing power for the considered approaches, dependence of filtering steps and 
the difference test had to be inferred. This was important because formula (22) (to 
analytically calculate the power of an approach) can only just be applied if the implemented 
steps are independent.   
 Due to using identical or overlapping subjects, all multi-test 1- or combined 2-stage 
approaches (i.e., those that involve multiple statistical tests) require statistical independence 
of steps in order to calculate power analytically by formula (22). To evaluate this, statistical 
dependence of steps was inferred using the simulation-based data set from type 1 error 
evaluation. The simulated data sets (created under 𝐻𝑜
𝑛𝑜𝑒𝑓𝑓𝑒𝑐𝑡
) were filtered for nominal 
significant overall, stratified or joint association (1 = 0.05), and the distribution of difference 
P-Values for the remaining subset of SNPs was depicted in QQ plots (Appendix Figure 3).  
 Clearly, filtering for overall association did not affect the distribution of difference P-
Values. Thus, the overall association test can be considered as independent of the difference 
test and equation (22) can be employed to analytically calculate the power of approach 
[Overallα1→DiffαBonf] and of approach [[Overallα1]→DiffαBonf]. 
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 In contrast, filtering for stratified or joint association yielded an inflated distribution of 
difference P-Values. Thus, the stratified or the joint test association tests have to be 
considered as dependent of the difference test and equation (22) cannot be employed to 
calculate the power for the discovery stage of approaches [Strat𝛼1 ,Diff𝛼2]→[Diffαdiff]  and 
[Joint𝛼1 ,Diff𝛼2]→[Diffαdiff]. Power for the discovery stages of these approaches has to be 
estimated from simulated probability distributions (see Appendix 9.3 for details). 
 
 
 
Appendix Figure 3. Inference of statistical dependence between filtering and difference 
tests. Shown is the distribution of difference P-Values after filtering for nominal significant 
overall association (black), stratified association (orange) and joint association (green). The 
plots depict simulation results for the 1-stage approaches based on 𝐻𝑜
𝑛𝑜𝑒𝑓𝑓𝑒𝑐𝑡
and for SNP A: 
rs6002481 (MAF=0.02), B: rs8138969 (MAF=0.3), and C: rs6007738 (MAF=0.5). 
 
 
9.3 Simulation-based estimation of power for approaches 
with dependent discovery steps 
For the replication-based 2-stage approaches [Stratα1 , Diffα2] → [DiffαBonf]  and 
[Jointα1 , Diffα2] → [DiffαBonf]  that include discovery filtering steps on PStrat and PJoint, 
respectively, accompanied by a second discovery filtering step on PDiff, the power of the 
discovery stage needs to be calculated using simulated probability distributions. The reason 
for this is that the two discovery filtering steps are dependent. 
9.3.1 Estimation of discovery power for approach [𝐒𝐭𝐫𝐚𝐭𝛂𝟏 , 𝐃𝐢𝐟𝐟𝛂𝟐] →
[𝐃𝐢𝐟𝐟𝛂𝐛𝐨𝐧𝐟] 
The discovery power of approach [Stratα1 , Diffα2] → [DiffαBonf] (𝑃𝑤𝑟𝐷𝑖𝑠𝑐𝑜𝑣𝑒𝑟𝑦 = 𝑃𝑤𝑟𝑆𝑡𝑟𝑎𝑡∩𝐷𝑖𝑓𝑓) 
that set sets the two discovery steps into an AND relationship has to be estimated based on 
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simulated probability distributions. Here, n1 refers to the discovery sample size of stratum 1. 
The probability 𝑃𝑤𝑟𝑆𝑡𝑟𝑎𝑡∩𝐷𝑖𝑓𝑓 can be written as 
𝑃𝑤𝑟𝑆𝑡𝑟𝑎𝑡∩𝐷𝑖𝑓𝑓(𝛼1, 𝛼2, 𝑅1
2, 𝑅2
2, 𝑛1, 𝑓) =  𝑃 ({𝑇1 ≤ 𝑡𝑛1−2,
𝛼1/2
2
 ∪ 𝑇1 ≥ 𝑡𝑛1−2,1−
𝛼1/2
2
∪ 𝑇2 ≤ 𝑡𝑓𝑛1−2,
𝛼1/2
2
 ∪
𝑇2 ≥ 𝑡𝑓𝑛1−2,1−
𝛼1/2
2
} ∩ {𝑍𝐷𝑖𝑓𝑓 ≤ 𝑧𝛼2
2
∪ 𝑍𝐷𝑖𝑓𝑓 ≥ 𝑧1−𝛼2
2
}) =  
= 𝑃({(𝑇1
∗ ≤ 𝑡
𝑛1−2,
𝛼1/2
2
− 𝑘𝑡(𝑅1
2, 𝑛1)) ∪ (𝑇1
∗ ≥ 𝑡
𝑛1−2,1−
𝛼1/2
2
− 𝑘𝑡(𝑅1
2, 𝑛1))
∪ (𝑇2
∗ ≤ 𝑡
𝑓𝑛1−2,
𝛼1/2
2
− 𝑘𝑡(𝑅2
2, 𝑓𝑛1)) ∪ (𝑇2
∗ ≥ 𝑡
𝑓𝑛1−2,1−
𝛼1/2
2
− 𝑘𝑡(𝑅2
2, 𝑓𝑛1))}
∩ {(𝑍𝑑𝑖𝑓𝑓
∗ ≤ 𝑧𝛼2
2
− 𝑘𝑑𝑖𝑓𝑓(𝑅1
2, 𝑅2
2, 𝑛1, 𝑓)) ∪ (𝑍𝑑𝑖𝑓𝑓
∗ ≥ 𝑧
1−
𝛼2
2
− 𝑘𝑑𝑖𝑓𝑓(𝑅1
2, 𝑅2
2, 𝑛1, 𝑓))}) 
(43) 
 where – under the alternative hypothesis – the stratum-specific t statistics 𝑇𝑖
∗~t𝑛𝑖−2 (i = 1,2, 
i.e., the two strata) follow a t distribution with ni-2 df, and 𝑍𝑑𝑖𝑓𝑓
∗ ~N(0,1) follows a standard 
normal distribution. To account for the multiple testing of two strata, the stratum-specific -
levels are corrected for two tests. The constants kt and kdiff can be calculated from the given 
stratum-specific explained variances  𝑅𝑖
2 as follows: 
𝑘𝑡(𝑅𝑖
2, 𝑛𝑖) = √𝑛𝑖𝑅𝑖
2/(1 − 𝑅𝑖
2) (44) 
𝑘𝑑𝑖𝑓𝑓(𝑅1
2, 𝑅2
2, 𝑛1, 𝑓) = √𝑛1
|𝑅1| − |𝑅2|
√1 − 𝑅1
2 +
1
𝑓 (1 − 𝑅2
2)
 (45). 
The probability of the intersection is estimated from 100,000 simulated data points for 𝑇1
∗, 𝑇2
∗ 
and 𝑍𝑑𝑖𝑓𝑓
∗  for which the distribution parameters and thresholds are known or inferred from the 
given values. 
9.3.2 Estimation of discovery power for approach [𝐉𝐨𝐢𝐧𝐭𝛂𝟏 , 𝐃𝐢𝐟𝐟𝛂𝟐] →
[𝐃𝐢𝐟𝐟𝛂𝐛𝐨𝐧𝐟] 
The discovery power of approach [Jointα1 , Diffα2] → [DiffαBonf] (𝑃𝑤𝑟𝐷𝑖𝑠𝑐𝑜𝑣𝑒𝑟𝑦 = 𝑃𝑤𝑟𝐽𝑜𝑖𝑛𝑡∩𝐷𝑖𝑓𝑓) 
that set sets the two discovery steps into an AND relationship has to be estimated based on 
simulated probability distributions. Here, n1 refers to the stratum 1 sample size of the 
discovery stage. The probability 𝑃𝑤𝑟𝐽𝑜𝑖𝑛𝑡∩𝐷𝑖𝑓𝑓 can be written as 
𝑃𝑤𝑟𝐽𝑜𝑖𝑛𝑡∩𝐷𝑖𝑓𝑓(𝛼1, 𝛼2, 𝑅1
2, 𝑅2
2, 𝑛1, 𝑓) = 
= 𝑃 ({𝐶𝐽𝑜𝑖𝑛𝑡 ≥ 𝜒2,1−𝛼1} ∩ {𝑍𝐷𝑖𝑓𝑓 ≤ 𝑧𝛼2
2
∪ 𝑍𝐷𝑖𝑓𝑓 ≥ 𝑧1−𝛼22
}) = 
(46) 
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=   𝑃 ({𝐶𝐽𝑜𝑖𝑛𝑡 ≥ 𝜒2,1−𝛼1}
∩ {(𝑍𝐷𝑖𝑓𝑓
∗ ≤ 𝑧𝛼2
2
− 𝑘𝑑𝑖𝑓𝑓(𝑅1
2, 𝑅2
2, 𝑛1, 𝑓))
∪ (𝑍𝐷𝑖𝑓𝑓
∗ ≥ 𝑧
1−
𝛼2
2
− 𝑘𝑑𝑖𝑓𝑓(𝑅1
2, 𝑅2
2, 𝑛1, 𝑓))}) 
 where – under the alternative hypothesis - 𝐶𝐽𝑜𝑖𝑛𝑡~Χ2,𝜆(𝑅12,𝑅22,𝑛1,𝑓)
2  follows a non-central chi-
squared distribution with 2 df and non-centrality parameter 𝜆 that can be estimated using 
formula (20), and 𝑍𝐷𝑖𝑓𝑓
∗ ~N(0,1) follows a standard normal distribution. Again, the constant kdiff 
can be calculated using equation (45). The probability of the intersection is estimated from 
100,000 simulated data points for 𝐶𝐽𝑜𝑖𝑛𝑡 and 𝑍𝐷𝑖𝑓𝑓
∗  for which the distribution parameters and 
thresholds are known or inferred from the given values.  
9.4 Validation of simulated data sets used for evaluation of 
type 1 error of age- and sex-stratified GWAMA 
approaches 
Prior to investigating type 1 error of the age- and sex-stratified GWAMA approaches, the 
simulated data sets were validated. Across SNPs and across implied null hypotheses, the 
type 1 error rate of the difference-of-difference test ranged from 4.99% to 5.05% and no 
inflation of difference-of-difference P-Values was observable in QQ plots (Appendix Figure 
4). Thus, the simulated data sets were considered to reflect real ‘difference-of-difference’ null 
data sets.  
 
 
Appendix Figure 4. QQ plots showing the distribution of 1,000,000 age- and sex-difference 
P-Values that are based on 750 younger men, 750 older men, 750 younger women and 750 
older women from the KORA study. The distributions are depicted for each SNP, rs6002481 
(blue), rs8138968 (purple) and rs6007738 (red) and for each of the three implied null 
hypotheses, A: 𝐻𝑜
𝑛𝑜𝑒𝑓𝑓𝑒𝑐𝑡
, B: 𝐻𝑜
𝑒𝑓𝑓𝑒𝑐𝑡
and C: 𝐻𝑜
𝑠𝑒𝑥𝑑𝑖𝑓𝑓
. 
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9.5 Simulation-based inference of statistical dependence 
between steps for the age- and sex-stratified GWAMA 
approaches 
Prior to computing power for the validated approaches, dependence of filtering steps 
(marginal difference , marginal stratified, marginal joint and overall test) and the difference 
test had to be inferred. This was important because formula (22) (to analytically calculate the 
power of an approach) can only just be applied if the implemented steps are independent. 
In addition, to calculate power of a marginal test, independence of the respective sex- 
and age-version is required. Each marginal test is a combination of an age- and a sex-
version and the power formulae of the marginal tests include an intersection of the age- and 
sex-version, which again can only be multiplicatively calculated if  the age- and sex-versions 
of the test are independent. 
9.5.1 Dependence between filtering and difference-of-difference tests 
Due to using identical subjects, all validated approaches ( [Overallα1→DiffDiffαDiffDiff] , 
[MarDiffα1→DiffDiffαDiffDiff], [MarStratα1→DiffDiffαDiffDiff] and [MarJointα1→DiffDiffαDiffDiff]) require 
statistical independence of steps in order to calculate power analytically by formula (22). To 
evaluate this, statistical dependence of steps was inferred using the simulation-based data 
set from type 1 error evaluation. The simulated data sets (created under 𝐻𝑜
𝑛𝑜𝑒𝑓𝑓𝑒𝑐𝑡
) were 
filtered for nominal significant overall, marginal difference, marginal stratified, or marginal 
joint association (1 = 0.05), and the distribution of difference-of-difference P-Values for the 
remaining subset of SNPs was depicted in QQ plots (Appendix Figure 5).  
Clearly, none of the four filtering tests did affect the distribution of difference-of-
difference P-Values. Thus, filtering on overall association, marginal difference, marginal 
stratified or marginal joint association can be considered as independent of the difference-of-
difference test and equation (22) can be employed to analytically calculate the power of the 
respective approach. 
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Appendix Figure 5. Inference of statistical dependence between validated filtering and 
difference-of-difference tests. Shown is the distribution of difference-of-difference P-Values 
after filtering for nominal significant overall association (black), marginal difference (purple), 
marginal stratified association (orange) and marginal joint association (green). The plots 
depict simulation results based on H0-noeffect and for SNP A: rs6002481 (MAF=0.02), B: 
rs8138969 (MAF=0.3), and C: rs6007738 (MAF=0.5). 
 
 
9.5.2 Dependence between marginal age- and marginal sex-tests 
Next, dependence of the marginal age- and sex-tests was evaluated for approaches 
[MarStratα1→DiffDiffαDiffDiff], [MarDiffα1→DiffDiffαDiffDiff] and [MarJointα1→DiffDiffαDiffDiff] . This is 
important because formula (22) can only just be applied - to analytically calculate power of 
step 1 - if the implemented step 1 tests are statistically independent. The simulated data from 
the type 1 error inference (for 𝐻𝑜
𝑛𝑜𝑒𝑓𝑓𝑒𝑐𝑡
and for rs8138968, MAF = 0.3) was used to evaluate 
dependence of tests. The distribution of marginal sex-tests was illustrated in dependence of 
marginal age-tests (Appendix Figure 6).  
Clearly, the marginal age-difference and the marginal sex-difference test were found 
to be statistically independent, i.e. filtering on age-difference cannot bias the distribution of 
the sex-difference. Thus, power of step 1 (the marginal difference test) can completely be 
analytically calculated using formula (22) for approach [MarDiffα1→DiffDiffαDiffDiff]. 
In contrast, the marginal age-stratified and the marginal sex-stratified test, as well the 
marginal age-joint and the marginal sex-joint test, were found to be statistically dependent., 
Thus, the power computation has to be supplied by simulated probability distributions for 
approaches [MarStratα1→DiffDiffαDiffDiff] and [MarJointα1→DiffDiffαDiffDiff] (see Appendix 9.6 for 
details).  
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Appendix Figure 6. Inference of statistical dependence between marginal age- and 
marginal sex-tests. A: Distribution of marginal PSexdiff with (red) and without (black) filtering for 
marginal PAgediff < 0.05; B: Distribution of marginal PSexstrat with (red) and without (black) 
filtering for marginal PAgestrat < 0.05; and C: Distribution of marginal PSexjoint with (red) and 
without (black) filtering for marginal PAgejoint < 0.05. 
 
 
9.6 Simulation-based estimation of power for age- and sex-
stratified GWAMA approaches that involve dependent 
statistical tests  
For the age- and sex-stratified GWAMA approaches [MarStratα1 → DiffDiffαDiffDiff]  and 
[MarJointα1 → DiffDiffαDiffDiff]  that include initial filtering steps on PMarStrat and PMarJoint, 
respectively, the power of the filtering step needs to be calculated using simulated probability 
distributions. The reason for this is that for both approaches, the filtering steps comprise a 
combination of two statistically dependent tests. 
9.6.1 Estimation of filtering power for approach [𝐌𝐚𝐫𝐒𝐭𝐫𝐚𝐭𝛂𝟏 →
𝐃𝐢𝐟𝐟𝐃𝐢𝐟𝐟𝛂𝐛𝐨𝐧𝐟] 
The filtering power of approach  [MarStratα1 → DiffDiffαBonf] 
( 𝑃𝑤𝑟𝑀𝑎𝑟𝑆𝑡𝑟𝑎𝑡 = 𝑃𝑤𝑟𝐴𝑔𝑒𝑠𝑡𝑟𝑎𝑡∪𝑆𝑒𝑥𝑠𝑡𝑟𝑎𝑡 = 𝑃𝑤𝑟𝐴𝑔𝑒𝑠𝑡𝑟𝑎𝑡 + 𝑃𝑤𝑟𝑆𝑒𝑥𝑠𝑡𝑟𝑎𝑡 − 𝑃𝑤𝑟𝐴𝑔𝑒𝑠𝑡𝑟𝑎𝑡∩𝑆𝑒𝑥𝑠𝑡𝑟𝑎𝑡 ) that 
sets the dependent marginal age-stratified and marginal sex-stratified tests into an OR 
relationship has to be supported by simulated probability distributions for the power of the 
intersection  𝑃𝑤𝑟𝐴𝑔𝑒𝑠𝑡𝑟𝑎𝑡∩𝑆𝑒𝑥𝑠𝑡𝑟𝑎𝑡 . The probability 𝑃𝑤𝑟𝐴𝑔𝑒𝑠𝑡𝑟𝑎𝑡∩𝑆𝑒𝑥𝑠𝑡𝑟𝑎𝑡  can be written in 
dependence of the stratum-specific sample size n, the -level and the stratum-specific 
explained variances as follows: 
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𝑃𝑤𝑟𝐴𝑔𝑒𝑠𝑡𝑟𝑎𝑡∩𝑆𝑒𝑥𝑠𝑡𝑟𝑎𝑡(𝛼, 𝑅𝑀≤50
2 , 𝑅𝐹≤50
2 , 𝑅𝑀>50
2 , 𝑅𝐹>50
2 , 𝑛) = 
𝑃 ({𝑇≤50 ≤ 𝑡2𝑛−2,𝛼 4⁄
2
 ∪ 𝑇≤50 ≥ 𝑡2𝑛−2,1−𝛼/4
2
∪ 𝑇>50 ≤ 𝑡2𝑛−2,𝛼/4
2
 ∪ 𝑇>50 ≥ 𝑡2𝑛−2,1−𝛼/4
2
)} ∩ {𝑇𝐹 ≤
𝑡
2𝑛−2,
𝛼 4⁄
2
 ∪ 𝑇𝐹 ≥ 𝑡2𝑛−2,1−𝛼/4
2
∪ 𝑇𝑀 ≤ 𝑡2𝑛−2,𝛼/4
2
 ∪ 𝑇𝑀 ≥ 𝑡2𝑛−2,1−𝛼/4
2
)}) =  
= 𝑃({(𝑇≤50
∗ ≤ 𝑡
2𝑛−2,
𝛼 4⁄
2
− 𝑘𝑡(𝑅𝑀≤50
2 , 𝑅𝐹≤50
2 , 𝑛)) ∪ (𝑇≤50
∗ ≥ 𝑡
2𝑛−2,1−
𝛼/4
2
− 𝑘𝑡(𝑅𝑀≤50
2 , 𝑅𝐹≤50
2 , 𝑛))
∪ (𝑇>50
∗ ≤ 𝑡
2𝑛−2,
𝛼 4⁄
2
− 𝑘𝑡(𝑅𝑀>50
2 , 𝑅𝐹>50
2 , 𝑛)) ∪ (𝑇>50
∗ ≥ 𝑡
2𝑛−2,1−
𝛼/4
2
− 𝑘𝑡(𝑅𝑀>50
2 , 𝑅𝐹>50
2 , 𝑛))}
∩ {(𝑇𝑀
∗ ≤ 𝑡
2𝑛−2,
𝛼 4⁄
2
− 𝑘𝑡(𝑅𝑀≤50
2 , 𝑅𝑀>50
2 , 𝑛)) ∪ (𝑇𝑀
∗ ≥ 𝑡
2𝑛−2,1−
𝛼/4
2
− 𝑘𝑡(𝑅𝑀≤50
2 , 𝑅𝑀>50
2 , 𝑛))
∪ (𝑇𝐹
∗ ≤ 𝑡
2𝑛−2,
𝛼 4⁄
2
− 𝑘𝑡(𝑅𝐹≤50
2 , 𝑅𝐹>50
2 , 𝑛)) ∪ (𝑇𝐹
∗ ≥ 𝑡
2𝑛−2,1−
𝛼/4
2
− 𝑘𝑡(𝑅𝐹≤50
2 , 𝑅𝐹>50
2 , 𝑛))}) 
(47). 
Assuming the alternative hypothesis, the marginal t statistics 𝑇𝑖
∗~t2𝑛−2 (i = ≤50, >50, M or F, 
i.e., the age- and sex-marginals) follow a t distribution with 2n-2 df. To account for the 
multiple testing of four marginal strata (younger, older, men, women), the -levels are 
corrected for four tests. The constants kt can be calculated from two stratum-specific 
explained variances  𝑅𝑖
2  each (e.g., for younger individual, from younger men and from 
younger women) and from the stratum-specific sample size n: 
𝑘𝑡(𝑅1
2, 𝑅2
2, 𝑛) = √𝑛 
∑
|𝑅𝑖|
(1 − 𝑅𝑖
2)
2
𝑖=1
√∑
1
(1 − 𝑅𝑖
2)
2
𝑖=1
 (48) 
The probability of the intersection is estimated from 100,000 simulated data points for 𝑇𝑖
∗, for 
which the distribution parameters and thresholds are known or inferred from the given 
values. 
9.6.2 Estimation of filtering power for approach [𝐌𝐚𝐫𝐉𝐨𝐢𝐧𝐭𝛂𝟏 →
𝐃𝐢𝐟𝐟𝐃𝐢𝐟𝐟𝛂𝐛𝐨𝐧𝐟] 
The filtering power of approach  [MarJointα1 → DiffDiffαBonf] 
( 𝑃𝑤𝑟𝑀𝑎𝑟𝐽𝑜𝑖𝑛𝑡 = 𝑃𝑤𝑟𝐴𝑔𝑒𝑗𝑜𝑖𝑛𝑡∪𝑆𝑒𝑥𝑗𝑜𝑖𝑛𝑡 = 𝑃𝑤𝑟𝐴𝑔𝑒𝑗𝑜𝑖𝑛𝑡 + 𝑃𝑤𝑟𝑆𝑒𝑥𝑗𝑜𝑖𝑛𝑡 − 𝑃𝑤𝑟𝐴𝑔𝑒𝑗𝑜𝑖𝑛𝑡∩𝑆𝑒𝑥𝑗𝑜𝑖𝑛𝑡 ) that 
sets the dependent marginal age-joint and marginal sex-joint tests into an OR relationship 
has to be supported by simulated probability distributions for the power of the 
intersection  𝑃𝑤𝑟𝐴𝑔𝑒𝑗𝑜𝑖𝑛𝑡∩𝑆𝑒𝑥𝑗𝑜𝑖𝑛𝑡 . The probability 𝑃𝑤𝑟𝐴𝑔𝑒𝑗𝑜𝑖𝑛𝑡∩𝑆𝑒𝑥𝑗𝑜𝑖𝑛𝑡  can be written in 
dependence of the stratum-specific sample size n, the -level and the stratum-specific 
explained variances as follows: 
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𝑃𝑤𝑟𝐴𝑔𝑒𝑗𝑜𝑖𝑛𝑡∩𝑆𝑒𝑥𝑗𝑜𝑖𝑛𝑡(𝛼, 𝑅𝑀≤50
2 , 𝑅𝐹≤50
2 , 𝑅𝑀>50
2 , 𝑅𝐹>50
2 , 𝑛) = 
= 𝑃 (𝐶𝐴𝑔𝑒𝑗𝑜𝑖𝑛𝑡 ≥ 𝜒2,1−𝛼2
∩ 𝐶𝑆𝑒𝑥𝑗𝑜𝑖𝑛𝑡 ≥ 𝜒2,1−𝛼2
) 
(49) 
, where – under the alternative hypothesis - 𝐶𝐴𝑔𝑒𝑗𝑜𝑖𝑛𝑡 and 𝐶𝑆𝑒𝑥𝑗𝑜𝑖𝑛𝑡 follow a non-central chi-
squared distribution with 2 df and non-centrality parameter 𝜆 that can be estimated using 
formula (20): 𝜆𝐴𝑔𝑒𝑗𝑜𝑖𝑛𝑡 = 𝜆((𝑅𝑀≤50
2 , 𝑅𝐹≤50
2 ), (𝑅𝑀>50
2 , 𝑅𝐹>50
2 ), 𝑛)  and 
𝜆𝑆𝑒𝑥𝑗𝑜𝑖𝑛𝑡 = 𝜆((𝑅𝑀≤50
2 , 𝑅𝑀>50
2 ), (𝑅𝐹≤50
2 , 𝑅𝐹>50
2 ), 𝑛). To account for the multiple testing of two 2-
way joint tests, the -levels are corrected for two tests. The probability of the intersection is 
estimated from 100,000 simulated data points for𝐶𝐴𝑔𝑒𝑗𝑜𝑖𝑛𝑡  and 𝐶𝑆𝑒𝑥𝑗𝑜𝑖𝑛𝑡 , for which the 
distribution parameters and thresholds are known or inferred from the given values. 
9.7 Example EasyStrata pipeline to evaluate sex-difference 
In the following, an example ecf-file pipeline (called sexdiff.ecf) to evaluate sex-stratified 
GWAMA results data is shown: 
 
############################################################################################## 
############################################################################################## 
#######################         Example EasyStrata ecf-pipeline        ####################### 
############################################################################################## 
## EasyStrata configuration parameters: 
 
DEFINE --pathOut /path2output/results 
 --acolIn SNP;A1;A2;EAF;BETA;SE;P 
 --acolInClasses character;character;character;numeric;numeric;numeric;numeric 
 
EASYIN --fileIn /path2input/GWAMA_result_Men.txt  
--fileInTag MEN 
 
EASYIN --fileIn /path2input/GWAMA_result_Women.txt  
--fileInTag WOMEN 
 
############################################################################################## 
## EasyStrata scripting interface: 
 
START EASYSTRATA 
 
## Merging the two input files: 
MERGEEASYIN --colInMarker SNP --blnMergeAll 0 
 
## Annotating results with Chr and Pos using a reference file 
MERGE --colInMarker SNP 
      --fileRef /path2reffile/reference_chr_pos.txt 
 --acolIn SNP;CHR;POS 
 --acolInClasses character;character;integer 
      --colRefMarker SNP 
      --blnInAll 1 
      --blnRefAll 0 
    
## Adjust allele directions in men to women 
ADJUSTALLELES --colInA1 A1.MEN  
--colInA2 A2.MEN 
  --colInFreq EAF.MEN 
  --colInBeta BETA.MEN 
  --colRefA1 A1.WOMEN 
  --colRefA2 A2.WOMEN 
 
## Perform difference test (yields sex-difference P-Values) 
CALCPDIFF --acolBETAs BETA.MEN;BETA.WOMEN 
  --acolSEs SE.MEN;SE.WOMEN 
   --colOutPdiff PSexdiff 
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## Create QQ plot showing men- and women-specific association P-Values 
##   as well as sex-difference P-Values  
QQPLOT --acolQQPlot P.MEN;P.WOMEN;PSexdiff 
        --astrColour blue;red;magenta 
 --numPvalOffset 0.05 
 
## Create a Miami-plot that contrasts men- and women-specific association P-Values 
MIAMIPLOT --colMIAMIPlotUp P.WOMEN 
           --colMIAMIPlotDown P.MEN 
   --colInChr CHR 
   --colInPos POS 
    --numPvalOffset 0.05 
 
## Create a Manhattan-plot od sex-difference P-Values     
MHPLOT --colMHPlot PSexdiff 
 --colInChr CHR 
 --colInPos POS 
 --numPvalOffset 0.05 
 
## Extract independent lead SNPs with genome-wide significant PSexdiff 
##   using a distance-based criterion d<500KB 
INDEP --rcdCriterion PSexdiff<5e-8 
      --colIndep PSexdiff 
      --colInChr CHR 
      --colInPos POS 
      --numPosLim 500000 
 
STOP EASYSTRATA 
############################################################################################## 
############################################################################################## 
############################################################################################## 
 
The pipeline assumes that each sex-stratified GWAMA result data set contains SNP-
specific results in rows and contains columns for the effect allele (column A1), other allele 
(column A2), the effect allele frequency (column EAF), the genetic effect (column BETA), 
with standard error (column SE), as well as the association P-value (column P).  
The pipeline consecutively 1) merges the men- and women-specific GWAMA results, 
2) adds chromosomal and base positions to each SNP using a reference mapping file, 3) 
adjusts allele directions between the men- and women-specific results, 4) performs a sex-
difference difference test for each SNP (yields sex-difference P-values for each SNP), 5) 
creates a QQ plot that simultaneously displays men- and women-specific association P-
Values as well as sex-difference P-Values for all SNPs genome-wide, 6) creates a Miami plot 
that contrast men- and women-specific association P-Values, 7) creates a Manhattan plot of 
sex-difference P-Values, and finally 8) extracts independent lead-SNPs that display genome-
wide significant sex-difference.  
 To start the pipeline the pipeline is called from the R command line by the EasyStrata 
R function: > EasyStrata(“/path2ecffile/sexdiff.ecf”). 
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9.8 Extended features and applicability of EasyStrata 
9.8.1 Extended applicability 
9.8.1.1 Dichotomous outcomes.  
In contrast to linear regression based stratified GWAMAs, stratified GWAMAs of dichotomous 
traits report stratum-specific, pooled odds ratio (OR) with respective confidence intervals for 
each SNP. Since stratum-specific effect sizes and standard errors – required by the 
statistical approaches implemented in EasyStrata – can be obtained from the OR and the 
confidence intervals using a log-transformation, the package is fully applicable to 
dichotomous traits GWAMAs.  
9.8.1.2 General GWAMA  
Except the functionality for between strata comparison, all implemented features are directly 
applicable for general GWAMA results. For example, for a single GWAMA result data set, 
EasyStrata can be used to i) extract significant results, e.g. by applying a multiple testing 
correction to the association P-Values and clumping significant SNPs into independent loci, 
and ii) to obtain standard graphical presentation of results, e.g., by creating Manhattan- and 
QQ-plots.  
9.8.1.3 Multiple phenotypes 
The features of the package to compare GWAMA results between multiple strata can readily 
be translated to comparing GWAMA results between multiple phenotypes. For example, 
plotting GWAMAs results on BMI and WHRadjBMI in a single QQ plot or contrasting the results 
in a Miami-plot may be useful to compare their association content generally or by locus.  
9.8.1.4 Interaction analyses  
Meta-analyses that are based on study-specific gene-environment interaction testing, i.e. 
GWAs including an interaction term in the regression model, typically include SNP-specific 
summary statistics for the SNP main effect, for the SNP x E interaction effect and for the joint 
(main + interaction) effect (Manning et al., 2011). Again, the general functionality of 
EasyStrata to extract significant results and to graphically present results can be applied to 
each of these tests. Some of the functionality to contrast stratum-specific results may be 
used to compare results between the different tests, e.g., to contrast main association P-
Values with the SNP x E interaction P-Values in a Miami- or QQ-plot.  
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9.8.1.5 Data handling 
 In addition to the specific functionality described, EasyStrata makes available a toolbox of 
functions for general data handling, data manipulation and data extraction (see Appendix 
Table 2 for an overview of general data handling functions). 
 
 
Appendix Table 2. Overview of EasyStrata’s general data handling functions. More details 
are shown in the EasyStrata manual that is accessible from www.genepi-
regensburg.de/software. 
 Function Name Functionality 
Column handling: ADDCOL Add column 
 EDITCOL Edit column values  
 GETCOLS Keep subset of columns 
 REMOVECOL Remove column 
 RENAMECOL Rename column 
 STRSPLITCOL Split string column 
Row handling: CLEAN Remove SNPs 
 CRITERION Extract SNPs 
 EXTRACTSNPS Extract subset of SNPs defined in a separate file 
 FILTER Filter SNPs 
Joins: EASYMERGE Join data from one separate external file per input 
 MERGE Join data from a single external file to each input 
 MERGEEASYIN Join data from all input files 
  
9.8.2 Extended statistical methods 
In addition to the implemented statistical tests to follow up stratified GWAMA results, 
EasyStrata provides functions to control for multiple testing of large numbers of SNPs and to 
control for potential population stratification problems: 
9.8.2.1 Multiple-testing correction  
The statistical tests from above are mostly applied to multiple SNPs, either to all SNPs 
genome-wide using a hypothesis free screening approach, e.g., to screen for SNPs with 
significant G x S effects genome-wide, or to a subset of follow-up SNPs, e.g., to follow-up a 
limited number of known trait-associated SNPs for potential G x S effects. In both cases the 
test-statistics need to be corrected for the multiple testing of numerous SNPs. EasyStrata’s 
BONFERRONI function allows correcting the calculated test statistics for the number of 
independent test using a conservative Bonferroni-correction (Johnson et al., 2010). 
Alternatively the function FDR offers a less conservative multiple-testing control using a 
False-Discovery-Rate (FDR) approach (Benjamini & Hochberg, 1995).  
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9.8.2.2 Genomic control correction   
A common problem in GWAs and GWAMAs is the inflation of test statistics due to population 
stratification. While there are several methods to control for population stratification on the 
study level, e.g. adjusting for principal components or correcting test-statistics by a study-
specific genomic-control inflation factor (single GC correction), the common approach in 
GWAMAs is to apply a second genomic-control correction to the meta-analyzed data set 
(double GC correction) (Devlin & Roeder, 1999). EasyStrata’s function GC facilitates 
genomic-control of the stratified GWAMA results.  
9.8.3 Extended graphical features  
In addition to the tailored functionality for between-strata comparison, further convenient 
graphical features are provided that are applicable not only to stratified but also to general 
GWAMA results. 
9.8.3.1 Locus annotation  
One of these additional graphical features is based on locus annotation. Particularly 
interesting loci, e.g. previously known or novel loci associated with the trait can be 
highlighted in Manhattan-or Miami-Plots or be omitted from QQ plots (Appendix Figure 7). 
For example, highlighting previously observed loci in a Manhattan plot allows the user to 
easily compare novel with previously identified associated loci and allows removing such loci 
from QQ plots, which is useful to visually examine the strength of the novel associations.  
 
 
 
Appendix Figure 7. QQ and Manhattan plot showing publically available GWAMA results for 
WHRadjBMI (Heid et al., 2010). The QQ plot displays all SNPs (black), all SNPs after exclusion 
of the locus previously reported by Lindgren and colleagues (Lindgren et al., 2009)(green) 
and after exclusion of loci identified by Heid and colleagues. The coloring in the Manhattan 
plot indicates loci identified by Lindgren (green) and Heid (orange).   
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9.8.3.2 Improved plotting speed  
Less significant, i.e. less interesting, SNPs can be excluded from QQ-, Manhattan- and 
Miami-plots, which can substantially improve plotting speed and thus reduce computational 
time (Appendix Figure 8). 
 
 
 
Appendix Figure 8. Improving plotting speed. QQ and Manhattan plots for the publically 
available GIANT GWAMA results on WHRadjBMI (Heid et al., 2010). A./B. QQ and Manhattan 
plots displaying all SNPs (computational times: 2min45sec and 3min13sec, respectively); 
C./D. QQ and Manhattan plot after exclusion of uninformative SNPs with P>0.05 
(computational time: 4sec for both). The plot is based on Supplementary Figure 5 from the 
EasyStrata manuscript (Winkler, Kutalik, et al., 2014). 
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9.8.3.3 Axes breaks  
Another helpful feature is the ability to break up the scale of the y-axis in Manhattan-, Miami- 
and QQ-plots. This is useful when the data set contains loci with very low association P-
Values, which would distort the scale of the y-axis and this limit the visibility of other 
associated loci (Appendix Figure 9). 
 
 
 
Appendix Figure 9. Plotting extreme P-values. QQ and Manhattan plots for the publically 
available GIANT GWAMA results on BMI (Speliotes et al., 2010). A./B. QQ and Manhattan 
plots using a constant scale; C./D. QQ and Manhattan plot with broken up y-axis scale at y = 
22 yielding two different scales. The break in the y-axis scale improves the visibility of less 
significant loci in the Manhattan plot which are squeezed together otherwise. The plot is 
based on Supplementary Figure 6 from the EasyStrata manuscript (Winkler, Kutalik, et al., 
2014). 
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9.8.3.4 Panel of plots  
To obtain a quick overview on numerous traits or analyses, QQ or scatter plots can 
automatically be displayed as panels of plots and stored into a single image file (Appendix 
Figure 10).  
 
 
 
Appendix Figure 10. Panel of QQ plots. This figure combines publically available sex-
stratified GIANT GWAMA results (Randall et al., 2013), displaying QQ plots (red: women, 
blue: men) for BMI, waist and hip circumferences and waist-hip ratio adjusted for BMI. The 
plot is based on Supplementary Figure 7 from the EasyStrata manuscript (Winkler, Kutalik, et 
al., 2014). 
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